# ::snt Deletion at ITPR1 Underlies Ataxia in Mice and Spinocerebellar Ataxia 15 in Humans .
# ::tok Deletion at ITPR1 Underlies Ataxia in Mice and Spinocerebellar Ataxia 15 in Humans .
# ::alignments 12-13|0.0.2 10-11|0.3 8-10|0.2.0.1+0.2.0.0+0.2.0+0.2 7-8|0 6-7|0.1 3-5|0.0.1.1+0.0.1.0+0.0.1+0.0 2-3|0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:44.519
(a / and 
      :location-of (t / thing 
            :location-of (d / deletion) 
            :name (n2 / name 
                  :op1 (u / Underlies) 
                  :op2 (a2 / Ataxia 
                        :mod (c / country 
                              :name (n3 / name 
                                    :op1 "ITPR1")))) 
            :quant-of (h / human)) 
      :op1 (m / mouse) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "Spinocerebellar" 
                  :op2 "Ataxia")) 
      :quant 15)

# ::snt We observed a severe autosomal recessive movement disorder in mice used within our laboratory .
# ::tok We observed a severe autosomal recessive movement disorder in mice used within our laboratory .
# ::alignments 13-14|0.0.0.1 12-13|0.0.0.1.0 10-11|0.0.0 9-10|0.0.0.0 7-8|0.1 6-7|0.1.0 5-6|0.1.0.0 4-5|0.1.0.1 3-4|0.1.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:45.368
(o / observe-01 
      :ARG0 (w2 / we 
            :ARG0-of (u / use-01 
                  :ARG1 (m / mouse) 
                  :location (l / laboratory 
                        :poss (w / we)))) 
      :ARG1 (d / disord 
            :ARG0-of (m2 / movement-07 
                  :ARG1 (r / recessive) 
                  :mod (a / autosomal)) 
            :mod (s / severe)))

# ::snt We pursued a series of experiments to define the genetic lesion underlying this disorder and to identify a cognate disease in humans with mutation at the same locus .
# ::tok We pursued a series of experiments to define the genetic lesion underlying this disorder and to identify a cognate disease in humans with mutation at the same locus .
# ::alignments 27-28|0.0.0.0.0.0.0.0.0 26-27|0.0.0.0.0.0.0.0.0.0 23-24|0.0.0.0.1.0.1 21-22|0.0.0.0.1.0.0.0 19-20|0.0.0.0.1.0.0 18-19|0.0.0.0.1.0.0.1 16-17|0.0.0.0.1.0 14-15|0.0.0.0.1 13-14|0 12-13|0.1 11-12|0.0 10-11|0.0.0 9-10|0.0.0.0.0.0.0.0.0.0.0 7-8|0.0.0.0 5-6|0.0.0.0.0.0.0.0 3-4|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:45.997
(d2 / disord 
      :ARG1-of (u / underlie-01 
            :ARG0 (l2 / lesion 
                  :ARG1-of (d3 / define-01 
                        :ARG0 (w / we 
                              :ARG0-of (p / pursue-01 
                                    :ARG1 (s2 / series 
                                          :quant-of (e / experiment-01 
                                                :ARG1 (l / locu 
                                                      :ARG1-of (s / same-01 
                                                            :ARG0 (g / gene))))))) 
                        :op1-of (a / and 
                              :op2 (i / identify-01 
                                    :ARG1 (d / disease 
                                          :location (h / human) 
                                          :mod (c / cognate)) 
                                    :manner (m / mutation)))))) 
      :mod (t / this))

# ::snt Through linkage and sequence analysis we show here that this disorder is caused by a homozygous in-frame 18-bp deletion in Itpr1 ( Itpr118/18 ) , encoding inositol 1,4,5-triphosphate receptor 1 .
# ::tok Through linkage and sequence analysis we show here that this disorder is caused by a homozygous in-frame 18-bp deletion in Itpr1 ( Itpr118/18 ) , encoding inositol 1,4,5-triphosphate receptor 1 .
# ::alignments 29-30|0.2.2.1 28-29|0.2.2.2.0 26-27|0.2.2.2.0.0 25-26|0.2.2.2 20-21|0.2.2.0.0.0+0.2.2.0.0+0.2.2.0 18-19|0.0 15-16|0.0.0 12-13|0 10-11|0.1 9-10|0.1.0 7-8|0.2.1 6-7|0.2 5-6|0.2.0 4-5|0.2.2 3-4|0.2.2.3.1 2-3|0.2.2.3 1-2|0.2.2.3.0 0-1|0.2.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:46.751
(c / cause-01 
      :ARG0 (d / deletion 
            :mod (h / homozygou)) 
      :ARG1 (d2 / disord 
            :mod (t / this)) 
      :ARG1-of (s / show-01 
            :ARG0 (w / we) 
            :location (h2 / here) 
            :manner (a / analyze-01 
                  :ARG0 (p / person 
                        :name (n / name 
                              :op1 "Itpr1")) 
                  :ARG1 1 
                  :ARG2 (e / encode-01 
                        :ARG1 (r / receptor 
                              :mod (i / inositol))) 
                  :op3-of (a2 / and 
                        :op1 (l / linkage) 
                        :op2 (s2 / sequence))) 
            :time (t2 / through)))

# ::snt A previously reported spontaneous Itpr1 mutation in mice causes a phenotype identical to that observed here .
# ::tok A previously reported spontaneous Itpr1 mutation in mice causes a phenotype identical to that observed here .
# ::alignments 15-16|0.1.0.1.0 14-15|0.1.0.1 11-12|0.1.0 10-11|0.1 8-9|0 7-8|0.1.0.0 5-6|0.0 4-5|0.0.1.0.0+0.0.1.0+0.0.1 3-4|0.0.2 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:46.918
(c / cause-01 
      :ARG0 (m2 / mutation 
            :ARG1-of (r / report-01 
                  :time (p3 / previous)) 
            :mod (p2 / person 
                  :name (n / name 
                        :op1 "Itpr1")) 
            :mod (s / spontaneous)) 
      :ARG1 (p / phenotype 
            :ARG2-of (i / identical-01 
                  :ARG1 (m / mouse) 
                  :ARG1-of (o / observe-01 
                        :location (h / here)))))

# ::snt In both models in-frame deletion within Itpr1 leads to a decrease in the normally high level of Itpr1 expression in cerebellar Purkinje cells .
# ::tok In both models in-frame deletion within Itpr1 leads to a decrease in the normally high level of Itpr1 expression in cerebellar Purkinje cells .
# ::alignments 22-23|0.2.0.1.1.0 21-22|0.2.0.1.1 20-21|0.2.0.1.1.0.0 18-19|0.2.0.1 15-16|0.2.0 14-15|0.2.0.0 13-14|0.2.0.0.0 10-11|0.2 7-8|0 6-7|0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 4-5|0.0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:47.317
(l2 / lead-03 
      :ARG0 (d2 / deletion) 
      :ARG1 (m / model 
            :mod (b / both)) 
      :ARG2 (d / decrease-01 
            :ARG0 (l / level 
                  :ARG1-of (h / high-02 
                        :ARG1-of (n / normal-02)) 
                  :mod (e / express-01 
                        :ARG0 (p2 / person 
                              :name (n2 / name 
                                    :op1 "Itpr1")) 
                        :ARG1 (p / purkinje 
                              :mod-of (c / cell 
                                    :mod (c2 / cerebellar)))))))

# ::snt Spinocerebellar ataxia 15 ( SCA15 ) , a human autosomal dominant disorder , maps to the genomic region containing ITPR1 ; however , to date no causal mutations had been identified .
# ::tok Spinocerebellar ataxia 15 ( SCA15 ) , a human autosomal dominant disorder , maps to the genomic region containing ITPR1 ; however , to date no causal mutations had been identified .
# ::alignments 30-31|0.0.1.1.1 27-28|0.0.1.1 26-27|0.0.1.1.3 25-26|0.0.1.1.1.1 24-25|0.0.1.1.2 20-21|0 18-19|0.0 17-18|0.0.0 13-14|0.0.0.0 11-12|0.0.1.0 10-11|0.0.1 9-10|0.0.1.0.0 8-9|0.0.1.0.0.0 2-3|0.0.1.1.0 0-2|0.0.1.1.1.0.0.1+0.0.1.1.1.0.0.0+0.0.1.1.1.0.0+0.0.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:48.445
(a / and 
      :ARG1-of (c2 / contain-01 
            :ARG0 (r / region 
                  :direction-of (m2 / map)) 
            :purpose (d3 / dominate-01 
                  :ARG1 (d2 / disord 
                        :mod (a2 / autosomal 
                              :mod (h / human))) 
                  :ARG1-of (m / mutate-01 
                        :ARG0 15 
                        :ARG1-of (i / identify-01 
                              :ARG0 (o / organization 
                                    :name (n / name 
                                          :op1 "Spinocerebellar" 
                                          :op2 "ataxia")) 
                              :polarity -) 
                        :ARG2 (d / date) 
                        :mod (c / causal)))))

# ::snt Because ataxia is a prominent feature in Itpr1 mutant mice , we performed a series of experiments to test the hypothesis that mutation at ITPR1 may be the cause of SCA15 .
# ::tok Because ataxia is a prominent feature in Itpr1 mutant mice , we performed a series of experiments to test the hypothesis that mutation at ITPR1 may be the cause of SCA15 .
# ::alignments 28-29|0 25-26|0.2 24-25|0.0.0.1.0+0.0.0.1+0.0.0 22-23|0.0 20-21|0.0.0.0.1.0.0.0.0 18-19|0.0.0.0.1.0.0.0 16-17|0.0.0.0 14-15|0.0.0.0.1 12-13|0.0.0.0.1.0 11-12|0.0.0.0.1.0.0 9-10|0.1.0 8-9|0.1 7-8|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 5-6|0.0.0.0.1.0.1.0.0 4-5|0.0.0.0.1.0.1.0 1-2|0.0.0.0.1.0.1.0.0.0 0-1|0.0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:50.880
(c / cause-01 
      :ARG0 (m / mutation 
            :location (c2 / country 
                  :ARG0-of (e / experiment-01 
                        :ARG1 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "Itpr1")) 
                        :quant (s / series 
                              :ARG1-of (p2 / perform-02 
                                    :ARG0 (w / we 
                                          :ARG0-of (t / test-01 
                                                :ARG1 (h / hypothesi))) 
                                    :ARG1-of (c3 / cause-01 
                                          :ARG0 (p3 / prominent 
                                                :mod-of (f / feature 
                                                      :domain (a / ataxia))))))) 
                  :name (n / name 
                        :op1 "ITPR1"))) 
      :ARG1 (m3 / mutant 
            :mod-of (m2 / mouse)) 
      :ARG1-of (p / possible-01))

# ::snt We show here that heterozygous deletion of the 5  part of the ITPR1 gene , encompassing exons 1 -- 10 , 1 -- 40 , and 1 -- 44 in three studied families , underlies SCA15 in humans .
# ::tok We show here that heterozygous deletion of the 5  part of the ITPR1 gene , encompassing exons 1 -- 10 , 1 -- 40 , and 1 -- 44 in three studied families , underlies SCA15 in humans .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:50.883
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt We have identified a spontaneous in-frame deletion mutation in the gene Itpr1 that causes a recessive movement disorder in mice .
# ::tok We have identified a spontaneous in-frame deletion mutation in the gene Itpr1 that causes a recessive movement disorder in mice .
# ::alignments 19-20|0 17-18|0.0 16-17|0.0.0 15-16|0.0.0.0 13-14|0.0.1 11-12|0.0.1.0.1.0+0.0.1.0.1+0.0.1.0 10-11|0.0.1.0.0 7-8|0.0.0.1.1 6-7|0.0.0.1.1.0 4-5|0.0.0.1.1.1 2-3|0.0.0.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:51.426
(m / mouse 
      :location-of (d / disord 
            :ARG0-of (m2 / movement-07 
                  :ARG1 (r / recessive) 
                  :purpose (i / identify-01 
                        :ARG0 (w / we) 
                        :ARG1 (m3 / mutation 
                              :mod (d2 / deletion) 
                              :mod (s / spontaneous)))) 
            :ARG1-of (c / cause-01 
                  :ARG0 (p / person 
                        :mod (g / gene) 
                        :name (n / name 
                              :op1 "Itpr1")))))

# ::snt In an attempt to define whether any similar disease occurs in humans we performed a literature search for diseases linked to the human chromosomal region containing ITPR1 .
# ::tok In an attempt to define whether any similar disease occurs in humans we performed a literature search for diseases linked to the human chromosomal region containing ITPR1 .
# ::alignments 26-27|0.1.0.0+0.1.0+0.1 25-26|0 24-25|0.0 23-24|0.0.0.0.0.0.1.0 22-23|0.0.0.0.0.0.1.0.0 19-20|0.0.0 18-19|0.0.0.0 16-17|0.0.0.0.0.0.1 15-16|0.0.0.0.0.0.1.1 13-14|0.0.0.0.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.1 9-10|0.0.0.0.0.0.0.0.0 8-9|0.0.0.0.0.0.0.0.0.0 7-8|0.0.0.0.0.0.0.0.0.0.0 6-7|0.0.0.0.0.0.0.0.0.0.1 4-5|0.0.0.0.0.0.0.0 2-3|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:52.143
(c2 / contain-01 
      :ARG0 (r / region 
            :ARG2-of (l / link-01 
                  :ARG1 (d / disease 
                        :ARG2-of (p / perform-02 
                              :ARG0 (w / we 
                                    :ARG0-of (a2 / attempt-01 
                                          :ARG1 (d3 / define-01 
                                                :ARG1 (o / occur-01 
                                                      :ARG1 (d2 / disease 
                                                            :ARG1-of (r2 / resemble-01) 
                                                            :mod (a / any))))) 
                                    :ARG0-of (s / search-01 
                                          :ARG1 (c3 / chromosomal 
                                                :mod (h / human)) 
                                          :medium (l2 / literature))) 
                              :ARG1 (h2 / human))))) 
      :ARG1 (c / country 
            :name (n / name 
                  :op1 "ITPR1")))

# ::snt We identified the disease spinocerebellar ataxia 15 as linked to this region .
# ::tok We identified the disease spinocerebellar ataxia 15 as linked to this region .
# ::alignments 11-12|0.0.0.1 10-11|0.0.0.1.0 8-9|0.0.0 6-7|0.0.0.0 5-6|0.1.1 4-5|0.1 3-4|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:52.315
(i / identify-01 
      :ARG0 (w / we 
            :ARG0-of (l / link-01 
                  :ARG1 15 
                  :ARG2 (r / region 
                        :mod (t / this)))) 
      :ARG1 (s / spinocerebellar 
            :mod (d / disease) 
            :mod (a / ataxia)))

# ::snt High-density genomic analysis of affected members from three families revealed that disease in these patients was caused by deletion of a large portion of the region containing ITPR1 .
# ::tok High-density genomic analysis of affected members from three families revealed that disease in these patients was caused by deletion of a large portion of the region containing ITPR1 .
# ::alignments 27-28|0.1.1.0+0.1.1+0.1 26-27|0 25-26|0.0 22-23|0.1.0.0.0.0.0.0.0 21-22|0.1.0.0.0.0.0.0.0.0 18-19|0.1.0.0.0.0.0.0 16-17|0.1.0.0.0.0.0 14-15|0.1.0.0.0.0.0.1.0.0.0+0.1.0.0.0.0.0.1.0.0+0.1.0.0.0.0.0.1.0 13-14|0.1.0.0.0.0.0.1.0.1 11-12|0.1.0.0.0.0.0.1 9-10|0.1.0.0.0.0 8-9|0.1.0.0.0.1 7-8|0.1.0.0.0.1.0 5-6|0.1.0.1+0.1.0+0.1.0.0 4-5|0.1.0.0.1 2-3|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:53.792
(c2 / contain-01 
      :ARG0 (r / region) 
      :ARG1 (c / country 
            :ARG1-of (h2 / have-org-role-91 
                  :ARG0 (p4 / person 
                        :ARG0-of (a2 / analyze-01 
                              :ARG0-of (r2 / reveal-01 
                                    :ARG1 (c3 / cause-01 
                                          :ARG0 (d / deletion 
                                                :poss (p / portion 
                                                      :mod (l / large))) 
                                          :ARG1 (d2 / disease 
                                                :location (p2 / person 
                                                      :ARG0-of (h / have-rel-role-91 
                                                            :ARG2 (p3 / patient)) 
                                                      :mod (t / this))))) 
                              :ARG1 (f / family 
                                    :quant 3)) 
                        :ARG1-of (a / affect-01)) 
                  :ARG2 (m / member)) 
            :name (n / name 
                  :op1 "ITPR1")))

# ::snt We show here that this mutation results in a dramatic reduction in ITPR1 in cells from these patients .
# ::tok We show here that this mutation results in a dramatic reduction in ITPR1 in cells from these patients .
# ::alignments 17-18|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 16-17|0.1.1.0.1 14-15|0.1.1.1 12-13|0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 10-11|0.1.1 9-10|0.1.1.3 6-7|0.1 5-6|0.1.0 4-5|0.1.0.0 2-3|0.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:54.158
(s / show-01 
      :ARG0 (w / we) 
      :ARG1 (r2 / result-01 
            :ARG1 (m / mutation 
                  :mod (t2 / this)) 
            :ARG2 (r / reduce-01 
                  :ARG0 (p / person 
                        :ARG0-of (h / have-rel-role-91 
                              :ARG2 (p2 / patient)) 
                        :mod (t / this)) 
                  :ARG1 (c / cell) 
                  :location (c2 / country 
                        :name (n / name 
                              :op1 "ITPR1")) 
                  :manner (d / dramatic))) 
      :location (h2 / here))

# ::snt These data show convincingly that ITPR1 deletion underlies spinocerebellar ataxia 15 in humans .
# ::tok These data show convincingly that ITPR1 deletion underlies spinocerebellar ataxia 15 in humans .
# ::alignments 12-13|0.1.3 10-11|0.1.2.0 9-10|0.1.1 8-9|0.1.1.0 7-8|0.1 6-7|0.1.0 5-6|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 3-4|0.1.2 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:55.007
(s2 / show-01 
      :ARG0 (d2 / data 
            :mod (t / this)) 
      :ARG1 (u / underlie-01 
            :ARG0 (d / deletion 
                  :mod (c / country 
                        :name (n / name 
                              :op1 "ITPR1"))) 
            :ARG1 (a / ataxia 
                  :mod (s / spinocerebellar)) 
            :ARG1-of (c2 / convince-01 
                  :ARG0 15) 
            :location (h / human)))

# ::snt The use of forward genetics to define novel loci of interest in human disease has become increasingly viable with the implementation of large-scale mutagenesis programs .
# ::tok The use of forward genetics to define novel loci of interest in human disease has become increasingly viable with the implementation of large-scale mutagenesis programs .
# ::alignments 24-25|0.2.0 23-24|0.3 22-23|0.2.0.0 20-21|0.2 17-18|0.1 16-17|0.1.0 15-16|0 13-14|0.0.1.0.0.0 12-13|0.0.1.0.0.0.0 10-11|0.0.1.0.0 8-9|0.0.1.0 7-8|0.0.1.0.1 6-7|0.0.1 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:55.373
(b / become-01 
      :ARG1 (u / use-01 
            :ARG1 (g / genetic 
                  :mod (f / forward)) 
            :ARG2 (d2 / define-01 
                  :ARG1 (l2 / locus 
                        :ARG2-of (i3 / interest-01 
                              :ARG1 (d / disease 
                                    :mod (h / human))) 
                        :mod (n / novel)))) 
      :ARG2 (v / viable 
            :ARG1-of (i2 / increase-01)) 
      :time (i / implement-01 
            :ARG1 (p / program 
                  :mod (l / large-scale))) 
      :topic (m / mutagenesi))

# ::snt Prior to these initiatives this work was carried out in part by the investigation of spontaneous mutations that cause disorders in mouse breeding colonies .
# ::tok Prior to these initiatives this work was carried out in part by the investigation of spontaneous mutations that cause disorders in mouse breeding colonies .
# ::alignments 23-24|0.0.0 22-23|0.0 21-22|0 19-20|0.0.0.0.1 18-19|0.0.0.0 16-17|0.0.0.0.0 15-16|0.0.0.0.0.2 13-14|0.0.0.0.0.1 7-8|0.0.0.0.0.1.0 5-6|0.0.0.0.0.1.0.0 4-5|0.0.0.0.0.1.0.0.0 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:55.587
(m / mouse 
      :ARG1-of (b / breed-01 
            :ARG0 (c / colony 
                  :location-of (c2 / cause-01 
                        :ARG0 (m2 / mutate-01 
                              :ARG1 (i2 / initiative 
                                    :domain (t2 / this) 
                                    :op1-of (p / prior)) 
                              :ARG1-of (i / investigate-01 
                                    :ARG0-of (c3 / carry-out-03 
                                          :ARG1 (w / work-01 
                                                :mod (t / this)))) 
                              :mod (s / spontaneous)) 
                        :ARG1 (d / disorder)))))

# ::snt Careful observation of these serendipitous events has led to the establishment and study of many in vivo disease models [ 3 ] .
# ::tok Careful observation of these serendipitous events has led to the establishment and study of many in vivo disease models [ 3 ] .
# ::alignments 20-21|0.0.0.1 18-19|0.1.0.0 17-18|0.1.0 14-15|0.0.0.0.0.0 12-13|0.1 11-12|0 10-11|0.0 7-8|0.0.0 5-6|0.0.0.0.1 4-5|0.0.0.0.1.1 3-4|0.0.0.0.1.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:55.731
(a / and 
      :op1 (e / establish-01 
            :ARG2-of (l / lead-02 
                  :ARG0 (o / observation 
                        :ARG1-of (c / care-04 
                              :ARG0 (m2 / many)) 
                        :poss (e2 / event 
                              :mod (t / this) 
                              :mod (s2 / serendipitou))) 
                  :ARG1 3)) 
      :op2 (s / study-01 
            :ARG1 (d / disease 
                  :mod-of (m / model))))

# ::snt During the generation of a knockout line of mice we noted an early movement disorder that was inherited independently of targeting vector transmission .
# ::tok During the generation of a knockout line of mice we noted an early movement disorder that was inherited independently of targeting vector transmission .
# ::alignments 22-23|0.1.1.0.0 21-22|0.1.1.0.0.0 20-21|0.1.1.0 18-19|0.1.1.0.1 17-18|0.1.1 14-15|0.1 13-14|0.1.0 12-13|0.1.0.0 10-11|0 9-10|0.0 8-9|0.2 6-7|0.3.0 5-6|0.3.0.0 2-3|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:56.245
(n / note-01 
      :ARG0 (w / we) 
      :ARG1 (d / disord 
            :ARG0-of (m / movement-07 
                  :ARG1 (e / early)) 
            :ARG1-of (i2 / inherit-01 
                  :ARG0 (t2 / target-01 
                        :ARG1 (t / transmission 
                              :mod (v / vector)) 
                        :ARG2-of (i / independent)))) 
      :ARG2 (m2 / mouse) 
      :time (g / generation 
            :consist-of (l / line 
                  :mod (k / knockout))))

# ::snt We embarked on a series of experiments to identify the genetic lesion underlying this movement disorder and to identify a cognate disease and corresponding mutation in humans .
# ::tok We embarked on a series of experiments to identify the genetic lesion underlying this movement disorder and to identify a cognate disease and corresponding mutation in humans .
# ::alignments 26-27|0.1.0.0.1.0.0.0.1 24-25|0.1.0.0.1.0.0.0 23-24|0.1.0.0.1.0.0.0.0 22-23|0.1.0.0.1.0.0 21-22|0.1.0.0.1.0.1 20-21|0.1.0.0.1.0.1.0 18-19|0.1.0.0.1.0 16-17|0.1.0.0.1 15-16|0.1.0.0.0.0.0 14-15|0.1.0.0.0.0.0.0 13-14|0.1.0.0.0.0.0.1 12-13|0.1.0.0.0.0 11-12|0.1.0.0.0 10-11|0.1.0.0.1.0.0.0.0.0 8-9|0.1.0.0 6-7|0.1.0 4-5|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:58.207
(e2 / embark-01 
      :ARG0 (w / we) 
      :ARG1 (s / series 
            :quant-of (e / experiment-01 
                  :ARG1 (i2 / identify-01 
                        :ARG1 (l / lesion 
                              :ARG0-of (u / underlie-01 
                                    :ARG1 (d2 / disord 
                                          :ARG0-of (m2 / movement-07) 
                                          :mod (t / this)))) 
                        :op1-of (a2 / and 
                              :op2 (i / identify-01 
                                    :ARG0 (a / and 
                                          :op1 (m / mutation 
                                                :ARG1-of (c / correspond-01 
                                                      :ARG0 (g / gene)) 
                                                :location (h / human))) 
                                    :ARG1 (d / disease 
                                          :mod (c2 / cognate))))))))

# ::snt Here we describe this effort and the discovery of deletion at the ITPR1 locus as a cause of this disorder in mice and of spinocerebellar ataxia 15 ( SCA15 ) in humans .
# ::tok Here we describe this effort and the discovery of deletion at the ITPR1 locus as a cause of this disorder in mice and of spinocerebellar ataxia 15 ( SCA15 ) in humans .
# ::alignments 31-32|0.2.0.0 26-27|0.2.1.1.0.0 25-26|0.2.3.0 24-25|0.2.3 22-23|0.0 21-22|0.1.0 19-20|0.1 18-19|0.1.1 16-17|0 13-14|0.0.0 9-10|0.2.1.1.0.1 7-8|0.2.1.1.0 5-6|0.2.1.1 4-5|0.2.1 3-4|0.2.1.0 2-3|0.2 1-2|0.2.0 0-1|0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:59.123
(c / cause-01 
      :ARG0 (a2 / and 
            :location-of (l / locu)) 
      :ARG1 (d / disord 
            :location (m / mouse) 
            :mod (t / this)) 
      :subevent (d4 / describe-01 
            :ARG0 (w / we 
                  :poss-of (h / human)) 
            :ARG1 (e / effort 
                  :mod (t2 / this) 
                  :op1-of (a3 / and 
                        :op2 (d3 / discover-01 
                              :ARG0 15 
                              :ARG1 (d2 / deletion)))) 
            :location (h2 / here) 
            :op1-of (s / spinocerebellar 
                  :mod-of (a / ataxia))))

# ::snt During the generation of a line of mice with knockout of the gene Park7 we noted an early movement disorder that was inherited independently of targeting vector transmission .
# ::tok During the generation of a line of mice with knockout of the gene Park7 we noted an early movement disorder that was inherited independently of targeting vector transmission .
# ::alignments 27-28|0.1.1.0.0 26-27|0.1.1.0.0.0 25-26|0.1.1.0 23-24|0.1.1.0.1 22-23|0.1.1 19-20|0.1 18-19|0.1.0 17-18|0.1.0.0 15-16|0 14-15|0.0 13-14|0.2 12-13|0.2.0 9-10|0.2.1 7-8|0.2.2 5-6|0.3.0 2-3|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:59.448
(n / note-01 
      :ARG0 (w / we) 
      :ARG1 (d / disord 
            :ARG0-of (m / movement-07 
                  :ARG1 (e / early)) 
            :ARG1-of (i2 / inherit-01 
                  :ARG0 (t2 / target-01 
                        :ARG1 (t / transmission 
                              :mod (v / vector)) 
                        :ARG2-of (i / independent)))) 
      :ARG2 (p / Park7 
            :mod (g / gene) 
            :poss-of (k / knockout) 
            :prep-with-of (m2 / mouse)) 
      :time (g2 / generation 
            :consist-of (l / line)))

# ::snt Our initial observations suggested the affected mice suffered from an apparently paroxysmal movement disorder , often induced by touch .
# ::tok Our initial observations suggested the affected mice suffered from an apparently paroxysmal movement disorder , often induced by touch .
# ::alignments 18-19|0.1.1.1.0 16-17|0.1.1.1 15-16|0.1.1.1.1 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1.1.0.0 10-11|0.1.1.0.0.0 7-8|0.1 6-7|0.1.0 5-6|0.1.0.0 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:59.585
(s2 / suggest-01 
      :ARG0 (o2 / observation 
            :mod (i2 / initial) 
            :poss (w / we)) 
      :ARG1 (s / suffer-01 
            :ARG0 (m2 / mouse 
                  :ARG1-of (a2 / affect-01)) 
            :ARG1 (d / disord 
                  :ARG0-of (m / movement-07 
                        :ARG1 (p / paroxysmal 
                              :mod (a / apparent))) 
                  :ARG1-of (i / induce-01 
                        :ARG0 (t / touch-01) 
                        :frequency (o / often)))))

# ::snt The abnormal movements occurred predominantly below the cervical level , and the disorder appeared progressive .
# ::tok The abnormal movements occurred predominantly below the cervical level , and the disorder appeared progressive .
# ::alignments 14-15|0.1.0 13-14|0.1 12-13|0.1.0.0 10-11|0 8-9|0.0.1 7-8|0.0.1.0 5-6|0.0.3 4-5|0.0.2 3-4|0.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:06:59.723
(a2 / and 
      :op1 (o / occur-01 
            :ARG1 (m / move-01 
                  :mod (a3 / abnormal)) 
            :manner (l / level 
                  :mod (c / cervical)) 
            :mod (p2 / predominant) 
            :time (b / below)) 
      :op2 (a / appear-01 
            :ARG1 (p / progressive-02 
                  :ARG1 (d / disord))))

# ::snt At initial examination , a human movement disorder specialist ( K. G.-H . )
# ::tok At initial examination , a human movement disorder specialist ( K. G.-H . )
# ::alignments 10-12|0.0.0.1.1.0.1+0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 8-9|0.0+0.0.0 7-8|0 6-7|0.0.0.1 5-6|0.0.0.1.0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:00.288
(d / disord 
      :ARG1-of (s / specialize-01 
            :ARG0 (p2 / person 
                  :ARG0-of (e / examine-01 
                        :time (i / initial)) 
                  :ARG0-of (m / movement-07 
                        :ARG1 (h / human) 
                        :ARG2 (p / person 
                              :name (n / name 
                                    :op1 "K." 
                                    :op2 "G.-H"))))))

# ::snt likened the disorder to episodic intermittent ataxia or kinesiogenic paroxysmal dystonia and predicted the involvement of an ion channel mutation in the etiology .
# ::tok likened the disorder to episodic intermittent ataxia or kinesiogenic paroxysmal dystonia and predicted the involvement of an ion channel mutation in the etiology .
# ::alignments 22-23|0.1.1.0.0 19-20|0.1.1.0 18-19|0.1.0 17-18|0.1.1.0.1 14-15|0.1.1 12-13|0.1 11-12|0 10-11|0.0.1.2.0 9-10|0.0.1.2.0.0 7-8|0.0.1.2 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0.1.1 2-3|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:01.104
(a / and 
      :op1 (l / liken-01 
            :ARG1 (d2 / disord) 
            :ARG2 (a2 / ataxia 
                  :mod (i3 / intermittent) 
                  :mod (e2 / episodic) 
                  :op1-of (o / or 
                        :op2 (d / dystonia 
                              :mod (p2 / paroxysmal))))) 
      :op2 (p / predict-01 
            :ARG0 (c / channel) 
            :ARG1 (i2 / involve-01 
                  :ARG1 (m / mutation 
                        :location (e / etiology) 
                        :mod (i / ion)))))

# ::snt Affected mice presented at approximately postnatal day 14 , and survival time without weaning was on average 4 wk after onset .
# ::tok Affected mice presented at approximately postnatal day 14 , and survival time without weaning was on average 4 wk after onset .
# ::alignments 20-21|0.3.0 19-20|0.3 17-18|0.1.0.0.0 16-17|0.1.0.0.1 13-14|0.0 11-12|0.2 10-11|0.2.0 9-10|0 7-8|0.2.0.0 6-7|0.1.2 5-6|0.1.1 4-5|0.1.1.0 2-3|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:01.381
(a3 / and 
      :ARG1-of (w / wean-01) 
      :op1 (p2 / present-01 
            :ARG0 (m / mouse 
                  :ARG1-of (a5 / affect-01 
                        :ARG0 4 
                        :ARG1-of (a2 / average-01))) 
            :ARG1 (p / postnatal 
                  :mod (a4 / approximately)) 
            :time (d / day)) 
      :op2 (t / time 
            :purpose (s / survive-01 
                  :ARG1 14)) 
      :time (a / after 
            :op1 (o / onset)))

# ::snt Breeding experiments suggested that the observed disorder was inherited in an autosomal recessive manner .
# ::tok Breeding experiments suggested that the observed disorder was inherited in an autosomal recessive manner .
# ::alignments 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1.1.1 8-9|0.1 6-7|0.1.0 5-6|0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:01.441
(s / suggest-01 
      :ARG0 (e / experiment-01 
            :ARG1-of (b / breed-01)) 
      :ARG1 (i / inherit-01 
            :ARG1 (d / disord 
                  :ARG1-of (o / observe-01)) 
            :ARG2 (m / manner 
                  :mod (r / recessive) 
                  :mod (a / autosomal))))

# ::snt To map the location of the disease-causing lesion , we performed genome-wide linkage analysis using strain-specific single nucleotide polymorphisms ( SNPs ) at 120 loci across the mouse genome .
# ::tok To map the location of the disease-causing lesion , we performed genome-wide linkage analysis using strain-specific single nucleotide polymorphisms ( SNPs ) at 120 loci across the mouse genome .
# ::alignments 28-29|0.0.0.1.0.0 27-28|0.0.0.1.0.0.0 25-26|0.0.0.1.0 24-25|0.0.0.1 23-24|0.0.0.1.1 20-21|0 18-19|0.0.0.0 17-18|0.0.0.0.1 16-17|0.0.0.0.0 14-15|0.0.0 13-14|0.0 12-13|0.0.2 10-11|0.0.1 9-10|0.0.1.0 7-8|0.0.1.0.0.0.0 6-7|0.0.1.0.0.0.0.0 3-4|0.0.1.0.0.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:01.913
(s / snp 
      :ARG1-of (a2 / analyze-01 
            :ARG0-of (u / use-01 
                  :ARG1 (p / polymorphism 
                        :ARG1-of (s2 / single-02) 
                        :mod (n / nucleotide)) 
                  :ARG2 (l / locus 
                        :location (a / across 
                              :op1 (g / genome 
                                    :mod (m / mouse))) 
                        :quant 120)) 
            :ARG1-of (p2 / perform-02 
                  :ARG0 (w / we 
                        :ARG0-of (m2 / map-01 
                              :ARG1 (l4 / location 
                                    :location-of (l3 / lesion 
                                          :mod (d / disease-caus)))))) 
            :manner (l2 / linkage)))

# ::snt Analysis of these data showed a single genomic region with significant linkage to disease , providing a two-point LOD score of 5.13 at marker 20 .
# ::tok Analysis of these data showed a single genomic region with significant linkage to disease , providing a two-point LOD score of 5.13 at marker 20 .
# ::alignments 24-25|0.2.0.0 23-24|0.1.0.1 19-20|0.1.0.0 18-19|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 15-16|0.1.0 13-14|0.1.0.1.0 11-12|0.2 10-11|0.2.0 8-9|0.1 6-7|0.1.1 4-5|0 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:02.618
(s4 / show-01 
      :ARG0 (a / analysi 
            :mod (d2 / data 
                  :mod (t / this))) 
      :ARG1 (r / region 
            :ARG0-of (p / provide-01 
                  :ARG1 (s / score-01 
                        :ARG1 (c / country 
                              :name (n / name 
                                    :op1 "LOD"))) 
                  :ARG2 (m / mark-01 
                        :ARG1 (d / disease))) 
            :ARG1-of (s3 / single-02)) 
      :ARG2 (l / linkage 
            :ARG1-of (s2 / significant-02 
                  :ARG0 20)))

# ::snt MMHAP85FLG2 on Chromosome 6qE1 .
# ::tok MMHAP85FLG2 on Chromosome 6qE1 .
# ::alignments 2-4|0.0.0.1+0.0.0.0+0.0.0+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:02.634
(m / MMHAP85FLG2 
      :topic (t / thing 
            :name (n / name 
                  :op1 (c / Chromosome) 
                  :op2 6qE1)))

# ::snt The linked haplotype suggested the mutation had occurred on the 129x1/SvJ background ( Figure S1 ) .
# ::tok The linked haplotype suggested the mutation had occurred on the 129x1/SvJ background ( Figure S1 ) .
# ::alignments 13-15|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 11-12|0.1.2 7-8|0.1 5-6|0.1.0 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:02.730
(s / suggest-01 
      :ARG0 (h / haplotype 
            :ARG1-of (l / link-01)) 
      :ARG1 (o / occur-01 
            :ARG0 (m / mutation) 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "Figure" 
                        :op2 "S1")) 
            :ARG2 (b / background)))

# ::snt Literature searches revealed that among disease lines mapped to 6qE1 , the spontaneous mutant opt mouse displays a strikingly similar presentation to that described here [ 1 ] .
# ::tok Literature searches revealed that among disease lines mapped to 6qE1 , the spontaneous mutant opt mouse displays a strikingly similar presentation to that described here [ 1 ] .
# ::alignments 26-27|0.0.0 24-25|0.1.1.0.0.0 23-24|0.1.1.0.0 20-21|0.1.1 19-20|0.1.1.0 18-19|0.1.1.0.1 16-17|0.1 15-16|0.1.0 14-15|0.1.0.0 13-14|0.1.0.0.0 12-13|0.1.0.1 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:03.023
(r2 / reveal-01 
      :ARG0 (s3 / search-01 
            :ARG0 1 
            :ARG1 (m3 / map-01 
                  :ARG1 (l / line 
                        :mod (d3 / disease))) 
            :mod (l2 / literature)) 
      :ARG1 (d2 / display-01 
            :ARG0 (m / mouse 
                  :ARG1-of (o / opt-01 
                        :ARG0 (m2 / mutant)) 
                  :mod (s2 / spontaneous)) 
            :ARG1 (p / presentation 
                  :ARG1-of (r / resemble-01 
                        :ARG1-of (d / describe-01 
                              :location (h / here)) 
                        :degree (s / strikingly)))))

# ::snt The underlying genetic lesion causing the opt phenotype is a homozygous in-frame deletion of exons 43 and 44 of the gene Itpr1 ( Itpr1opt/opt ) , encoding inositol 1,4,5-triphosphate receptor 1 ( Itpr1 ) .
# ::tok The underlying genetic lesion causing the opt phenotype is a homozygous in-frame deletion of exons 43 and 44 of the gene Itpr1 ( Itpr1opt/opt ) , encoding inositol 1,4,5-triphosphate receptor 1 ( Itpr1 ) .
# ::alignments 30-31|0.1.0.1 29-30|0.2.1.0.0 27-28|0.2.1.0.0.0 26-27|0.2.1.0 21-22|0.2.1.2.0+0.2.1.2+0.2.1 20-21|0.2.1.1 17-18|0.1.0.0 16-17|0.2 15-16|0.0.0.0 14-15|0.2.0.1 12-13|0.2.0 10-11|0.2.0.0 7-8|0.1 6-7|0.1.0 4-5|0 3-4|0.0 2-3|0.2.1.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:04.553
(c / cause-01 
      :ARG0 (l / lesion 
            :ARG1-of (u / underlie-01 
                  :ARG0 43)) 
      :ARG1 (p2 / phenotype 
            :ARG1-of (o / opt-01 
                  :ARG0 44 
                  :ARG2 1)) 
      :op1-of (a / and 
            :op2 (d / deletion 
                  :mod (h / homozygou) 
                  :mod (e2 / exon)) 
            :poss (p / person 
                  :ARG0-of (e / encode-01 
                        :ARG1 (r / receptor 
                              :mod (i / inositol)) 
                        :ARG2 (g2 / gene)) 
                  :mod (g / gene) 
                  :name (n / name 
                        :op1 "Itpr1"))))

# ::snt Sequencing of all exons and intron -- exon boundaries of Itpr1 in affected mice from the current study revealed a single mutation within Itpr1 : a novel in-frame deletion of 18 bp within exon 36 ( Itpr118/18 ) .
# ::tok Sequencing of all exons and intron -- exon boundaries of Itpr1 in affected mice from the current study revealed a single mutation within Itpr1 : a novel in-frame deletion of 18 bp within exon 36 ( Itpr118/18 ) .
# ::alignments 34-35|0.1.0.1.0.0 33-34|0.2 30-31|0.1.0.0.0.3.0.0 28-29|0.0.0 26-27|0.0 21-22|0.1.0.1 20-21|0.1.0.1.0 18-19|0.1.0 17-18|0.1.0.0.0.3.0 16-17|0.1.0.0.0.3.0.1 13-14|0.1 12-13|0 10-11|0.1.0.0.0.3.1.0+0.1.0.0.0.3.1+0.1.0.0.0.3 8-9|0.1.0.0.0.2 7-8|0.1.0.0.0.2.0 5-6|0.1.0.0.0.1 4-5|0.1.0.0.0 3-4|0.1.0.0.0.0 2-3|0.1.0.0.0.4 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:05.250
(a / affect-01 
      :ARG0 (n / novel 
            :mod-of (d / deletion)) 
      :ARG1 (m2 / mouse 
            :location-of (r / reveal-01 
                  :ARG0 (s3 / sequence 
                        :op1-of (a2 / and 
                              :op2 (e3 / exon) 
                              :op3 (i / intron) 
                              :op4 (b / boundary 
                                    :mod (e2 / exon)) 
                              :poss (p / person 
                                    :ARG0-of (s2 / study-01 
                                          :ARG1 18 
                                          :time (c / current)) 
                                    :name (n2 / name 
                                          :op1 "Itpr1")) 
                              :quant (a3 / all))) 
                  :ARG1 (m / mutation 
                        :ARG1-of (s / single-02 
                              :ARG0 36)))) 
      :ARG2 (e / exon))

# ::snt To confirm the pathogenicity of this mutation we crossed heterozygous mice from the current study ( Itpr1wt/18 ) with mice heterozygous for the opt mutation ( Itpr1wt/opt ) .
# ::tok To confirm the pathogenicity of this mutation we crossed heterozygous mice from the current study ( Itpr1wt/18 ) with mice heterozygous for the opt mutation ( Itpr1wt/opt ) .
# ::alignments 24-25|0.0.0.2.0.0 23-24|0.0.0.2.0 19-20|0.0.0.3 14-15|0.0.0.2 13-14|0.0.0.2.1 10-11|0.0.0.1 9-10|0.0.0.1.0 8-9|0.0.0 7-8|0.0.0.0 6-7|0.1 5-6|0.1.0 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:06.152
(p / pathogenicity 
      :ARG1-of (c3 / confirm-01 
            :manner (c2 / cross-02 
                  :ARG0 (w / we) 
                  :ARG1 (m3 / mouse 
                        :mod (h / heterozygou)) 
                  :ARG2 (s / study-01 
                        :ARG1 (o / opt-01 
                              :ARG1 (m / mutation)) 
                        :time (c / current)) 
                  :manner (m2 / mouse))) 
      :poss (m4 / mutation 
            :mod (t / this)))

# ::snt This resulted in two litters of mice with a total of four affected Itpr1opt/18 pups ( from a total of 15 ) with a phenotype indistinguishable from that of the Itpr118/18 and Itpr1opt/opt mice [ 1 ] .
# ::tok This resulted in two litters of mice with a total of four affected Itpr1opt/18 pups ( from a total of 15 ) with a phenotype indistinguishable from that of the Itpr118/18 and Itpr1opt/opt mice [ 1 ] .
# ::alignments 35-36|0.2.3.0 33-34|0.2.3.1.0 31-32|0.1 27-28|0.1.0.0 25-26|0.1.0 24-25|0.2.0 20-21|0.2.2.0 18-19|0.2.2 14-15|0.2.3 12-13|0.2.3.1 11-12|0.2.3.2.0 9-10|0.2.3.2 6-7|0.2.1 4-5|0.2 3-4|0.2.4 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:06.579
(r / result-01 
      :ARG0 (t4 / this) 
      :ARG1 (a / and 
            :op1 (i / indistinguishable 
                  :domain (t / that))) 
      :ARG2 (l / litter-01 
            :ARG0 (p / phenotype) 
            :ARG1 (m2 / mouse) 
            :ARG1-of (t2 / total-01 
                  :ARG2 15) 
            :ARG2 (p2 / pup-01 
                  :ARG0 1 
                  :ARG1-of (a2 / affect-01 
                        :ARG0 (m / mouse)) 
                  :ARG1-of (t3 / total-01 
                        :ARG2 4)) 
            :quant 2))

# ::snt Furthermore , this phenotype was similar , although less severe , to that described in a mouse line with targeted deletion of Itpr1 , where ataxia was described as a prominent feature [ 4 ] .
# ::tok Furthermore , this phenotype was similar , although less severe , to that described in a mouse line with targeted deletion of Itpr1 , where ataxia was described as a prominent feature [ 4 ] .
# ::alignments 33-34|0.1.1.0 31-32|0.1.0.1 30-31|0.1.0.1.0 27-28|0.1.0 25-26|0.1.0.0 22-23|0.1.2.0+0.1.2+0.1 20-21|0 19-20|0.0 17-18|0.1.1.2 16-17|0.1.1.2.0 13-14|0.1.1 12-13|0.1.1.1 9-10|0.1.1.1.0.0.0 8-9|0.1.1.1.0.0 5-6|0.1.1.1.0 3-4|0.1.1.1.0.1 2-3|0.1.1.1.0.1.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:06.902
(d2 / deletion 
      :ARG1-of (t / target-01 
            :ARG0 (f2 / furthermore)) 
      :poss (p2 / person 
            :ARG0-of (d / describe-01 
                  :ARG1 (a / ataxia) 
                  :ARG2 (f / feature 
                        :mod (p / prominent))) 
            :ARG2-of (d3 / describe-01 
                  :ARG0 4 
                  :ARG1 (t2 / that 
                        :ARG2-of (r / resemble-01 
                              :ARG0 (l2 / less 
                                    :degree-of (s / severe)) 
                              :ARG1 (p3 / phenotype 
                                    :mod (t3 / this)))) 
                  :manner (l / line 
                        :mod (m / mouse))) 
            :name (n / name 
                  :op1 "Itpr1")))

# ::snt As with the Itpr1opt/opt mice , where the deletion of exons 43 and 44 is also predicted to leave the translational reading frame unaffected , the in-frame Itpr118/18 deletion mutation results in markedly decreased levels of Itpr1 in cerebellar Purkinje cells .
# ::tok As with the Itpr1opt/opt mice , where the deletion of exons 43 and 44 is also predicted to leave the translational reading frame unaffected , the in-frame Itpr118/18 deletion mutation results in markedly decreased levels of Itpr1 in cerebellar Purkinje cells .
# ::alignments 40-41|0.1.1.0 39-40|0.1.1 38-39|0.1.1.0.0 36-37|0.1.1.0.1.2 34-35|0.1.1.0.1 33-34|0.1.1.0.1.0 32-33|0.1.1.0.1.0.1 30-31|0.1.1.0.1.1 29-30|0.1.1.0.1.1.1 28-29|0.1.1.0.1.1.1.0 23-24|0.2+0 22-23|0.0 21-22|0.0.0 20-21|0.0.1 18-19|0.1 16-17|0.1.2 15-16|0.1.2.2 13-14|0.1.1.0.1.1.0 12-13|0.1.2.1 11-12|0.1.1.0.1.0.0 10-11|0.1.0.0 8-9|0.1.0 4-5|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:07.681
(a / affect-01 
      :ARG1 (f / frame 
            :mod (r2 / read-01) 
            :mod (t / translational)) 
      :ARG1-of (l2 / leave-11 
            :ARG0 (d3 / deletion 
                  :mod (e / exon)) 
            :ARG2 (p / purkinje 
                  :mod-of (c / cell 
                        :mod (c2 / cerebellar) 
                        :source-of (l / level 
                              :ARG1-of (d / decrease-01 
                                    :ARG0 43 
                                    :degree (m / markedly)) 
                              :ARG2-of (r / result-01 
                                    :ARG0 44 
                                    :ARG1 (m2 / mutation 
                                          :mod (d2 / deletion))) 
                              :mod (i / Itpr1)))) 
            :ARG2-of (p2 / predict-01 
                  :ARG0 (m3 / mouse) 
                  :ARG1 (a3 / and) 
                  :mod (a2 / also))) 
      :polarity -)

# ::snt In these two spontaneous mutants [ 1 ] and in the Itpr1-deficient mouse [ 4 ] generated by gene targeting , decreased Itpr1 expression is associated with the same autosomal recessive movement disorder ( Figure 1 ) .
# ::tok In these two spontaneous mutants [ 1 ] and in the Itpr1-deficient mouse [ 4 ] generated by gene targeting , decreased Itpr1 expression is associated with the same autosomal recessive movement disorder ( Figure 1 ) .
# ::alignments 35-36|0.0.1.0.1.1.0 34-35|0.0.1.2 32-33|0.0.1.0.0.0 31-32|0.0.1.0.0 30-31|0.0.1.0.0.1 29-30|0.0.1.0.0.2 28-29|0.0.1.0.0.0.0 25-26|0.0.1.0 23-24|0.0.1.0.1 21-22|0.0.1.0.1.1 19-20|0.0.1.1.0.0 18-19|0.0.1.1.0 16-17|0.0.1.1 14-15|0.0.1.0.1.0 12-13|0 11-12|0.0.0.0+0.0.0+0.0 8-9|0.0.1 6-7|0.0.1.0.0.0.0.0 4-5|0.0.1.1.1 3-4|0.0.1.1.1.0 2-3|0.0.1.1.1.2 1-2|0.0.1.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:08.915
(m2 / mouse 
      :mod (c / country 
            :name (n / name 
                  :op1 "Itpr1-deficient") 
            :op1-of (a3 / and 
                  :ARG2-of (a2 / associate-01 
                        :ARG0 (m / movement-07 
                              :ARG0 (d / disord 
                                    :ARG1-of (s / same-01 
                                          :ARG0 1)) 
                              :ARG1 (r / recessive) 
                              :mod (a / autosomal)) 
                        :ARG1 (e / express-01 
                              :ARG1 4 
                              :ARG1-of (d2 / decrease-01 
                                    :ARG0 1))) 
                  :op2 (g2 / generate-01 
                        :ARG0 (g / gene 
                              :ARG1-of (t / target-01)) 
                        :ARG1 (m3 / mutant 
                              :mod (s2 / spontaneous) 
                              :mod (t2 / this) 
                              :quant 2)) 
                  :op3 (f / figure))))

# ::snt Given our interest in human neurological disease we sought to identify any cognate human disorders where linkage had been established to the syntenic region of the human genome , but where no causal mutation had been identified .
# ::tok Given our interest in human neurological disease we sought to identify any cognate human disorders where linkage had been established to the syntenic region of the human genome , but where no causal mutation had been identified .
# ::alignments 36-37|0.1 33-34|0.1.0 32-33|0.1.0.0 31-32|0.1.1 29-30|0 27-28|0.0.2.0 26-27|0.0.2.0.0 23-24|0.0.2 19-20|0.0 16-17|0.0.1 14-15|0.0.0 13-14|0.0.0.1 12-13|0.0.0.0.0.0.0.0 11-12|0.0.0.2 10-11|0.0.0.0 8-9|0.0.0.0.1 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0.0.2 5-6|0.0.0.0.0.0.0.2.0 4-5|0.0.0.0.0.0.0.2.1 2-3|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.1 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:09.928
(c2 / contrast-01 
      :ARG1 (e / establish-01 
            :ARG0 (d / disorder 
                  :ARG1-of (i2 / identify-01 
                        :ARG0 (w / we 
                              :ARG0-of (g2 / give-01 
                                    :ARG1 (i3 / interest-01 
                                          :ARG0 (c3 / cognate) 
                                          :ARG1 (w2 / we) 
                                          :ARG2 (d2 / disease 
                                                :mod (n / neurological) 
                                                :mod (h3 / human))))) 
                        :ARG1-of (s / seek-01 
                              :ARG0 w)) 
                  :mod (h2 / human) 
                  :mod (a / any)) 
            :ARG1 (l / linkage) 
            :ARG2 (r / region 
                  :mod (g / genome 
                        :mod (h / human)))) 
      :ARG2 (i / identify-01 
            :ARG1 (m / mutation 
                  :mod (c / causal)) 
            :polarity -))

# ::snt SCA15 , an adult-onset autosomal dominant progressive ataxia is linked to this locus [ 5 ] .
# ::tok SCA15 , an adult-onset autosomal dominant progressive ataxia is linked to this locus [ 5 ] .
# ::alignments 14-15|0.0 12-13|0.1 11-12|0.2.1.0 9-10|0.2.0 7-8|0.2 6-7|0 5-6|0.2.1 4-5|0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:09.994
(p / progressive-02 
      :ARG0 5 
      :ARG1 (l / locu) 
      :ARG2 (a / ataxia 
            :ARG1-of (l2 / link-01) 
            :ARG1-of (d / dominate-01 
                  :ARG0 (t / this)) 
            :mod (a2 / autosomal)))

# ::snt Although missense mutation of ITPR1 had previously been ruled out [ 2 ] and the mode of inheritance was inconsistent with that seen in the Itpr118 and Itpr1opt mice , the phenotypic presence of ataxia in the mice led us to reexamine this candidate gene as a possible cause of SCA15 .
# ::tok Although missense mutation of ITPR1 had previously been ruled out [ 2 ] and the mode of inheritance was inconsistent with that seen in the Itpr118 and Itpr1opt mice , the phenotypic presence of ataxia in the mice led us to reexamine this candidate gene as a possible cause of SCA15 .
# ::alignments 48-49|0.0.0.0.1.0.0.2 47-48|0.0.0.0.1.0.0.2.0 44-45|0.0.0.0.1.0.0.1 43-44|0.0.0.0.1.0.0.1.0 42-43|0.0.0.0.1.0.0.1.1 41-42|0.0.0.0.1.0.0 38-39|0.0.0.0.1.0 37-38|0.0.0.0.1.0.0.0 34-35|0.0.0.0.1.1.0.0 32-33|0.0.0.0.1.1.0 31-32|0.0.0.0.1.1.0.1 28-29|0.2 27-28|0.2.0 26-27|0 25-26|0.1.0.0+0.1.0+0.1 22-23|0.0 21-22|0.0.0 19-20|0.0.0.0.2+0.0.0.0 17-18|0.0.0.0.0.0 15-16|0.0.0.0.0 13-14|0.0.0.0.1 11-12|0.0.0.0.0.0.0 8-9|0.0.0.0.1.1 6-7|0.0.0.0.1.1.2 2-3|0.0.0.0.1.1.1 1-2|0.0.0.0.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:10.988
(a2 / and 
      :ARG0-of (s / see-01 
            :ARG1 (t2 / that 
                  :ARG2-of (c4 / consistent-01 
                        :ARG1 (m3 / mode 
                              :topic (i2 / inherit-01 
                                    :ARG1 2)) 
                        :op2-of (a3 / and 
                              :ARG0-of (l / lead-02 
                                    :ARG1 (r / reexamine-01 
                                          :ARG0 (m / mouse) 
                                          :ARG1 (g / gene 
                                                :mod (c2 / candidate) 
                                                :mod (t / this)) 
                                          :ARG1-of (c / cause-01 
                                                :ARG1-of (p / possible-01)))) 
                              :op1 (r2 / rule-03 
                                    :ARG0 (p2 / presence 
                                          :mod (a / ataxia) 
                                          :mod (p3 / phenotypic)) 
                                    :ARG1 (m4 / mutation 
                                          :mod (m5 / missense)) 
                                    :time (p4 / previous))) 
                        :polarity -))) 
      :op1 (c3 / country 
            :name (n / name 
                  :op1 "Itpr118")) 
      :op2 (m2 / mouse 
            :mod (i / Itpr1opt)))

# ::snt We obtained genomic DNA from three affected family members and one family member with unknown disease status from the kindred originally used to define and map SCA15 ( family AUS1 , of Australian Anglo-Celtic origin ) [ 2 ] .
# ::tok We obtained genomic DNA from three affected family members and one family member with unknown disease status from the kindred originally used to define and map SCA15 ( family AUS1 , of Australian Anglo-Celtic origin ) [ 2 ] .
# ::alignments 37-38|0.0.1.0.1.2.1.0.1.0 34-35|0 32-33|0.1.1+0.1.0.0+0.1.0+0.1 29-30|0.2.0.0.0+0.2.0.0+0.2.0 28-29|0.2 26-27|0.0.1.0.1.2.1.0.1.1.1.0+0.0.1.0.1.2.1.0.1.1.1+0.0.1.0.1.2.1.0.1.1 25-26|0.0.1.0.1.2.1.0.1.1.0 24-25|0.0.1.0.1.2.1.0.1.1.2 23-24|0.0.1.0.1.2.1.0 21-22|0.0.1.0.1.2.1.0.1 20-21|0.0.1.0.1.2.1.0.1.2 19-20|0.0.1.0.1.2.1 16-17|0.0.1.0.1.2 15-16|0.0.1.0.1.2.0 14-15|0.0.1.0.1.2.0.0.0+0.0.1.0.1.2.0.0 12-13|0.0.1.0.1.1+0.0.1.0.1 11-12|0.0.1.0.1.0 9-10|0.0.1.0 8-9|0.0.0.1+0.0.0+0.0 7-8|0.0.0.0 6-7|0.0.1 5-6|0.0.1.0.1.2.1.0.0 3-4|0.0.1.0.0.1 1-2|0.0.1.0.0 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:13.274
(o / originate-01 
      :ARG1 (p / person 
            :ARG0-of (h2 / have-org-role-91 
                  :ARG1 (f3 / family) 
                  :ARG2 (m3 / member)) 
            :ARG1-of (a3 / affect-01 
                  :op2-of (a2 / and 
                        :op1 (o3 / obtain-01 
                              :ARG0 (w / we) 
                              :ARG1 (d3 / DNA)) 
                        :op3 (h / have-org-role-91 
                              :ARG1 (f2 / family) 
                              :ARG2 (m2 / member) 
                              :purpose (s / status 
                                    :mod (d2 / disease 
                                          :ARG1-of (k2 / know-01 
                                                :polarity -)) 
                                    :source (k / kindr 
                                          :ARG0-of (d / define-01 
                                                :ARG1 3 
                                                :ARG2-of (u / use-01 
                                                      :ARG0 2 
                                                      :ARG1 (t2 / thing 
                                                            :mod (m / map) 
                                                            :name (n3 / name 
                                                                  :op1 "SCA15") 
                                                            :op1-of (a / and)) 
                                                      :mod (o2 / original))))))))) 
      :ARG2 (c / country 
            :name (n / name 
                  :op1 "Australia") 
            :wiki "Australia") 
      :mod (f / family 
            :mod-of (t / thing 
                  :name (n2 / name 
                        :op1 "AUS1"))))

# ::snt We performed two experiments concurrently in three affected members of this family : sequence analysis of the coding exons of ITPR1 and high-density genome-wide SNP genotyping .
# ::tok We performed two experiments concurrently in three affected members of this family : sequence analysis of the coding exons of ITPR1 and high-density genome-wide SNP genotyping .
# ::alignments 25-26|0.2 24-25|0.2.0.1+0.2.0.0.0+0.2.0.0+0.2.0 21-22|0 20-21|0.1 18-19|0.3.1 17-18|0.3.1.0 14-15|0.3 13-14|0.3.0 11-12|0.0.0.0 10-11|0.0.0.0.0 8-9|0.0.0.1+0.0.0+0.0 7-8|0.0.2 6-7|0.0.3 4-5|0.0.1.0.1 3-4|0.0.1 2-3|0.0.1.1 1-2|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:14.389
(a / and 
      :op1 (p2 / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f / family 
                        :mod (t / this)) 
                  :ARG2 (m / member)) 
            :ARG1-of (e2 / experiment-01 
                  :ARG1-of (p3 / perform-02 
                        :ARG0 (w / we) 
                        :manner (c2 / concurrent)) 
                  :quant 2) 
            :ARG1-of (a3 / affect-01) 
            :quant 3) 
      :op2 (i / ITPR1) 
      :op3 (g / genotyp 
            :mod (p / political-party 
                  :name (n / name 
                        :op1 "SNP") 
                  :wiki "Scottish_National_Party")) 
      :subevent-of (a2 / analyze-01 
            :ARG0 (s / sequence) 
            :ARG1 (e / exon 
                  :ARG1-of (c / code-01))))

# ::snt Sequence analysis failed to show any coding alterations segregating with disease or any alterations that were inconsistent with Mendelian patterns of inheritance within the family .
# ::tok Sequence analysis failed to show any coding alterations segregating with disease or any alterations that were inconsistent with Mendelian patterns of inheritance within the family .
# ::alignments 24-25|0.2.0.0.1.0 21-22|0.2.0.0.1 19-20|0.2.0.0 18-19|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 16-17|0.2.0.1+0.2.0 13-14|0.2 12-13|0.2.1 11-12|0 10-11|0.1 8-9|0.0 7-8|0.0.0 6-7|0.0.0.1 5-6|0.0.0.2 4-5|0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:15.387
(o / or 
      :ARG2-of (s / segregate-01 
            :ARG1 (a3 / alteration 
                  :ARG1-of (s2 / show-01 
                        :ARG2-of (f2 / fail-01 
                              :ARG1 (a5 / analyze-01 
                                    :manner (s3 / sequence)))) 
                  :ARG1-of (c2 / code-01) 
                  :mod (a4 / any))) 
      :op1 (d / disease) 
      :op2 (a / alteration 
            :ARG1-of (c / consistent-01 
                  :ARG2 (p / pattern-01 
                        :ARG0 (t / thing 
                              :name (n / name 
                                    :op1 "Mendelian")) 
                        :ARG1 (i / inherit-01 
                              :ARG1 (f / family))) 
                  :polarity -) 
            :mod (a2 / any)))

# ::snt However , visualization of log R ratio and B allele frequency metrics from the genome-wide SNP genotyping experiments clearly showed data consistent with a heterozygous genomic deletion across the first one-third of ITPR1 and across the first half of a neighboring gene , SUMF1 ( Figure 2 ) .
# ::tok However , visualization of log R ratio and B allele frequency metrics from the genome-wide SNP genotyping experiments clearly showed data consistent with a heterozygous genomic deletion across the first one-third of ITPR1 and across the first half of a neighboring gene , SUMF1 ( Figure 2 ) .
# ::alignments 46-47|0.1.0.0.0.0.0.0.0.0 45-46|0.0.0.2 43-44|0.1.0.0.2.0.0+0.1.0.0.2.0+0.1.0.0.2 41-42|0.1.0.0.0.0.0.0 40-41|0.1.0.0.0.0.0.0.0 37-38|0.1.0.0.0.0.0 34-35|0.1.0.0.0.0 33-34|0.1.0.0.0 30-31|0.1.0.0.0.0.0.0.0.1.0 27-28|0.1.0.0.0.0.0.0.0.1 26-27|0.1.0.0 24-25|0.1.0.0.1 21-22|0.1.0 20-21|0.1 19-20|0 18-19|0.2 17-18|0.0.0.1.1 15-16|0.0.0.1.1.0.1+0.0.0.1.1.0.0.0+0.0.0.1.1.0.0+0.0.0.1.1.0 11-12|0.0.0.1 10-11|0.0.0.1.0 9-10|0.0.0.1.0.0 8-9|0.0.0.0.0.0.1+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.1 4-5|0.0.0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:16.600
(s / show-01 
      :ARG0 (v / visualization 
            :op1-of (a5 / and 
                  :op2 (r / ratio 
                        :ARG1-of (l2 / log-01 
                              :ARG0 (l / location 
                                    :name (n4 / name 
                                          :op1 "B") 
                                    :wiki -)) 
                        :op1 (r2 / r)) 
                  :op3 (m / metric 
                        :mod (f2 / frequency 
                              :mod (a4 / allele)) 
                        :mod (e / experiment-01 
                              :ARG1 (p2 / political-party 
                                    :name (n3 / name 
                                          :op1 "SNP") 
                                    :wiki "Scottish_National_Party"))) 
                  :op4 (f / figure))) 
      :ARG1 (d2 / data 
            :ARG1-of (c / consistent-01 
                  :ARG2 (d / deletion 
                        :location (a2 / and 
                              :op1 (a / across 
                                    :op1 (h / half 
                                          :poss (g / gene 
                                                :ARG1-of (n2 / neighbor-01 
                                                      :ARG0 2 
                                                      :ARG2 (a3 / across 
                                                            :op1 (o / one-third))))))) 
                        :mod (h2 / heterozygou) 
                        :poss (p / person 
                              :name (n / name 
                                    :op1 "SUMF1"))))) 
      :ARG1-of (c2 / clear-06))

# ::snt This deletion was apparent in all three affected family members studied and absent from the family member with unknown affection status ( Figure 3 ) .
# ::tok This deletion was apparent in all three affected family members studied and absent from the family member with unknown affection status ( Figure 3 ) .
# ::alignments 23-24|0.1.0 22-23|0.0.1.2.0 20-21|0.0.1.1.2.0 19-20|0.0.1.1.2 18-19|0.0.1.1.2.0.0.0+0.0.1.1.2.0.0 16-17|0.0.1.1.1+0.0.1.1 15-16|0.0.1.1.0 12-13|0.1 11-12|0 10-11|0.0 9-10|0.0.1.0.1+0.0.1.0+0.0.1 8-9|0.0.1.0.0 7-8|0.0.1.2 6-7|0.0.1.4 5-6|0.0.1.3 3-4|0.0.0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:17.285
(a3 / and 
      :op1 (s2 / study-01 
            :ARG0 (d / deletion 
                  :domain-of (a6 / apparent) 
                  :mod (t / this)) 
            :ARG1 (p / person 
                  :ARG0-of (h2 / have-org-role-91 
                        :ARG1 (f3 / family) 
                        :ARG2 (m2 / member)) 
                  :ARG0-of (h / have-org-role-91 
                        :ARG1 (f2 / family) 
                        :ARG2 (m / member) 
                        :manner (a / affection 
                              :mod-of (s / status 
                                    :ARG1-of (k / know-01 
                                          :polarity -)))) 
                  :ARG1-of (a4 / affect-01 
                        :ARG0 (f / figure)) 
                  :quant (a5 / all) 
                  :quant 3)) 
      :op2 (a2 / absent-01 
            :ARG1 3))

# ::snt The SNP data showed a deletion of between 188 kb and 210 kb in size ; examination of SNPs at the flanking unknown regions of this deletion allowed us to delimit the borders of the deletion to 7.5 kb on the telomeric side of the deletion ( between rs12634249 and rs793396 ) and ~ 14.4 kb on the centromeric side of the deletion ( between rs4073665 and rs17709863 ) .
# ::tok The SNP data showed a deletion of between 188 kb and 210 kb in size ; examination of SNPs at the flanking unknown regions of this deletion allowed us to delimit the borders of the deletion to 7.5 kb on the telomeric side of the deletion ( between rs12634249 and rs793396 ) and ~ 14.4 kb on the centromeric side of the deletion ( between rs4073665 and rs17709863 ) .
# ::alignments 67-68|0.3.0.0.0.1.1 66-67|0.3.0.0.0.1 65-66|0.3.0.0.0.1.0 62-63|0.3.0.2.1.0.0.0.0 59-60|0.3.0.2.1.0.0.0 58-59|0.3.0.2.1.0.0 52-53|0.3.0.0.0 50-51|0.3.0.0.0.0.1 49-50|0.3.0.0.0.0 48-49|0.3.0.0.0.0.0 45-46|0.3.0.0.1.2.0 42-43|0.3.0.0.1.2 35-36|0.3.0.0.1.1.0 32-33|0.3.0.0.1.1 30-31|0.3.0.0.1 27-28|0.3.0.0 26-27|0.3.0.0.1.0 25-26|0.3.0.0.1.0.0 23-24|0.3.0.2.1 22-23|0.3.0.2.2+0.3.0.2 21-22|0.3.0.2.1.0 18-19|0.3.0.1 16-17|0.3.0 15-16|0.3 14-15|0.4 10-11|0.2 8-9|0.3.0.2.0 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:22.405
(s5 / show-01 
      :ARG0 (d7 / data 
            :mod (p / political-party 
                  :name (n / name 
                        :op1 "SNP") 
                  :wiki "Scottish_National_Party")) 
      :ARG1 (d6 / deletion) 
      :op1-of (a6 / and) 
      :op1-of (a5 / and 
            :op2 (e / examine-01 
                  :ARG0-of (a4 / allow-01 
                        :ARG1 (a2 / and 
                              :op1 (a3 / and 
                                    :op1 (r4 / rs12634249) 
                                    :op2 (r3 / rs793396)) 
                              :op2 (a / and 
                                    :op1 (r2 / rs4073665) 
                                    :op2 (r / rs17709863))) 
                        :ARG2 (d4 / delimit-01 
                              :ARG0 (d5 / deletion 
                                    :mod (t / this)) 
                              :ARG1 (b / border 
                                    :mod (d3 / deletion)) 
                              :ARG2 (s2 / side 
                                    :mod (d2 / deletion)))) 
                  :ARG1 (s3 / snp) 
                  :ARG2 (k / know-01 
                        :ARG0 188 
                        :ARG1 (r5 / region 
                              :ARG1-of (f / flank-01 
                                    :ARG0 (c / centromeric 
                                          :mod-of (s / side 
                                                :mod (d / deletion))))) 
                        :polarity -))) 
      :time (s4 / size))

# ::snt In an attempt to define whether this variation was a benign polymorphism we analyzed genome-wide SNP data at this locus , produced using the same genotyping chip , from 577 individuals of European descent who were either controls or individuals with an unrelated neurological disorder .
# ::tok In an attempt to define whether this variation was a benign polymorphism we analyzed genome-wide SNP data at this locus , produced using the same genotyping chip , from 577 individuals of European descent who were either controls or individuals with an unrelated neurological disorder .
# ::alignments 44-45|0.0.0.0.0.1.0.1.0 43-44|0.0.0.0.0.1.0.1.0.1 42-43|0.0.0.0.0.1.0.1.0.0.0+0.0.0.0.0.1.0.1.0.0 39-40|0.0.0.0.0.1.0.2 38-39|0.0.0.0.0.1.0 37-38|0.0.0.0.0.1.0.1 36-37|0.0.0.0.0.1.0.0 33-34|0.0.0.0.1.0 32-33|0.0.0.0.1.0.0.1+0.0.0.0.1.0.0.0.0+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0 30-31|0.0.0.0.1 26-27|0.0.0.0.0.1.2.0 24-25|0.0.0.0.0.1.2.0.0 22-23|0.0.0.0.0.1.2 21-22|0.0.0.0.0.1 19-20|0.0.0.0.0.1.1 18-19|0.0.0.0.0.1.1.0 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 13-14|0.0.0.0.0 12-13|0.0.0.0 11-12|0 10-11|0.2 7-8|0.1 6-7|0.1.0 4-5|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:24.002
(p3 / polymorphism 
      :ARG1-of (d4 / define-01 
            :ARG1-of (a2 / attempt-01 
                  :ARG0 (w / we 
                        :ARG0-of (a / analyze-01 
                              :ARG1 (d3 / data 
                                    :mod (p2 / political-party 
                                          :name (n3 / name 
                                                :op1 "SNP") 
                                          :wiki "Scottish_National_Party")) 
                              :purpose (p / produce-01 
                                    :ARG0 (o / or 
                                          :mod (e / either) 
                                          :op1 (c / control-01 
                                                :ARG1 (d / disord 
                                                      :ARG1-of (r / relate-01 
                                                            :polarity -) 
                                                      :mod (n / neurological))) 
                                          :op2 (i / individual)) 
                                    :ARG1 (l / locu 
                                          :mod (t / this)) 
                                    :ARG2-of (u / use-01 
                                          :ARG1 (c3 / chip 
                                                :ARG1-of (s / same-01))))) 
                        :poss-of (i2 / individual 
                              :ARG0-of (d2 / descend-01 
                                    :ARG1 (c2 / continent 
                                          :name (n2 / name 
                                                :op1 "Europe") 
                                          :wiki "Europe")))))) 
      :domain (v / variation 
            :mod (t2 / this)) 
      :domain-of (b / benign))

# ::snt We failed to find any deletions affecting the coding sequence of either gene , ITPR1 or SUMF1 ; we did , however , identify a single individual with a possible heterozygous deletion approximately 6 kb in size within intron 40 -- 41 of ITPR1 , at least 5 kb away from exon 40 .
# ::tok We failed to find any deletions affecting the coding sequence of either gene , ITPR1 or SUMF1 ; we did , however , identify a single individual with a possible heterozygous deletion approximately 6 kb in size within intron 40 -- 41 of ITPR1 , at least 5 kb away from exon 40 .
# ::alignments 52-53|0.4.1.1 51-52|0.4.0.1.0.0 49-50|0.4.0.1.0.2 47-48|0.4.0.2 41-42|0.4.0.0.0.0.0.0.0.1.0.0 39-40|0.4.0.1.0.1 38-39|0.4.0.0.0.0.0.0.0.1.0 36-37|0.4.0.0.0.0.0.0.0.1 34-35|0.4.0.0.0.0.0.0.0.0 33-34|0.4.1.0.1.0 32-33|0.4.1.0.1 31-32|0.4.1.0 30-31|0.4.1.0.0 29-30|0.4.1 26-27|0.4.0.1 25-26|0.4.0.1.0 23-24|0.4.0 18-19|0.4.0.0.0.0.0.1 17-18|0.4 16-17|0.3.0.0+0.3.0+0.3 15-16|0 14-15|0.2 12-13|0.1 11-12|0.0 9-10|0.4.0.0.0.0.0.0 8-9|0.4.0.0.0.0.0.0.0 6-7|0.4.0.0.0.0.0 5-6|0.4.0.0.0.0 4-5|0.4.0.0.0.0.1 3-4|0.4.0.0.0 1-2|0.4.0.0.1 0-1|0.4.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:26.094
(o / or 
      :mod (e2 / either) 
      :op1 (g / gene) 
      :op2 (i4 / ITPR1) 
      :op3 (p2 / person 
            :name (n / name 
                  :op1 "SUMF1")) 
      :op4 (a3 / and 
            :op1 (i3 / identify-01 
                  :ARG0 (w2 / we 
                        :ARG0-of (f / find-01 
                              :ARG1 (d2 / deletion 
                                    :ARG0-of (a4 / affect-01 
                                          :ARG1 (s3 / sequence 
                                                :ARG1-of (c / code-01 
                                                      :ARG2 (k / kb) 
                                                      :op1-of (s / size 
                                                            :location (i / intron 
                                                                  :quant 41)))) 
                                          :ARG2 (w / we)) 
                                    :mod (a5 / any))) 
                        :ARG0-of (f2 / fail-01 
                              :ARG2 f)) 
                  :ARG1 (i2 / individual 
                        :ARG1-of (s2 / single-02 
                              :ARG2 (e / exon) 
                              :op1-of 40 
                              :op1-of (a / away))) 
                  :ARG2 5) 
            :op2 (p / possible-01 
                  :ARG1 (d / deletion 
                        :mod (h / heterozygou) 
                        :quant (a2 / approximately 
                              :op1 6)) 
                  :op1-of 40)))

# ::snt Given the location of this alteration it is unlikely to effect the expression or splicing of ITPR1 .
# ::tok Given the location of this alteration it is unlikely to effect the expression or splicing of ITPR1 .
# ::alignments 14-15|0.2 13-14|0 12-13|0.1 10-11|0.0 8-9|0.0.0.1+0.0.0 5-6|0.0.0.0.1 4-5|0.0.0.0.1.0 2-3|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:26.355
(o / or 
      :ARG1-of (e2 / effect-03 
            :ARG1-of (l / likely-01 
                  :ARG0 (l2 / location 
                        :ARG1-of (g / give-01) 
                        :part-of (a / alteration 
                              :mod (t / this))) 
                  :polarity -)) 
      :op1 (e / express-01) 
      :op2 (s / splice-01))

# ::snt In an attempt to fine-map the breakpoints of the disease-causing deletion we performed a series of experiments designed to refine the unknown intervals at the edges between definite deleted and definite diploid sequences .
# ::tok In an attempt to fine-map the breakpoints of the disease-causing deletion we performed a series of experiments designed to refine the unknown intervals at the edges between definite deleted and definite diploid sequences .
# ::alignments 32-33|0.0.0.2.0.1 31-32|0.0.0.2.0.1.0 30-31|0.0.0.2.0.1.1 29-30|0 28-29|0.0 27-28|0.0.1 25-26|0.0.0.0.1.0.0 22-23|0.0.0.0.1.0 21-22|0.0.0.1.0+0.0.0.1 19-20|0.0.0.0.1 17-18|0.0.0.0 16-17|0.0.0 14-15|0.0.0.2 12-13|0.0.0.2.0 11-12|0.0.0.2.0.0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.0 6-7|0.0.0.2.0.0.0.0 2-3|0.0.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:26.674
(a / and 
      :op1 (d3 / delete-01 
            :ARG1 (e2 / experiment-01 
                  :ARG1-of (d5 / design-01 
                        :ARG0 (d6 / deletion 
                              :mod (d7 / disease-caus)) 
                        :ARG3 (r / refine-01 
                              :ARG1 (i / interval 
                                    :location (e / edge)))) 
                  :ARG1-of (k / know-01 
                        :polarity -) 
                  :quant (s2 / series 
                        :ARG1-of (p / perform-02 
                              :ARG0 (w / we 
                                    :ARG0-of (a2 / attempt-01 
                                          :ARG1 (b / breakpoint))) 
                              :ARG2 (s / sequence 
                                    :mod (d / diploid) 
                                    :mod (d2 / definite))))) 
            :mod (d4 / definite)))

# ::snt These data narrowed the unknown borders to ~ 4 kb on the telomeric side and ~ 7 kb on the centromeric side .
# ::tok These data narrowed the unknown borders to ~ 4 kb on the telomeric side and ~ 7 kb on the centromeric side .
# ::alignments 21-22|0.0 20-21|0 16-17|0.0.0.0.0.2 14-15|0.0.0.0.0.1 13-14|0.0.0.0.0.1.0.0 9-10|0.0.0.0.0.1.0 8-9|0.0.0.0.0.1.0.1 5-6|0.0.0.0 4-5|0.0.0.1+0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:27.085
(c / centromeric 
      :mod-of (s / side 
            :ARG2-of (k2 / know-01 
                  :mod-of (b / border 
                        :ARG1-of (n / narrow-01 
                              :ARG0 (d / data 
                                    :mod (t / this)) 
                              :ARG2 (a / and 
                                    :op1 (k / kb 
                                          :location (s2 / side) 
                                          :quant 4)) 
                              :op1-of 7)) 
                  :polarity -)))

# ::snt We used all possible combinations of forward orientation primers designed within the newly defined telomeric boundary and of reverse orientation primers designed within the newly defined centromeric boundary in PCR assays in an attempt to amplify across the deletion in affected family members .
# ::tok We used all possible combinations of forward orientation primers designed within the newly defined telomeric boundary and of reverse orientation primers designed within the newly defined centromeric boundary in PCR assays in an attempt to amplify across the deletion in affected family members .
# ::alignments 42-43|0.0.0.1+0.0.0+0.0 41-42|0.0.0.0 40-41|0 38-39|0.0.1.0.0.1.0.1.0 36-37|0.0.1.0.0.1.0.1 35-36|0.0.1.0.0.1.0 33-34|0.0.1.0.0.1 30-31|0.0.1.0.0.1.0.0 27-28|0.0.1.0.1.0.0.0.1.0.0 26-27|0.0.1.0.1.0.0.0.1.0.0.0 25-26|0.0.1.0.1.0.0.0.1.0 21-22|0.0.1.0.1.0.0 20-21|0.0.1.0.1.0.0.0 19-20|0.0.1.0.1.0.0.0.1 18-19|0.0.1.0.1.0.0.0.0 16-17|0.0.1 15-16|0.0.1.0.0.1.0.2.0 13-14|0.0.1.0.0.1.0.2 12-13|0.0.1.0.0.1.0.2.1 9-10|0.0.1.0.0.0 8-9|0.0.1.0.0.0.0 7-8|0.0.1.0.0.0.0.0 6-7|0.0.1.0.0.0.0.1 4-5|0.0.1.0.1 3-4|0.0.1.0.1.0 2-3|0.0.1.0.1.1 1-2|0.0.1.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:28.860
(a / affect-01 
      :ARG1 (p / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f / family) 
                  :ARG2 (m / member)) 
            :op1-of (a6 / and 
                  :ARG2-of (u / use-01 
                        :ARG0 (w / we 
                              :ARG0-of (d5 / design-01 
                                    :ARG1 (p3 / primer 
                                          :mod (o2 / orientation) 
                                          :mod (f2 / forward))) 
                              :ARG0-of (a4 / attempt-01 
                                    :ARG1 (a3 / amplify-01 
                                          :ARG0 (a5 / assay) 
                                          :ARG1 (a2 / across 
                                                :op1 (d / deletion)) 
                                          :ARG2 (d4 / define-01 
                                                :ARG1 (b2 / boundary) 
                                                :degree (n / newly))))) 
                        :ARG1 (c2 / combination 
                              :ARG1-of (p4 / possible-01 
                                    :ARG3-of (d3 / design-01 
                                          :ARG1 (p2 / primer 
                                                :ARG1-of (r / reverse-01) 
                                                :mod (o / orientation 
                                                      :ARG0-of (d2 / define-01 
                                                            :ARG1 (b / boundary 
                                                                  :mod (c / centromeric))))))) 
                              :quant (a7 / all))))))

# ::snt Using PCR primers T3F and C11R , which should be more than 200 kb apart , we were able to amplify a fragment 953 bp in size using DNA from each of the three affected family members as template .
# ::tok Using PCR primers T3F and C11R , which should be more than 200 kb apart , we were able to amplify a fragment 953 bp in size using DNA from each of the three affected family members as template .
# ::alignments 38-39|0.1.2.0.2.1.0 36-37|0.1.0.1+0.1.0+0.1 35-36|0.1.0.0 34-35|0 33-34|0.1.3 30-31|0.1.1 28-29|0.1.2.0.2.3.1 27-28|0.1.2.0.2.3 26-27|0.1.2.0.2.3.0 22-23|0.2 20-21|0.1.2.0.2 18-19|0.1.2.0.2.1 16-17|0.1.2.0.2.0 14-15|0.1.2.0.2.2 13-14|0.1.2.0.2.0.0 12-13|0.0 10-11|0.0.0 8-9|0.1.2.0.1 5-6|0.1.2.1.0.0+0.1.2.1.0+0.1.2.1 4-5|0.1.2 3-4|0.1.2.0.0.1.0+0.1.2.0.0.1+0.1.2.0.0 2-3|0.1.2.0.0.0 0-1|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:31.945
(a / affect-01 
      :ARG0 (2 / 200 
            :op1-of (m2 / more)) 
      :ARG1 (p / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f / family) 
                  :ARG2 (m / member)) 
            :mod (e / each) 
            :op2-of (a4 / and 
                  :ARG0-of (u2 / use-01 
                        :ARG1 (o2 / organization 
                              :mod (p3 / primer) 
                              :name (n2 / name 
                                    :op1 "T3F")) 
                        :ARG1-of (r / recommend-01) 
                        :manner-of (a2 / amplify-01 
                              :ARG0 (w / we 
                                    :poss-of (k / kb)) 
                              :ARG1-of (p2 / possible-01 
                                    :ARG0 (t / template)) 
                              :mod (a3 / apart) 
                              :purpose (u / use-01 
                                    :ARG0 (s / size) 
                                    :ARG1 (d / DNA)))) 
                  :op1 (o / organization 
                        :name (n / name 
                              :op1 "C11R"))) 
            :quant 3) 
      :ARG1-of (f2 / fragment-01))

# ::snt Sequencing of this fragment revealed a deletion of 201,509 bp ( Figure S3 ) , removing the first three of the nine exons of SUMF1 and the first ten of the 58 exons of ITPR1 .
# ::tok Sequencing of this fragment revealed a deletion of 201,509 bp ( Figure S3 ) , removing the first three of the nine exons of SUMF1 and the first ten of the 58 exons of ITPR1 .
# ::alignments 32-33|0.3.0 31-32|0.2.0 25-26|0.3.1 24-25|0.3.1.2.0.0+0.3.1.2.0+0.3.1.2 22-23|0.3.1.1 21-22|0.2.1 18-19|0.3.1.1.0 15-16|0.3 11-13|0.3.1.0.0.1+0.3.1.0.0.0+0.3.1.0.0+0.3.1.0 6-7|0.1 4-5|0 3-4|0.2 2-3|0.2.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:32.911
(r2 / reveal-01 
      :ARG0 (s / sequence) 
      :ARG1 (d / deletion) 
      :manner (f / fragment-01 
            :ARG0 58 
            :ARG1 9 
            :mod (t / this)) 
      :purpose (r / remove-01 
            :ARG0 (e / exon) 
            :op2-of (a / and 
                  :op1 (o / organization 
                        :name (n2 / name 
                              :op1 "Figure" 
                              :op2 "S3")) 
                  :op3 (e2 / exon 
                        :quant 3) 
                  :op4 (p / person 
                        :name (n / name 
                              :op1 "SUMF1")))))

# ::snt We were unable to amplify the deletion-specific fragment in the family member of unknown affection status , or in 275 neurologically normal controls .
# ::tok We were unable to amplify the deletion-specific fragment in the family member of unknown affection status , or in 275 neurologically normal controls .
# ::alignments 22-23|0.0.0.1.1 21-22|0.0.0.1.1.0 17-18|0.0.0.1 15-16|0.0 14-15|0.0.1 13-14|0.1+0 11-12|0.0.0.0+0.0.0 10-11|0.0.2 7-8|0.0.0.1.0 4-5|0.0.0.1.0.0 0-1|0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:33.343
(k / know-01 
      :ARG1 (s / status 
            :ARG1-of (h / have-org-role-91 
                  :ARG2 (m / member) 
                  :op1-of (o / or 
                        :ARG1-of (f2 / fragment-01 
                              :ARG1-of (a2 / amplify-01 
                                    :ARG0 (w / we))) 
                        :op2 (c / control-01 
                              :ARG1-of (n / normal-02)))) 
            :mod (a / affection) 
            :mod (f / family)) 
      :polarity -)

# ::snt To further establish genetic deletion at ITPR1 as the cause of SCA15 we analyzed two additional families with an inherited cerebellar ataxia similar to that described in the AUS1 family , ascertained through neurology clinics in London , United Kingdom .
# ::tok To further establish genetic deletion at ITPR1 as the cause of SCA15 we analyzed two additional families with an inherited cerebellar ataxia similar to that described in the AUS1 family , ascertained through neurology clinics in London , United Kingdom .
# ::alignments 38-40|0.0.0.1.1.1+0.0.0.1.1.0.1+0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 36-37|0.0.0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0 34-35|0.0.0.0.0.0.0.0 33-34|0.0.0.0.0.0.0.0.1 31-32|0.0.0.0.0.0.0 29-30|0.0.0.0.0.0.1.0.0.1 28-29|0.0.0.0.0.0.1.0.0.1.0.0.0+0.0.0.0.0.0.1.0.0.1.0.0+0.0.0.0.0.0.1.0.0.1.0 25-26|0.0.0.0.0.0.1.0.0 24-25|0.0.0.0.0.0.1.0 22-23|0.0.0.0.0.0.1 21-22|0.0.0.0.0.0 20-21|0.0.0.0.0.0.2 19-20|0.0.0.0.0 16-17|0.0.0.1 15-16|0.0.0.1.0 14-15|0.0.0.1.2 13-14|0.0.0 12-13|0.0.0.0 11-12|0.0.1.0+0.0.1+0.0 9-10|0 4-5|0.0.0.0.1.0 3-4|0.0.0.0.0.0.1.0.0.0 2-3|0.0.0.0.1 1-2|0.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:34.101
(c5 / cause-01 
      :ARG1 (t3 / thing 
            :ARG2-of (a4 / analyze-01 
                  :ARG0 (w / we 
                        :ARG0-of (i / inherit-01 
                              :ARG1 (a2 / ataxia 
                                    :ARG1-of (a / ascertain-01 
                                          :ARG0 (c3 / clinic 
                                                :location (c2 / city 
                                                      :name (n2 / name 
                                                            :op1 "London") 
                                                      :wiki "London") 
                                                :mod (n3 / neurology))) 
                                    :ARG1-of (r / resemble-01 
                                          :ARG2 (t2 / that 
                                                :ARG1-of (d / describe-01 
                                                      :ARG0 (g / gene) 
                                                      :ARG2 (f / family 
                                                            :mod (t / thing 
                                                                  :name (n4 / name 
                                                                        :op1 "AUS1")))))) 
                                    :mod (c4 / cerebellar))) 
                        :ARG0-of (e / establish-01 
                              :ARG1 (d2 / deletion) 
                              :degree (f3 / further))) 
                  :ARG1 (f2 / family 
                        :mod (a3 / additional) 
                        :mod (c / country 
                              :name (n / name 
                                    :op1 "United" 
                                    :op2 "Kingdom") 
                              :wiki "United_Kingdom") 
                        :quant 2)) 
            :name (n5 / name 
                  :op1 "SCA15")))

# ::snt DNA extracted from probands from these two families ( family H33 and family H27 ) were also analyzed using Illumina Infinium HumanHap550 genotyping chips .
# ::tok DNA extracted from probands from these two families ( family H33 and family H27 ) were also analyzed using Illumina Infinium HumanHap550 genotyping chips .
# ::alignments 23-24|0.1.1.0.0 21-22|0.1.0 19-21|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 18-19|0.1 17-18|0 16-17|0.2 13-14|0.0.1.0.2.0+0.0.1.0.2+0.0.1.0 12-13|0.0.1.0.1 11-12|0.0.1 10-11|0.0.0.0+0.0.0+0.0 9-10|0.0.1.0.0 7-8|0.1.1.0.1 6-7|0.1.1.0.1.1 5-6|0.1.1.0.1.0 3-4|0.1.1.0.2 1-2|0.1.1.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:35.645
(a / analyze-01 
      :ARG0 (p2 / person 
            :name (n3 / name 
                  :op1 "H33") 
            :op1-of (a3 / and 
                  :op2 (o / organization 
                        :mod (f2 / family) 
                        :mod (f / family) 
                        :name (n2 / name 
                              :op1 "H27")))) 
      :ARG1 (u / use-01 
            :ARG1 (h / HumanHap550 
                  :mod (p / person 
                        :name (n / name 
                              :op1 "Illumina" 
                              :op2 "Infinium"))) 
            :ARG2 (d / DNA 
                  :ARG1-of (e / extract-01 
                        :ARG0 (c / chip) 
                        :ARG2 (f3 / family 
                              :mod (t / this) 
                              :quant 2) 
                        :source (p3 / proband)))) 
      :mod (a2 / also))

# ::snt These experiments showed deletion at the SCA15 locus in all affected members assayed , from SUMF1 through ITPR1 .
# ::tok These experiments showed deletion at the SCA15 locus in all affected members assayed , from SUMF1 through ITPR1 .
# ::alignments 15-16|0.2.0.0+0.2.0+0.2 11-12|0.3.0.1+0.3.0+0.3.0.0 10-11|0.3.0.0.0 9-10|0.3.0.0.1 7-8|0.3 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:36.189
(s / show-01 
      :ARG0 (e / experiment-01 
            :mod (t / this)) 
      :ARG1 (d / deletion) 
      :ARG2 (p / person 
            :name (n / name 
                  :op1 "SUMF1")) 
      :time (l / locu 
            :ARG1-of (h / have-org-role-91 
                  :ARG0 (p2 / person 
                        :ARG1-of (a / affect-01) 
                        :quant (a2 / all)) 
                  :ARG2 (m / member))))

# ::snt These mutations segregated with disease in these two families ( Figure S3 ) .
# ::tok These mutations segregated with disease in these two families ( Figure S3 ) .
# ::alignments 10-12|0.1.0.1+0.1.0.0+0.1.0+0.1 8-9|0.2.0 7-8|0.2.0.1 6-7|0.2.0.0 4-5|0.2 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:36.319
(s / segregate-01 
      :ARG0 (m / mutate-01 
            :mod (t2 / this)) 
      :ARG1 (o / organization 
            :name (n / name 
                  :op1 "Figure" 
                  :op2 "S3")) 
      :ARG2 (d / disease 
            :location (f / family 
                  :mod (t / this) 
                  :quant 2)))

# ::snt A strategy similar to the one outlined above enabled us to sequence over the breakpoint in family H27 but not family H33 .
# ::tok A strategy similar to the one outlined above enabled us to sequence over the breakpoint in family H27 but not family H33 .
# ::alignments 21-22|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 20-21|0.0.0.0.0.0 19-20|0.0.0.0.0.1.0.0 18-19|0 17-18|0.1.2.0+0.1.2+0.1 16-17|0.1.1 14-15|0.1.0 11-12|0.0 8-9|0.0.0 7-8|0.0.0.0.0.1.0.1 6-7|0.0.0.0.0.1.0 5-6|0.0.0.0.0.1 2-3|0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:36.668
(c / contrast-01 
      :ARG1 (s / sequence 
            :ARG1-of (e / enable-01 
                  :ARG0 (s2 / strategy 
                        :ARG1-of (r / resemble-01 
                              :ARG0 (f / family 
                                    :mod-of (p / person 
                                          :name (n / name 
                                                :op1 "H33"))) 
                              :ARG2 (o3 / one 
                                    :ARG1-of (o2 / outline-01 
                                          :ARG0 - 
                                          :ARG2 (a / above))))))) 
      :ARG2 (o / organization 
            :location-of (b / breakpoint) 
            :mod (f2 / family) 
            :name (n2 / name 
                  :op1 "H27")))

# ::snt In the former , the deletion spans 344,408 bp , removing exons 1 -- 3 of SUMF1 and 1 -- 44 of ITPR1 ; in the latter , we estimate that the deletion is 310 kb in length and that it removes exons 1 -- 3 of SUMF1 and exons 1 -- 40 of ITPR1 .
# ::tok In the former , the deletion spans 344,408 bp , removing exons 1 -- 3 of SUMF1 and 1 -- 44 of ITPR1 ; in the latter , we estimate that the deletion is 310 kb in length and that it removes exons 1 -- 3 of SUMF1 and exons 1 -- 40 of ITPR1 .
# ::alignments 52-53|0.1.4.0.0.2.2 50-51|0.0.0.2 48-49|0 45-46|0.1.4.0.0.2.1 43-44|0.1.4.0.0.2.3 42-43|0.1.1 41-42|0.1 38-39|0.1.4 37-38|0.1.0 32-33|0.0.0.1 29-30|0.0.0 28-29|0.0.0.0 26-27|0.0.0.3 23-24|0.0 20-21|0.1.1.0 18-19|0.1.2 17-18|0.1.4.0 14-15|0.1.0.0 12-13|0.1.3 11-12|0.1.4.0.0.2.0 10-11|0.1.4.0.0.2 6-7|0.1.4.0.0 5-6|0.1.4.0.0.0 2-3|0.1.4.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:37.195
(a / and 
      :op1 (a3 / and 
            :op1 (e2 / estimate-01 
                  :ARG0 (w / we) 
                  :ARG1 (d / deletion) 
                  :ARG2 1 
                  :prep-in (l2 / latter))) 
      :op2 (r / remove-01 
            :ARG0 (l / length 
                  :mod-of 3) 
            :ARG1 (e / exon 
                  :mod-of 44) 
            :ARG2 1 
            :op1-of 1 
            :op2-of (a2 / and 
                  :op1 (a4 / and 
                        :ARG2-of (s / span-01 
                              :ARG0 (d2 / deletion) 
                              :ARG1 (f / former) 
                              :ARG3 (r2 / remove-01 
                                    :ARG1 (e3 / exon) 
                                    :op1-of 3 
                                    :op1-of 40 
                                    :op1-of 1))))))

# ::snt The site of mutation is of interest , particularly the fact that in each of the three families the telomeric end of the deletion is anchored between exons 3 and 4 of SUMF1 ; sequence searches failed to identify any repeat sequences that might explain this phenomenon .
# ::tok The site of mutation is of interest , particularly the fact that in each of the three families the telomeric end of the deletion is anchored between exons 3 and 4 of SUMF1 ; sequence searches failed to identify any repeat sequences that might explain this phenomenon .
# ::alignments 46-47|0.0.1 45-46|0.0.1.0 44-45|0.0 43-44|0 41-42|0.0.0 40-41|0.0.0.1 39-40|0.0.0.2 38-39|0.0.0.0 36-37|0.0.0.0.0 35-36|0.0.0.0.0.0 34-35|0.0.0.0.0.0.0 33-34|0.0.0.0.0.1 32-33|0.0.0.0.0.1.1.0.0+0.0.0.0.0.1.1.0+0.0.0.0.0.1.1 30-31|0.0.0.0.0.1.0.1.0.0 29-30|0.1 28-29|0.0.0.1.0 27-28|0.1.0.1.0 25-26|0.1.0.1 23-24|0.1.0.0 20-21|0.1.0 17-18|0.1.0.2 16-17|0.1.0.2.2 13-14|0.1.0.2.0 10-11|0.0.0.0.0.1.0.1 8-9|0.1.0.2.1 6-7|0.0.0.0.0.1.0.1.0 3-4|0.0.0.0.0.1.0.0 1-2|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:39.225
(p2 / possible-01 
      :ARG1 (e / explain-01 
            :ARG0 (s / sequence 
                  :ARG1-of (i / identify-01 
                        :ARG2-of (f / fail-01 
                              :ARG1 (s2 / search-01 
                                    :ARG1 (s3 / sequence)) 
                              :op2-of (a2 / and 
                                    :domain (s4 / site 
                                          :consist-of (m / mutation) 
                                          :domain-of (f3 / fact 
                                                :ARG2-of (i2 / interest-01 
                                                      :ARG0 4))) 
                                    :op1 (p3 / person 
                                          :name (n / name 
                                                :op1 "SUMF1"))))) 
                  :ARG1-of (r / repeat-01 
                        :ARG0 3) 
                  :mod (a / any)) 
            :ARG1 (p / phenomenon 
                  :mod (t / this))) 
      :op1-of (a3 / and 
            :ARG0-of (e3 / end-01 
                  :ARG1 (d / deletion) 
                  :ARG1-of (a4 / anchor-01 
                        :ARG0 (e2 / exon)) 
                  :ARG2 (f2 / family 
                        :mod (e4 / each) 
                        :op1-of (p4 / particular) 
                        :quant 3))))

# ::snt With three cerebellar ataxia families segregating a SUMF1 -- ITPR1 deletion , and this deletion not observed in a control population , we may reasonably conclude that the association is causal , and that the deletion is indeed the genetic basis of the disease , with SCA15 the diagnosis in the two British families as well as the original Australian family .
# ::tok With three cerebellar ataxia families segregating a SUMF1 -- ITPR1 deletion , and this deletion not observed in a control population , we may reasonably conclude that the association is causal , and that the deletion is indeed the genetic basis of the disease , with SCA15 the diagnosis in the two British families as well as the original Australian family .
# ::alignments 60-61|0.1.0.0.0 59-60|0.1.0.0.0.0.1+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 58-59|0.1.0.0.0.1 53-54|0.1.0.0.1 52-53|0.1.0.0.3+0.1.0.0.2.0+0.1.0.0.2+0.1.0.0 51-52|0.1.0.0.1.0 48-49|0.3.0 43-44|0.1.1.0.0.1.0.2.0.0 39-40|0.1.1.0.0.1.0.3 37-38|0.1.1.0.0.1.0.1 35-36|0.1.1.0.0.1.0.2.0.0.0 32-33|0.1.1 30-31|0.1 28-29|0.1.0 25-26|0 24-25|0.3 23-24|0.2 22-23|0.0 20-21|0.1.1.0.0.1.0.2 19-20|0.1.1.0.0.1.0.2.0 16-17|0.1.1.0.0.1.0 15-16|0.1.1.0.0.1.0.4 14-15|0.1.1.0.0.1.0.0 13-14|0.1.1.0.0.1.0.0.0 12-13|0.1.1.0.0.1 10-11|0.1.1.0.0.1.1 7-8|0.1.1.0.1.0+0.1.1.0.1+0.1.1.0 5-6|0.1.1.0.0 4-5|0.1.1.0.0.0 3-4|0.1.1.0.0.0.0 2-3|0.1.1.0.0.0.0.0 1-2|0.1.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:41.534
(c4 / conclude-02 
      :ARG0 (w / we) 
      :ARG1 (c3 / causal 
            :domain (a2 / associate-01 
                  :ARG1 (c2 / country 
                        :mod-of (f / family 
                              :mod (c / country 
                                    :name (n / name 
                                          :op1 "Australia") 
                                    :wiki "Australia") 
                              :mod (o / original)) 
                        :mod-of (f2 / family 
                              :quant 2) 
                        :name (n2 / name 
                              :op1 "Britain") 
                        :wiki "United_Kingdom")) 
            :op2-of (a / and 
                  :op1 (p3 / person 
                        :ARG2-of (s / segregate-01 
                              :ARG0 (f3 / family 
                                    :mod (a4 / ataxia 
                                          :mod (c6 / cerebellar)) 
                                    :quant 3) 
                              :ARG1 (a3 / and 
                                    :ARG0-of (o2 / observe-01 
                                          :ARG1 (d4 / deletion 
                                                :mod (t / this)) 
                                          :ARG2 (i / indeed) 
                                          :ARG3 (p2 / population 
                                                :instrument-of (c5 / control-01 
                                                      :ARG1 (d2 / disease 
                                                            :location (d3 / deletion)))) 
                                          :op1-of (g / gene) 
                                          :polarity -) 
                                    :op1 (d5 / deletion))) 
                        :name (n3 / name 
                              :op1 "SUMF1")))) 
      :ARG1-of (p / possible-01) 
      :ARG1-of (r / reasonable-02 
            :ARG0 (d / diagnosi)))

# ::snt It is improbable that heterozygosity for the deletion of SUMF1 , encoding sulfatase modifying factor 1 , of itself causes or contributes to SCA15 .
# ::tok It is improbable that heterozygosity for the deletion of SUMF1 , encoding sulfatase modifying factor 1 , of itself causes or contributes to SCA15 .
# ::alignments 23-24|0.1.1.0.0+0.1.1.0+0.1.1 21-22|0.2 20-21|0 19-20|0.1 15-16|0.2.1 14-15|0.1.0.0.0.0.0.0 13-14|0.1.0.0.0.0.0 12-13|0.1.0.0.0.0 11-12|0.1.0.0.0 9-10|0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 7-8|0.1.0 4-5|0.2.0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:42.047
(o / or 
      :domain-of (i / improbable 
            :domain (i2 / it)) 
      :op1 (c2 / cause-01 
            :ARG0 (d / deletion 
                  :poss (p / person 
                        :ARG0-of (e / encode-01 
                              :ARG1 (s / sulfatase 
                                    :ARG0-of (m / modify-01 
                                          :ARG1 (f / factor)))) 
                        :name (n2 / name 
                              :op1 "SUMF1"))) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "SCA15"))) 
      :op2 (c / contribute-01 
            :ARG0 (h / heterozygosity) 
            :ARG1 1))

# ::snt Homozygous mutation of SUMF1 results in autosomal recessive multiple sulfatase deficiency , a metabolic disorder characterized by hepatosplenomegaly , deafness , and developmental delay [ 6,7 ] .
# ::tok Homozygous mutation of SUMF1 results in autosomal recessive multiple sulfatase deficiency , a metabolic disorder characterized by hepatosplenomegaly , deafness , and developmental delay [ 6,7 ] .
# ::alignments 23-24|0.1.0 22-23|0.1.0.0 21-22|0.1 19-20|0.1.3 17-18|0.1.2 15-16|0.1.2.0 14-15|0.1.2.0.0 13-14|0.1.2.0.0.0 10-11|0.1.1 8-9|0.1.2.0.0.1 7-8|0 6-7|0.0 4-5|0.2.0.0+0.2.0 1-2|0.2 0-1|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:42.561
(r / recessive 
      :consist-of (a2 / autosomal) 
      :op1-of (a / and 
            :ARG1-of (d / delay-01 
                  :ARG0 (d2 / developmental)) 
            :op2 (d5 / deficiency) 
            :op3 (h / hepatosplenomegaly 
                  :ARG0-of (c / characterize-01 
                        :ARG1 (d4 / disord 
                              :mod (m / metabolic) 
                              :quant (m2 / multiple)))) 
            :op4 (d3 / deafnes)) 
      :time (m3 / mutation 
            :consist-of (t / thing 
                  :ARG2-of (r2 / result-01)) 
            :mod (h2 / homozygou)))

# ::snt No co-occurrence of ataxia has been described in ( heterozygous ) parents of patients with multiple sulfatase deficiency .
# ::tok No co-occurrence of ataxia has been described in ( heterozygous ) parents of patients with multiple sulfatase deficiency .
# ::alignments 17-18|0.2 15-16|0.2.0 13-14|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 11-12|0.0.0.1+0.0.0+0.0 9-10|0.3.0 6-7|0 3-4|0.1.0 1-2|0.1 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:42.924
(d2 / describe-01 
      :ARG0 (p3 / person 
            :ARG0-of (h2 / have-rel-role-91 
                  :ARG1 (p / person 
                        :ARG0-of (h / have-rel-role-91 
                              :ARG2 (p2 / patient))) 
                  :ARG2 (p4 / parent))) 
      :ARG1 (c / co-occurrence 
            :mod (a / ataxia)) 
      :ARG2 (d / deficiency 
            :quant (m / multiple)) 
      :polarity (- / - 
            :mod-of (h3 / heterozygou)))

# ::snt Conversely , mutation of ITPR1 is biologically plausible as a cause of ataxia : the protein is highly expressed in Purkinje cells ; as we have shown here , mice with mutation at this locus present with ataxia ; and perturbed Ca2 + signaling has previously been implicated in the etiology of ataxia , notably in episodic ataxia type 2 and SCA6 [ 8 ] .
# ::tok Conversely , mutation of ITPR1 is biologically plausible as a cause of ataxia : the protein is highly expressed in Purkinje cells ; as we have shown here , mice with mutation at this locus present with ataxia ; and perturbed Ca2 + signaling has previously been implicated in the etiology of ataxia , notably in episodic ataxia type 2 and SCA6 [ 8 ] .
# ::alignments 63-64|0.0.3.2.0.2 60-61|0.0.3.0 59-60|0.0.3.2.0.0 58-59|0.0.3.1.0.1.1.0 57-58|0.0.3.1.0.1.1 56-57|0.0.3.1.0.1.1.0.0 54-55|0.0.3.1.0.1 52-53|0.0.3.2.1.0 50-51|0.0.3.2.1 47-48|0.0.3.2 45-46|0.0.3.2.2 43-44|0.0.3.2.0 40-42|0.0.3.2.0.1.0.1+0.0.3.2.0.1.0.0+0.0.3.2.0.1.0+0.0.3.2.0.1 39-40|0.0.3 37-38|0.0.3.1.2 35-36|0.0.3.1 34-35|0.0.3.1.1 33-34|0.0.3.1.1.1 31-32|0.0.3.1.1.0 29-30|0.0.3.1.0.1.0 27-28|0.0.3.1.0.2 26-27|0.0.3.1.0 24-25|0.0.3.1.0.0 22-23|0.0.0.0.0.0 21-22|0.0.2 20-21|0.0.2.0 18-19|0.0 17-18|0.0.1 15-16|0 12-13|0.0.0.0.0.1 10-11|0.0.0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.1 2-3|0.0.0 0-1|0.0.3.1.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:44.906
(p5 / protein 
      :ARG1-of (e3 / express-01 
            :ARG0 (m3 / mutation 
                  :domain-of (p6 / plausible 
                        :compared-to (c3 / cause-01 
                              :ARG0 (a6 / and) 
                              :ARG1 (a7 / ataxia)) 
                        :manner (b / biology))) 
            :degree (h2 / high) 
            :manner (c2 / cell 
                  :mod (p4 / purkinje)) 
            :op1-of (a4 / and 
                  :op1-of (a / and) 
                  :op2 (p3 / present 
                        :ARG1-of (s2 / show-01 
                              :ARG0 (w / we) 
                              :ARG2 (n / notable-04 
                                    :ARG0 (m2 / mouse) 
                                    :ARG1 (a2 / ataxia 
                                          :mod-of (t / type 
                                                :mod (e / episodic))) 
                                    :op1-of (c4 / conversely)) 
                              :location (h / here)) 
                        :consist-of (l / locu 
                              :location-of (m / mutation) 
                              :mod (t3 / this)) 
                        :prep-with (a5 / ataxia)) 
                  :op3 (i / implicate-01 
                        :ARG1 (s / signal-01 
                              :ARG0 2 
                              :ARG1 (t2 / thing 
                                    :name (n2 / name 
                                          :op1 (p2 / perturbed) 
                                          :op2 (c / Ca2))) 
                              :op1-of 8) 
                        :ARG2 (e2 / etiology 
                              :mod (a3 / ataxia)) 
                        :time (p / previous)))))

# ::snt In further support of this conclusion , analysis of protein levels of ITPR1 in Epstein-Barr virus ( EBV ) immortalized lymphocytes from affected and unaffected AUS1 family members revealed that all affected members showed a dramatic decrease in ITPR1 levels when compared with the family member without the deletion ( Figure 4 ) .
# ::tok In further support of this conclusion , analysis of protein levels of ITPR1 in Epstein-Barr virus ( EBV ) immortalized lymphocytes from affected and unaffected AUS1 family members revealed that all affected members showed a dramatic decrease in ITPR1 levels when compared with the family member without the deletion ( Figure 4 ) .
# ::alignments 51-52|0.0.0.0.0 50-51|0.0.0.1.0.1.0.0.0 48-49|0.0.1.3 45-46|0.0.1.1+0.0.1 44-45|0.0.1.0 41-42|0.0.1.2 39-40|0.0.1.2.0 36-37|0.0.0.0 35-36|0.0.0.0.1 33-34|0.0.0 32-33|0.0.3.1+0.0.3+0.0 31-32|0 30-31|0.0.4 28-29|0.0.0.1 27-28|0.0.0.1.0.0.1+0.0.0.1.0.0+0.0.0.1.0 26-27|0.0.0.1.0.0.0 25-26|0.0.0.1.0.0.0.0.0.0+0.0.0.1.0.0.0.0.0+0.0.0.1.0.0.0.0 24-25|0.0.0.1.0.1.0.0.1+0.0.0.1.0.1.0.0 23-24|0.0.0.1.0.1.0 22-23|0.0.0.1.0.1 20-21|0.0.0.1.0.1.0.1 17-18|0.0.2.0.0.0 15-16|0.0.3.0.0 14-15|0.0.3.0.1.0+0.0.3.0.1+0.0.3.0 10-11|0.0.2.1 9-10|0.0.2.1.0 7-8|0.0.2 5-6|0.0.2.0.0 4-5|0.0.2.0.0.1 2-3|0.0.2.0 1-2|0.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:47.752
(a / affect-01 
      :ARG1 (p / person 
            :ARG0-of (s / show-01 
                  :ARG1 (d2 / decrease-01 
                        :ARG1 4 
                        :mod (d3 / dramatic)) 
                  :ARG1-of (r / reveal-01 
                        :ARG0 (p2 / person 
                              :ARG0-of (h3 / have-org-role-91 
                                    :ARG1 (f3 / family 
                                          :mod (t / thing 
                                                :name (n / name 
                                                      :op1 "AUS1"))) 
                                    :ARG2 (m3 / member)) 
                              :ARG1-of (a5 / affect-01 
                                    :op1-of (a4 / and 
                                          :op2 (a3 / affect-01 
                                                :ARG1 (f / figure) 
                                                :polarity -) 
                                          :quant (l2 / lymphocyt)))))) 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f2 / family) 
                  :ARG2 (m / member) 
                  :ARG2-of (c / compare-01 
                        :ARG1 (l / level)) 
                  :time (d / deletion)) 
            :ARG0-of (a6 / analyze-01 
                  :ARG0-of (s2 / support-01 
                        :ARG1 (c3 / conclude-01 
                              :ARG1 (e / ebv) 
                              :mod (t2 / this)) 
                        :mod (f4 / further)) 
                  :ARG1 (l3 / level 
                        :mod (p3 / protein))) 
            :ARG0-of (h2 / have-org-role-91 
                  :ARG1 (c2 / country 
                        :mod-of (v / virus) 
                        :name (n2 / name 
                              :op1 "Epstein-Barr")) 
                  :ARG2 (m2 / member)) 
            :quant (a2 / all)))

# ::snt Itpr1 contains three domains , an N-terminal inositol triphosphate binding domain , a coupling domain , and a C-terminal transmembrane domain ; it also contains two protein kinase A phosphorylation sites and an ATP-binding site .
# ::tok Itpr1 contains three domains , an N-terminal inositol triphosphate binding domain , a coupling domain , and a C-terminal transmembrane domain ; it also contains two protein kinase A phosphorylation sites and an ATP-binding site .
# ::alignments 34-35|0.1.4.0.1.1.0 33-34|0.1.4.0.1.1.0.0 31-32|0.1.4 30-31|0.1.4.0 29-30|0.1.4.0.0 27-28|0.1.2.0.0 26-27|0.1.4.0.2 25-26|0.1.4.0.3 24-25|0.1.4.0.1 23-24|0.1.4.0.1.0 21-22|0.1.4.0.1.1 20-21|0.1.3 19-20|0.1.3.0 16-17|0.1 14-15|0.1.2 13-14|0.1.2.0 10-11|0.1.1 9-10|0.1.1.0 8-9|0.1.1.0.0 7-8|0.1.1.1 3-4|0.1.0 2-3|0.1.4.0.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:49.348
(c3 / contain-01 
      :ARG0 (i2 / Itpr1) 
      :ARG1 (a5 / and 
            :op1 (d4 / domain) 
            :op2 (d3 / domain 
                  :ARG1-of (b / binding-07 
                        :ARG0 (t2 / triphosphate)) 
                  :mod (i / inositol)) 
            :op3 (d2 / domain 
                  :ARG1-of (c2 / couple-01 
                        :ARG0 (k / kinase))) 
            :op4 (d / domain 
                  :mod (t / transmembrane)) 
            :op5 (a2 / and 
                  :op1 (s2 / site 
                        :ARG0-of (p / phosphorylate-01 
                              :ARG1 3) 
                        :ARG1-of (c / contain-01 
                              :mod (a3 / also) 
                              :op1-of (a4 / and 
                                    :op2 (s / site 
                                          :mod (a / atp-bind)))) 
                        :location-of (p2 / protein) 
                        :quant 2))))

# ::snt Itpr1 is coupled to Ca2 + channels and facilitates Ca2 + release from the endoplasmic reticulum after binding by the intracellular second messenger inositol 1,4,5-triphosphate [ 9 ] .
# ::tok Itpr1 is coupled to Ca2 + channels and facilitates Ca2 + release from the endoplasmic reticulum after binding by the intracellular second messenger inositol 1,4,5-triphosphate [ 9 ] .
# ::alignments 26-27|0.0.1.0 23-24|0.0.0 22-23|0.1.1.0 20-21|0.1.0 17-18|0.1.1.0.0 16-17|0.2 15-16|0.1.1.1 11-12|0.1.1 8-9|0.1 7-8|0 6-7|0.0.1 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:49.461
(a2 / and 
      :op1 (c2 / couple-01 
            :ARG1 (i / inositol) 
            :ARG2 (c / channel 
                  :poss 9)) 
      :op2 (f / facilitate-01 
            :ARG0 (i2 / intracellular) 
            :ARG1 (r2 / release-01 
                  :ARG1 (m / messenger 
                        :ARG0-of (b / binding-07)) 
                  :ARG2 (r / reticulum))) 
      :time (a / after))

# ::snt Itpr1 is enriched in the Purkinje cells of the cerebellum [ 4 ] .
# ::tok Itpr1 is enriched in the Purkinje cells of the cerebellum [ 4 ] .
# ::alignments 11-12|0.0 9-10|0.2 6-7|0.3 5-6|0.3.0 2-3|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:49.499
(e / enrich-01 
      :ARG0 4 
      :ARG1 (i / Itpr1) 
      :ARG2 (c / cerebellum) 
      :location (c2 / cell 
            :mod (p / purkinje)))

# ::snt ITPR1 mutations have more than one potential pathogenic mechanism .
# ::tok ITPR1 mutations have more than one potential pathogenic mechanism .
# ::alignments 8-9|0.0.0 6-7|0.0.0.0 3-4|0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:49.533
(m3 / mutate-01 
      :ARG0 (m2 / more 
            :quant-of (m / mechanism 
                  :mod (p / potential))) 
      :ARG1 (i / ITPR1))

# ::snt First , the disease may be a result of haploinsufficiency at ITPR1 ; this concept is consistent with the observation that heterozygous deletion leads to a later onset disorder in humans , whereas homozygous deletion in mice leads to an early onset disorder , able to be expressed within the much shorter life span of the mouse .
# ::tok First , the disease may be a result of haploinsufficiency at ITPR1 ; this concept is consistent with the observation that heterozygous deletion leads to a later onset disorder in humans , whereas homozygous deletion in mice leads to an early onset disorder , able to be expressed within the much shorter life span of the mouse .
# ::alignments 56-57|0.0.1 53-54|0.0 52-53|0.0.0 51-52|0.0.2 50-51|0.1.0.1 47-48|0 44-45|0.1 42-43|0.1.0.2 41-42|0.1.0.2.0 40-41|0.1.1.0.0.0.0 37-38|0.1.0 36-37|0.1.0.0.0 34-35|0.1.0.0 33-34|0.1.0.0.1 32-33|0.1.0.3 30-31|0.1.1.0.1.0 28-29|0.1.1.0.1 27-28|0.1.1.0.1.1 26-27|0.1.1.0.1.2 23-24|0.1.1.0 22-23|0.1.1.0.2 19-20|0.1.1.0.0 16-17|0.1.1.0.0.0 14-15|0.1.1.0.0.0.1 13-14|0.1.1.0.0.0.1.0 12-13|0.1.1 9-10|0.1.1.1.0.0 7-8|0.1.1.1.0 4-5|0.1.1.1.0.1 3-4|0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:50.932
(e / express-01 
      :ARG1 (s / span-01 
            :ARG0 (l / life) 
            :ARG1 (m / mouse) 
            :mod (s2 / short)) 
      :ARG1-of (p / possible-01 
            :ARG2 (l2 / lead-03 
                  :ARG0 (d2 / deletion 
                        :location (m3 / mouse) 
                        :mod (h / homozygou)) 
                  :ARG1 (m2 / much) 
                  :ARG2 (d / disord 
                        :mod (o / onset)) 
                  :op1-of (w / whereas)) 
            :op1-of (a / and 
                  :ARG2-of (l4 / lead-03 
                        :ARG0 (o3 / observation 
                              :ARG2-of (c / consistent-01 
                                    :ARG0 (e2 / early) 
                                    :ARG1 (c2 / concept 
                                          :mod (t / this)))) 
                        :ARG1 (d3 / disord 
                              :location (h2 / human) 
                              :mod (o2 / onset) 
                              :time (l3 / late)) 
                        :mod (d4 / deletion)) 
                  :domain (d5 / disease 
                        :ARG0-of (r / result-01 
                              :ARG1 (h3 / haploinsufficiency) 
                              :ARG1-of (p2 / possible-01))))))

# ::snt Second , we can not rule out the existence of an alternate start site for ITPR1 that may result in a product that confers a pathogenic gain of function to the protein ; however , Western blot analysis of cells derived from affected AUS1 family members , which was performed using an antibody raised against the C-terminal portion of ITPR1 , failed to identify any disease-specific truncated protein products .
# ::tok Second , we can not rule out the existence of an alternate start site for ITPR1 that may result in a product that confers a pathogenic gain of function to the protein ; however , Western blot analysis of cells derived from affected AUS1 family members , which was performed using an antibody raised against the C-terminal portion of ITPR1 , failed to identify any disease-specific truncated protein products .
# ::alignments 68-69|0.0.0 67-68|0 66-67|0.0 64-65|0.0.0.0.1.0.0.0.0.0.0.0 63-64|0.0.0.0 61-62|0.0.0.0.1 57-58|0.0.0.0.1.0.0.0.0.0.0.1.0.0 53-54|0.0.0.0.1.0.0.0.0.0.0.1.0 52-53|0.0.0.0.1.0.0.0.0.0.0.1 50-51|0.0.0.0.1.0.0.0.0.0.0 49-50|0.0.0.0.1.0.0.0.0.0 45-46|0.0.0.0.1.0.0.0.0.1.1+0.0.0.0.1.0.0.0.0.1+0.0.0.0.1.0.0.0.0 44-45|0.0.0.0.1.0.0.0.0.1.0 43-44|0.0.0.0.1.0.0.0.0.1.0.0.0.0+0.0.0.0.1.0.0.0.0.1.0.0.0+0.0.0.0.1.0.0.0.0.1.0.0 42-43|0.0.0.0.1.0.0.0.0.2 40-41|0.0.0.0.1.0.0.0 39-40|0.0.0.0.1.0.0 37-38|0.0.0.0.1.0 36-37|0.0.0.0.1.0.1 35-36|0.0.0.0.1.0.2.1+0.0.0.0.1.0.2.0.0+0.0.0.0.1.0.2.0+0.0.0.0.1.0.2 32-33|0.0.0.0.0 31-32|0.0.0.0.0.0.0.0.2.0.1 28-29|0.0.0.0.0.0.0.0.2.0.0.0 26-27|0.0.0.0.0.0.0.0.2.0.0 25-26|0.0.0.0.0.0.0.0.2.0.0.1 23-24|0.0.0.0.0.0.0.0.2.0 21-22|0.0.0.0.0.0.0.0.2 18-19|0.0.0.0.0.0.0.0 17-18|0.0.0.0.0.0.0.0.1 13-14|0.0.0.0.0.0.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.0.0.1 8-9|0.0.0.0.0.0.0.0.0 5-6|0.0.0.0.0.0.0.0.0.0 4-5|0.0.0.0.0.0.0.0.0.0.2 3-4|0.0.0.0.0.0.0.0.0.0.1 2-3|0.0.0.0.0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:54.989
(p2 / protein 
      :ARG1-of (t / truncate-01 
            :mod-of (p / product 
                  :ARG1-of (i / identify-01 
                        :ARG0 (a5 / and 
                              :op1 (s2 / start-01 
                                    :mod-of (s / site 
                                          :ARG0-of (r2 / result-01 
                                                :ARG1 (e / exist-01 
                                                      :ARG1-of (r3 / rule-03 
                                                            :ARG0 (w2 / we) 
                                                            :ARG1-of (p10 / possible-01 
                                                                  :ARG1-of (s3 / second-01)) 
                                                            :polarity -)) 
                                                :ARG1-of (p9 / possible-01) 
                                                :ARG2 (p8 / product 
                                                      :ARG0-of (c2 / confer-01 
                                                            :ARG1 (g / gain-02 
                                                                  :ARG1 (f3 / function-01) 
                                                                  :mod (p7 / pathogenic)) 
                                                            :ARG3 (p6 / protein)))) 
                                          :mod (a6 / alternate-01)))) 
                        :ARG2-of (f / fail-01 
                              :ARG1 (a4 / analyze-01 
                                    :ARG1 (c / cell 
                                          :ARG1-of (d / derive-01 
                                                :ARG2 (p5 / person 
                                                      :ARG0-of (p4 / perform-02 
                                                            :ARG1 (u / use-01 
                                                                  :ARG0 (a / any) 
                                                                  :ARG1 (a2 / antibody 
                                                                        :ARG1-of (r / raise-01 
                                                                              :prep-against (p3 / portion))))) 
                                                      :ARG0-of (h / have-org-role-91 
                                                            :ARG1 (f2 / family 
                                                                  :mod (t2 / thing 
                                                                        :name (n / name 
                                                                              :op1 "AUS1"))) 
                                                            :ARG2 (m / member)) 
                                                      :ARG1-of (a3 / affect-01)))) 
                                    :ARG2 (b / blot-01) 
                                    :manner (w / world-region 
                                          :name (n2 / name 
                                                :op1 "West") 
                                          :wiki "Western_world")))))))

# ::snt Clearly , the identification of distinct ITPR1 mutations underlying SCA15 will help elucidate the pathogenic mechanism of this disorder .
# ::tok Clearly , the identification of distinct ITPR1 mutations underlying SCA15 will help elucidate the pathogenic mechanism of this disorder .
# ::alignments 18-19|0.0.0.0.0.1 17-18|0.0.0.0.0.1.0 15-16|0.1.0 14-15|0.1.0.0 12-13|0.1 11-12|0 9-10|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 8-9|0.0.0.0 7-8|0.0.0 6-7|0.0.0.1 5-6|0.0.0.2 3-4|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:55.203
(h / help-01 
      :ARG0 (i2 / identify-02 
            :ARG1 (m2 / mutate-01 
                  :ARG0-of (u / underlie-01 
                        :ARG1 (t2 / thing 
                              :name (n / name 
                                    :op1 "SCA15") 
                              :poss-of (d / disord 
                                    :mod (t / this)))) 
                  :ARG1 (i / ITPR1) 
                  :mod (d2 / distinct))) 
      :ARG1 (e / elucidate-01 
            :ARG1 (m / mechanism 
                  :mod (p / pathogenic))) 
      :ARG1-of (c / clear-06))

# ::snt We show here the utility of investigating spontaneous mouse mutations in understanding human disease .
# ::tok We show here the utility of investigating spontaneous mouse mutations in understanding human disease .
# ::alignments 13-14|0.1.0.2.0 12-13|0.1.0.2.0.0 11-12|0.1.0.2 9-10|0.1.0 8-9|0.1.0.0 7-8|0.1.0.3 6-7|0.1.0.1 4-5|0.1 2-3|0.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:55.312
(s2 / show-01 
      :ARG0 (w / we) 
      :ARG1 (u2 / utility 
            :ARG0-of (m / mutate-01 
                  :ARG1 (m2 / mouse) 
                  :ARG1-of (i / investigate-01) 
                  :ARG2 (u / understand-01 
                        :ARG1 (d / disease 
                              :mod (h / human))) 
                  :mod (s / spontaneous))) 
      :location (h2 / here))

# ::snt Currently , the small number of aged Itpr1wt/18 animals precludes us from examining these mice for subtle signs and symptoms similar to those seen in SCA15 patients ; however , these mice are clearly of interest to us as a potential model of SCA15 .
# ::tok Currently , the small number of aged Itpr1wt/18 animals precludes us from examining these mice for subtle signs and symptoms similar to those seen in SCA15 patients ; however , these mice are clearly of interest to us as a potential model of SCA15 .
# ::alignments 41-42|0.1.1.0.0 40-41|0.1.1.0.0.0 35-36|0.0.1.0.1 33-34|0.0.1.0.0 31-32|0.0.1.0 30-31|0.0.1.0.2 27-28|0.0.1 26-27|0.0.0.0+0.0.0+0.0 25-26|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 23-24|0 20-21|0.1.1.0 19-20|0.1.1 18-19|0.1 17-18|0.1.1.0.1 16-17|0.1.1.1 14-15|0.1.0.0 13-14|0.1.0.0.0 12-13|0.1.0 9-10|0.1.0.1 8-9|0.1.0.1.0 6-7|0.1.0.1.0.0 4-5|0.1.0.1.0.1 3-4|0.1.0.1.0.1.0 0-1|0.1.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:56.875
(s / see-01 
      :ARG0 (p2 / person 
            :ARG0-of (h / have-rel-role-91 
                  :ARG2 (p3 / patient 
                        :mod (t2 / thing 
                              :name (n / name 
                                    :op1 "SCA15")))) 
            :op1-of (a / and 
                  :op2 (m2 / mouse 
                        :ARG1-of (c / clear-06) 
                        :ARG1-of (i / interest-01) 
                        :mod (t / this)))) 
      :ARG1 (a2 / and 
            :op1 (e / examine-01 
                  :ARG1 (m3 / mouse 
                        :mod (t3 / this)) 
                  :ARG2-of (p4 / preclude-01 
                        :ARG0 (a3 / animal 
                              :ARG1-of (a4 / age-01) 
                              :quant (n2 / number 
                                    :mod (s5 / small))) 
                        :time (c2 / current))) 
            :op2 (s2 / symptom 
                  :ARG1-of (r / resemble-01 
                        :ARG0 (m / model 
                              :mod (p / potential)) 
                        :ARG2 (s3 / sign)) 
                  :mod (s4 / subtle))))

# ::snt These data also demonstrate that genome-wide SNP assay can facilitate rapid detection of structural genomic mutations that may underlie disease .
# ::tok These data also demonstrate that genome-wide SNP assay can facilitate rapid detection of structural genomic mutations that may underlie disease .
# ::alignments 19-20|0.0.1 18-19|0.0 17-18|0 15-16|0.0.0 13-14|0.0.0.1 11-12|0.0.0.0 10-11|0.0.0.0.1 9-10|0.0.0.0.0 8-9|0.0.0.0.0.1 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 3-4|0.0.0.0.0.1.0 2-3|0.0.0.0.0.1.0.1 1-2|0.0.0.0.0.1.0.0 0-1|0.0.0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:56.986
(p / possible-01 
      :ARG1 (u / underlie-01 
            :ARG0 (m / mutate-01 
                  :ARG1-of (d2 / detect-01 
                        :ARG1-of (f / facilitate-01 
                              :ARG0 (a / assay 
                                    :mod (p3 / political-party 
                                          :name (n / name 
                                                :op1 "SNP") 
                                          :wiki "Scottish_National_Party")) 
                              :ARG1-of (p2 / possible-01 
                                    :ARG1-of (d3 / demonstrate-01 
                                          :ARG0 (d4 / data 
                                                :mod (t / this)) 
                                          :mod (a2 / also)))) 
                        :manner (r / rapid)) 
                  :mod (s / structure)) 
            :ARG1 (d / disease)))

# ::snt The data provided by these approaches provide compelling evidence that heterozygous deletion of ITPR1 causes SCA15 .
# ::tok The data provided by these approaches provide compelling evidence that heterozygous deletion of ITPR1 causes SCA15 .
# ::alignments 14-15|0 11-12|0.0 10-11|0.0.0 8-9|0.1 7-8|0.1.0 6-7|0.1.1 5-6|0.2 4-5|0.2.1 2-3|0.2.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:07:57.264
(c / cause-01 
      :ARG0 (d / deletion 
            :mod (h / heterozygou)) 
      :ARG1 (e / evidence-01 
            :ARG1-of (c2 / compel-01) 
            :ARG1-of (p / provide-01)) 
      :time (a / approach-02 
            :ARG0-of (p2 / provide-01 
                  :ARG1 (d2 / data)) 
            :mod (t / this)))

# ::snt Clearly , sequence analysis of ITPR1 in potential SCA15 cases may provide additional insight into the disease , particularly if a stop mutation were to be identified ; however , the mutational mechanism noted here means that standard sequencing approaches alone are insufficient to confidently rule out ITPR1 mutation as a cause of disease : a comprehensive gene dosage approach is also required .
# ::tok Clearly , sequence analysis of ITPR1 in potential SCA15 cases may provide additional insight into the disease , particularly if a stop mutation were to be identified ; however , the mutational mechanism noted here means that standard sequencing approaches alone are insufficient to confidently rule out ITPR1 mutation as a cause of disease : a comprehensive gene dosage approach is also required .
# ::alignments 62-63|0.1.2.1.1.1.2 61-62|0.1.2.1.1.1.2.2 59-60|0.1.2.1.1.1.2.1 58-59|0.1.2.1.1.1.2.1.1 57-58|0.1.2.1.1.1.2.1.2 56-57|0.1.2.1.0 53-54|0.0 51-52|0 48-49|0.1.1 45-46|0.1 44-45|0.1.2.1.1.1.1.0.0 42-43|0.1.2.2+0.1.2 40-41|0.1.2.1.1.1.2.0 39-40|0.1.0 38-39|0.1.0.0 37-38|0.1.0.1 35-36|0.1.2.1 34-35|0.1.2.1.1.1.2.1.0 33-34|0.1.2.1.1 32-33|0.1.2.1.1.0 31-32|0.1.2.1.1.0.0 27-28|0.1.2.1.1.2 26-27|0.1.2.1.1.1 22-23|0.1.2.1.1.1.1 21-22|0.1.2.1.1.1.1.0 18-19|0.1.2.1.2.0 16-17|0.1.2.1.2.1.2 13-14|0.1.2.1.2.1.0 12-13|0.1.2.1.2.1.0.0 11-12|0.1.2.1.2.1 10-11|0.1.2.1.2 9-10|0.1.2.0.0 8-9|0.1.2.0.1.0+0.1.2.0.1+0.1.2.0 7-8|0.1.2.0.0.0 3-4|0.1.2.1.1.1.0 2-3|0.1.2.1.1.1.0.0 0-1|0.1.2.1.2.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:00.287
(c2 / cause-01 
      :ARG1 (d2 / disease) 
      :ARG2-of (r2 / rule-03 
            :ARG0 (a4 / approach-02 
                  :ARG1 (s2 / sequence) 
                  :ARG1-of (s3 / standard-02)) 
            :ARG1 (m / mutation) 
            :ARG1-of (s / suffice-01 
                  :ARG0 (t / thing 
                        :ARG1-of (c4 / case-03 
                              :mod (p4 / potential)) 
                        :name (n2 / name 
                              :op1 "SCA15")) 
                  :ARG1-of (m2 / mean-01 
                        :ARG0 (c / comprehensive) 
                        :ARG1-of (n / note-01 
                              :ARG0 (m3 / mechanism 
                                    :mod (m4 / mutational)) 
                              :ARG2 (i / identify-01 
                                    :ARG0 (a7 / analyze-01 
                                          :ARG1 (s5 / sequence)) 
                                    :ARG1 (m5 / mutation 
                                          :mod (s4 / stop-01 
                                                :ARG0 (c3 / confidently))) 
                                    :ARG2-of (r / require-01 
                                          :ARG0 (a3 / alone) 
                                          :ARG1 (a2 / approach-02 
                                                :ARG0 (h / here) 
                                                :ARG1 (d / dosage) 
                                                :mod (g / gene)) 
                                          :mod (a / also))) 
                              :op1-of (a5 / and)) 
                        :ARG2 (p3 / possible-01 
                              :ARG0 (p / particular) 
                              :ARG1 (p2 / provide-01 
                                    :ARG1 (i2 / insight 
                                          :mod (a6 / additional)) 
                                    :ARG1-of (c5 / clear-06) 
                                    :ARG2 (d3 / disease)))) 
                  :polarity -)))

# ::snt Given that SCA16 and autosomal dominant congenital nonprogressive ataxia have both recently been mapped to regions overlapping with the SCA15 locus [ 10,11 ] , ITPR1 is a gene of importance for screening in these families .
# ::tok Given that SCA16 and autosomal dominant congenital nonprogressive ataxia have both recently been mapped to regions overlapping with the SCA15 locus [ 10,11 ] , ITPR1 is a gene of importance for screening in these families .
# ::alignments 35-36|0.0.0.0.0 34-35|0.0.0.0.0.0 32-33|0.0.0.0 30-31|0.0.0.0.1 28-29|0.0.0.0.1.0 20-21|0.2.0.0 16-17|0.1.0 15-16|0.1 13-14|0 11-12|0.3 10-11|0.3.0 8-9|0.0 7-8|0.0.1 6-7|0.0.2 5-6|0.0.0 4-5|0.0.1.0 3-4|0.2 2-3|0.2.1.0.0+0.2.1.0+0.2.1 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:00.758
(m / map-01 
      :ARG1 (a / ataxia 
            :ARG1-of (d / dominate-01 
                  :ARG2 (s / screen-01 
                        :ARG1 (f / family 
                              :mod (t / this)) 
                        :ARG2 (i / important 
                              :mod-of (g / gene)))) 
            :mod (n / nonprogressive 
                  :mod (a2 / autosomal)) 
            :mod (c / congenital)) 
      :ARG2 (r / region 
            :ARG0-of (o / overlap-01)) 
      :op2-of (a3 / and 
            :ARG2-of (g2 / give-01 
                  :ARG1 (l / locu)) 
            :op1 (c2 / country 
                  :name (n2 / name 
                        :op1 "SCA16"))) 
      :time (r2 / recent 
            :mod (b / both)))

# ::snt These data add weight to a role for aberrant intracellular Ca2 + signaling in Purkinje cells in the pathogenesis of spinocerebellar ataxia .
# ::tok These data add weight to a role for aberrant intracellular Ca2 + signaling in Purkinje cells in the pathogenesis of spinocerebellar ataxia .
# ::alignments 21-22|0.0 20-21|0.0.0 18-19|0 15-16|0.1 14-15|0.1.1 12-13|0.1.0 10-11|0.1.0.1 9-10|0.1.0.1.0 8-9|0.1.0.1.1 6-7|0.1.0.1.2 3-4|0.1.0.0.0.0 2-3|0.1.0.0.0 1-2|0.1.0.0 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:01.049
(p / pathogenesi 
      :mod (a / ataxia 
            :mod (s / spinocerebellar)) 
      :part (c / cell 
            :ARG2-of (s2 / signal-01 
                  :ARG0 (d / data 
                        :ARG1-of (a3 / add-02 
                              :ARG2 (w / weight)) 
                        :mod (t / this)) 
                  :ARG1 (c2 / Ca2 
                        :mod (i / intracellular) 
                        :mod (a2 / aberrant) 
                        :purpose-of (r / role))) 
            :mod (p2 / purkinje)))

# ::snt Genome-wide linkage in mice .
# ::tok Genome-wide linkage in mice .
# ::alignments 3-4|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:01.058
(l / linkage 
      :location (m / mouse))

# ::snt One hundred and twenty DNA fragments were amplified across the genome , each selected to contain one or more strain-specific SNPs that would differentiate between C57BL/6J and 129x1/SvJ inbred strains [ 12 ] .
# ::tok One hundred and twenty DNA fragments were amplified across the genome , each selected to contain one or more strain-specific SNPs that would differentiate between C57BL/6J and 129x1/SvJ inbred strains [ 12 ] .
# ::alignments 31-32|0.0.1.1.0.0.0 29-30|0.0.1.1.1.1.2 28-29|0.0.1.1.1.1.2.0 26-27|0.0.1.1.1.1 25-26|0.0.1.1.1.1.1.0.0+0.0.1.1.1.1.1.0+0.0.1.1.1.1.1 23-24|0.0.1.0 20-21|0.0.1 18-19|0.0.0 17-18|0.0 15-16|0.0.1.1 13-14|0.0.1.1.1 12-13|0.0.1.1.1.0 10-11|0.0.1.1.1.1.0.0.0 8-9|0.0.1.1.1.1.0.0 7-8|0.0.1.1.1.1.0 5-6|0.0.1.1.0.0 4-5|0.0.1.1.0 3-4|0.0.1.0.1 2-3|0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:01.816
(a4 / and 
      :op1-of (o / or 
            :op2 (m / more) 
            :quant-of (s2 / snp 
                  :ARG0-of (d / differentiate-01 
                        :ARG2 1 
                        :op1-of (t / twenty)) 
                  :ARG1-of (c2 / contain-01 
                        :ARG0 (d2 / DNA 
                              :ARG1-of (f / fragment-01 
                                    :ARG0 12)) 
                        :ARG1-of (s3 / select-01 
                              :ARG0 (e / each) 
                              :op2-of (a / and 
                                    :op1 (a3 / amplify-01 
                                          :ARG1 (a2 / across 
                                                :op1 (g / genome))) 
                                    :op3 (c / country 
                                          :name (n / name 
                                                :op1 "C57BL/6J")) 
                                    :op4 (s / strain 
                                          :mod (i / inbred))))))))

# ::snt Each fragment was initially amplified in 11 affected mice and nine unaffected mice ; genotype calling was performed by dye-terminator sequencing of these fragments .
# ::tok Each fragment was initially amplified in 11 affected mice and nine unaffected mice ; genotype calling was performed by dye-terminator sequencing of these fragments .
# ::alignments 23-24|0.0.0.0.0.1.0.0 22-23|0.0.0.0.0.1.0.0.1 17-18|0.0 15-16|0.0.0 14-15|0.0.0.1 13-14|0 12-13|0.0.0.0.1 11-12|0.0.0.0.1.0.0+0.0.0.0.1.0 10-11|0.0.0.0.0.1.0.0.0 9-10|0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.2 4-5|0.0.0.0.0.1 3-4|0.0.0.0.0.1.1 1-2|0.0.0.0.0.1.0 0-1|0.0.0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:02.104
(a / and 
      :op1 (p / perform-02 
            :ARG1 (c / call-03 
                  :ARG1 (a3 / and 
                        :op1 (m2 / mouse 
                              :ARG1-of (a4 / affect-01) 
                              :medium-of (a5 / amplify-01 
                                    :ARG1 (f2 / fragment-01 
                                          :ARG1 (f / fragment-01 
                                                :ARG1 9 
                                                :mod (t / this)) 
                                          :mod (e / each)) 
                                    :time (i / initial)) 
                              :quant 11) 
                        :op2 (m / mouse 
                              :ARG1-of (a2 / affect-01 
                                    :polarity -))) 
                  :mod (g / genotype))))

# ::snt Linkage analysis using these data was performed using mlink [ 13 ] , which revealed a positive linkage at Chromosome 6qE1 , on the 129x1/SvJ background ( two-point LOD score 5.13 at marker 20 .
# ::tok Linkage analysis using these data was performed using mlink [ 13 ] , which revealed a positive linkage at Chromosome 6qE1 , on the 129x1/SvJ background ( two-point LOD score 5.13 at marker 20 .
# ::alignments 33-34|0.1.0.0.1.0 32-33|0 29-30|0.1 28-29|0.1.0.1.0+0.1.0.1+0.1.0 25-26|0.1.0.0.0.0 19-20|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 17-18|0.1.1.0 16-17|0.1.1.0.0 14-15|0.1.1 10-11|0.0 8-9|0.1.0.0.0.2 7-8|0.1.0.0 6-7|0.1.0.0.1 4-5|0.1.0.0.0.1.0 3-4|0.1.0.0.0.1.0.0 2-3|0.1.0.0.0.1 1-2|0.1.0.0.0 0-1|0.1.0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:02.644
(m / mark-01 
      :ARG0 13 
      :ARG2-of (s / score-01 
            :ARG1 (c / country 
                  :ARG0-of (u / use-01 
                        :ARG1 (a / analyze-01 
                              :ARG0 (b / background) 
                              :ARG0-of (u2 / use-01 
                                    :ARG1 (d / data 
                                          :mod (t / this))) 
                              :ARG1 (m2 / mlink) 
                              :manner (l2 / linkage)) 
                        :ARG1-of (p2 / perform-02 
                              :ARG0 20)) 
                  :name (n / name 
                        :op1 "LOD")) 
            :medium-of (r / reveal-01 
                  :ARG1 (l / linkage 
                        :mod (p / positive)) 
                  :destination (c2 / country 
                        :name (n2 / name 
                              :op1 "Chromosome")))))

# ::snt MMHAP85FLG2 ) .
# ::tok MMHAP85FLG2 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:02.647
(a / amr-empty)

# ::snt In an attempt to narrow the disease interval we performed backcross experiments that resulted in the generation of three additional affected mice .
# ::tok In an attempt to narrow the disease interval we performed backcross experiments that resulted in the generation of three additional affected mice .
# ::alignments 21-22|0.0 20-21|0 19-20|0.0.1 18-19|0.0.0.0.0.0.0.0.0.0 16-17|0.0.0 13-14|0.0.0.0 11-12|0.0.0.0.0 10-11|0.0.0.0.0.1 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0.0.0 7-8|0.0.0.0.0.0.0.0.0.1 6-7|0.0.0.0.0.0.0.0.0.1.0 4-5|0.0.0.0.0.0.0.0.0 2-3|0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:02.805
(a / affect-01 
      :ARG1 (m / mouse 
            :consist (g / generation 
                  :ARG2-of (r / result-01 
                        :ARG1 (e / experiment-01 
                              :ARG1-of (p / perform-02 
                                    :ARG0 (w / we 
                                          :ARG0-of (a3 / attempt-01 
                                                :ARG1 (n / narrow-01 
                                                      :ARG0 3 
                                                      :ARG1 (i / interval 
                                                            :mod (d / disease)))))) 
                              :mod (b / backcros)))) 
            :mod (a2 / additional)))

# ::snt Genotyping of all affected mice across the disease-segregating interval revealed flanking recombinants and a candidate region of ~ 5 Mb , between markers D6Mit37 and 44 .
# ::tok Genotyping of all affected mice across the disease-segregating interval revealed flanking recombinants and a candidate region of ~ 5 Mb , between markers D6Mit37 and 44 .
# ::alignments 25-26|0.4.0.0.0 24-25|0.3 22-23|0.2.0.0 19-20|0.4.0.1 18-19|0.1.0.0 15-16|0.4.0 14-15|0.4.0.0 12-13|0.4 11-12|0.1 10-11|0.1.0 9-10|0 8-9|0.2.1.0 7-8|0.2.1.0.0 5-6|0.2.1 4-5|0.2 3-4|0.2.0 2-3|0.2.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:03.605
(r3 / reveal-01 
      :ARG0 (g / genotyp) 
      :ARG2 (r2 / recombinant 
            :ARG1-of (f / flank-01 
                  :ARG0 5)) 
      :instrument (m3 / mouse 
            :ARG1-of (a4 / affect-01 
                  :ARG0 (m / marker)) 
            :location (a3 / across 
                  :op1 (i / interval 
                        :mod (d / disease-segregat))) 
            :quant (a5 / all)) 
      :op1-of (a / and) 
      :op1-of (a2 / and 
            :op2 (r / region 
                  :mod (c / candidate 
                        :poss 44) 
                  :mod (m2 / mb))))

# ::snt MMHAP85FLG5 ( Figure S1 ) .
# ::tok MMHAP85FLG5 ( Figure S1 ) .
# ::alignments 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:03.614
(f / figure)

# ::snt This region contains 16 genes and predicted transcripts .
# ::tok This region contains 16 genes and predicted transcripts .
# ::alignments 7-8|0.0.0.0 6-7|0.0.0 5-6|0.0.0.1 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:03.711
(c / contain-01 
      :ARG0 (r / region 
            :ARG0-of (p / predict-01 
                  :ARG1 (t / transcript) 
                  :op1-of (a / and)) 
            :mod (t2 / this)) 
      :ARG1 (g / gene 
            :quant 16))

# ::snt Identification of the underlying genetic lesion in mice .
# ::tok Identification of the underlying genetic lesion in mice .
# ::alignments 7-8|0.0.1 5-6|0.0 4-5|0.0.2 3-4|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:03.731
(i / identification 
      :mod (l / lesion 
            :ARG1-of (u / underlie-01) 
            :location (m / mouse) 
            :mod (g / gene)))

# ::snt Identification of similar phenotypes in mice linked to the 6qE1 interval was performed by literature searches .
# ::tok Identification of similar phenotypes in mice linked to the 6qE1 interval was performed by literature searches .
# ::alignments 15-16|0.0 14-15|0.0.1 12-13|0.0.0 10-11|0 9-10|0.2 6-7|0.1 5-6|0.1.1 3-4|0.1.0 2-3|0.1.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:03.973
(i / interval 
      :ARG0-of (s / search-01 
            :ARG0-of (p / perform-02 
                  :ARG1 (i2 / identification)) 
            :ARG1 (l / literature)) 
      :ARG2-of (l2 / link-01 
            :ARG0 (p2 / phenotyp 
                  :ARG1-of (r / resemble-01)) 
            :ARG1 (m / mouse)) 
      :mod 6qE1)

# ::snt This revealed the Itpr1opt/opt mouse , in which disease is caused by homozygous deletion mutation of exons 43 and 44 of Itpr1 .
# ::tok This revealed the Itpr1opt/opt mouse , in which disease is caused by homozygous deletion mutation of exons 43 and 44 of Itpr1 .
# ::alignments 21-22|0.3 19-20|0.4 18-19|0.2.0.3 17-18|0.2.2 16-17|0.2.0.1 14-15|0.2.0 13-14|0.2.0.0 12-13|0.2.0.2 10-11|0.2 8-9|0.2.1 4-5|0.1 3-4|0.1.0.0.0+0.1.0.0+0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:04.451
(r / reveal-01 
      :ARG0 (t2 / this) 
      :ARG1 (m2 / mouse 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "Itpr1opt/opt"))) 
      :ARG2 (c / cause-01 
            :ARG0 (m / mutation 
                  :mod (d / deletion) 
                  :mod (e / exon) 
                  :mod (h / homozygou) 
                  :op1-of (a / and)) 
            :ARG1 (d2 / disease) 
            :time 43) 
      :op1-of (i / Itpr1) 
      :op1-of 44)

# ::snt Primer pairs were designed to sequence each of the coding exons and at least 50 bp of each flanking intronic sequence of Itpr1 .
# ::tok Primer pairs were designed to sequence each of the coding exons and at least 50 bp of each flanking intronic sequence of Itpr1 .
# ::alignments 22-23|0.0.1.1.0.1 20-21|0.0.1.1.0 18-19|0.0.1.1 17-18|0.0.1.1.0.0 14-15|0.0.0 11-12|0 10-11|0.1 9-10|0.1.0 6-7|0.1.1 5-6|0.0.2 3-4|0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:04.604
(a / and 
      :op1 (d / design-01 
            :ARG0 50 
            :ARG1 (p / pair-01 
                  :ARG1 (p2 / primer) 
                  :ARG2 (f / flank-01 
                        :ARG1 (s / sequence 
                              :mod (e / each) 
                              :mod (i / Itpr1)))) 
            :ARG3 (s2 / sequence)) 
      :op2 (e2 / exon 
            :ARG1-of (c / code-01) 
            :mod (e3 / each)))

# ::snt PCR amplification of each exon was performed using DNA from two affected mice as templates .
# ::tok PCR amplification of each exon was performed using DNA from two affected mice as templates .
# ::alignments 14-15|0.0.1.0 12-13|0.1 11-12|0 10-11|0.1.0 8-9|0.0.0 7-8|0.0 6-7|0.0.1 4-5|0.0.2.1 3-4|0.0.2.1.0 1-2|0.0.2 0-1|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:04.874
(a / affect-01 
      :ARG1 (u / use-01 
            :ARG1 (d / DNA) 
            :ARG1-of (p / perform-02 
                  :ARG0 (t / templat)) 
            :ARG2 (a2 / amplification 
                  :mod (p2 / PCR) 
                  :poss (e / exon 
                        :mod (e2 / each)))) 
      :ARG2 (m / mouse 
            :quant 2))

# ::snt The Itpr118/18 mutation was confirmed by sequencing in all affected mice ( Figure S2 ) .
# ::tok The Itpr118/18 mutation was confirmed by sequencing in all affected mice ( Figure S2 ) .
# ::alignments 12-14|0.2.0.0.0.1+0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 10-11|0.2 9-10|0.2.0 8-9|0.2.1 6-7|0.0 4-5|0 2-3|0.1 1-2|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:05.054
(c / confirm-01 
      :ARG0 (s2 / sequence) 
      :ARG1 (m2 / mutation 
            :mod (t2 / thing 
                  :name (n2 / name 
                        :op1 "Itpr118/18"))) 
      :location (m / mouse 
            :ARG1-of (a / affect-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 (f / Figure) 
                              :op2 (s / S2)))) 
            :quant (a2 / all)))

# ::snt Breeding experiments were performed between two female mice heterozygous for the current mutation ( Itpr1wt/18 ) and a male mouse heterozygous for the Itpr1opt mutation ( Itpr1wt/opt ) .
# ::tok Breeding experiments were performed between two female mice heterozygous for the current mutation ( Itpr1wt/18 ) and a male mouse heterozygous for the Itpr1opt mutation ( Itpr1wt/opt ) .
# ::alignments 24-25|0 20-21|0.0.0.1 19-20|0.0.0.1.0 18-19|0.0.1.0 16-17|0.0.0 12-13|0.0.0.0 11-12|0.0.0.0.0 8-9|0.0.2 7-8|0.0.2.0 6-7|0.0.1.1.0 5-6|0.0.2.1 3-4|0.0 1-2|0.0.1 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:05.322
(m / mutation 
      :ARG2-of (p / perform-02 
            :ARG0 (a / and 
                  :op1 (m4 / mutation 
                        :time (c / current)) 
                  :op2 (h / heterozygou 
                        :mod (m2 / mouse))) 
            :ARG1 (e / experiment-01 
                  :ARG0 (m3 / male) 
                  :ARG1-of (b / breed-01 
                        :ARG0 (f / female))) 
            :time (h2 / heterozygou 
                  :mod (m5 / mouse) 
                  :quant 2)))

# ::snt This resulted in two litters of mice with a total of four affected Itpr1opt/18 pups ( from a total of 15 ; two of seven from first mating ; two of eight from the second mating ) with a phenotype indistinguishable from that of the Itpr118/18 and Itpr1opt/opt mice .
# ::tok This resulted in two litters of mice with a total of four affected Itpr1opt/18 pups ( from a total of 15 ; two of seven from first mating ; two of eight from the second mating ) with a phenotype indistinguishable from that of the Itpr118/18 and Itpr1opt/opt mice .
# ::alignments 48-49|0.1.1.1.1.0.2.0 47-48|0.1.1.1.1.0.2.1.0+0.1.1.1.1.0.2.1+0.1.1.1.1.0.2 46-47|0.1.1.1.1.0 45-46|0.1.1.1.1.0.1.1.0+0.1.1.1.1.0.1.1+0.1.1.1.1.0.1 42-43|0.1.1.1.1.0.1.0 40-41|0.1.1.1.1.0.1.0.0 39-40|0.1.1.0 35-36|0.1.1.2 31-32|0.1.1.3.0 29-30|0.1.1.1.0 27-28|0.1.1.1 24-25|0.1.1.4.0 22-23|0.1.1.1.1.0.0.1 21-22|0.1.1.1.1.0.0 20-21|0.1.1.1.1.0.0.0 18-19|0.1.1.1.1 14-15|0.1.1 12-13|0.1.1.4 11-12|0.1.1.3.1 9-10|0.1.1.3 6-7|0.1.0 4-5|0.1 3-4|0.1.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:06.177
(r / result-01 
      :ARG1 (t6 / this) 
      :ARG2 (l / litter-01 
            :ARG1 (m4 / mouse) 
            :ARG2 (p2 / pup-01 
                  :ARG0 (p / phenotype) 
                  :ARG1 (m3 / mate-01 
                        :ARG1 2 
                        :ARG1-of (t4 / total-01 
                              :ARG2 (a / and 
                                    :op1 (a2 / and 
                                          :op1 15 
                                          :op2 2) 
                                    :op2 (t2 / thing 
                                          :mod (t3 / that 
                                                :domain-of (i / indistinguishable)) 
                                          :name (n2 / name 
                                                :op1 "Itpr118/18")) 
                                    :op3 (t / thing 
                                          :mod-of (m / mouse) 
                                          :name (n / name 
                                                :op1 "Itpr1opt/opt"))))) 
                  :ARG1-of (m2 / mate-01) 
                  :ARG1-of (t5 / total-01 
                        :ARG0 8 
                        :ARG2 4) 
                  :ARG1-of (a3 / affect-01 
                        :ARG0 7)) 
            :quant 2))

# ::snt Analysis of Itpr1 protein in mice .
# ::tok Analysis of Itpr1 protein in mice .
# ::alignments 5-6|0.0.0 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:06.187
(a / analysi 
      :mod (p / protein 
            :location (m / mouse)))

# ::snt We performed Western blot analyses using standard techniques with ECL detection kits ( Amersham , http://www.amersham.com ) .
# ::tok We performed Western blot analyses using standard techniques with ECL detection kits ( Amersham , http://www.amersham.com ) .
# ::alignments 13-14|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 11-12|0.1.0.0.0.0 10-11|0.1.0.0.0 9-10|0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0 4-5|0 3-4|0.1.0.0 2-3|0.2.1+0.2.0.0+0.2.0+0.2 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:06.417
(a / analysis 
      :ARG0-of (u / use-01 
            :ARG1 (t2 / technique 
                  :ARG1-of (s / standard-02 
                        :ARG2 (c / country 
                              :name (n / name 
                                    :op1 "Amersham"))))) 
      :ARG1-of (p / perform-02 
            :ARG0 (w2 / we 
                  :ARG0-of (b / blot-01 
                        :ARG1 (d / detect-01 
                              :ARG0 (k / kit) 
                              :ARG1 (t / thing 
                                    :name (n2 / name 
                                          :op1 "ECL")))))) 
      :mod (w / world-region 
            :name (n3 / name 
                  :op1 "West") 
            :wiki "Western_world"))

# ::snt Briefly , dissected whole brains from postnatal day 21 littermates were homogenized in a buffer containing 50 mM Tris-HCl , 150 mM NaCl , 1 mM EDTA , 1 % Triton X-100 , 1 % sodium deoxycholate , 0.1 % SDS , and a cocktail of protease inhibitors ( Roche , http://www.roche.com ) .
# ::tok Briefly , dissected whole brains from postnatal day 21 littermates were homogenized in a buffer containing 50 mM Tris-HCl , 150 mM NaCl , 1 mM EDTA , 1 % Triton X-100 , 1 % sodium deoxycholate , 0.1 % SDS , and a cocktail of protease inhibitors ( Roche , http://www.roche.com ) .
# ::alignments 49-50|0.1.6.0.0+0.1.6.0+0.1.6 47-48|0.0 46-47|0.0.0 44-45|0 42-43|0.1 40-41|0.1.5 39-40|0.1.3.0.0 38-39|0.1.3.0.0.0 36-37|0.1.4 35-36|0.1.4.0 34-35|0.1.4.0.0 33-34|0.1.4.0.0.0 30-32|0.1.3.2.1+0.1.3.2.0+0.1.3.2+0.1.3 29-30|0.1.3.1 28-29|0.1.3.1.0 26-27|0.1.2.0.0+0.1.2.0+0.1.2 24-25|0.1.0.2.0.1 22-23|0.1.1.1.0+0.1.1.1+0.1.1 20-21|0.1.1.2 18-19|0.1.0.1.0.1.0+0.1.0.1.0.1+0.1.0.1.0 17-18|0.1.0.1.0.0 16-17|0.1.0.2.0.0 15-16|0.1.0.1 14-15|0.1.0 9-10|0.1.3.0 8-9|0.1.0.1.1 7-8|0.1.0.0.0 6-7|0.1.0.0 4-5|0.1.0.2 3-4|0.1.0.2.1 2-3|0.1.0.2.0 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:08.449
(c / cocktail 
      :consist-of (i / inhibitor 
            :mod (p2 / protease)) 
      :op7-of (a / and 
            :op1 (b / buffer-01 
                  :ARG0 (p7 / postnatal 
                        :mod-of (d2 / day)) 
                  :ARG0-of (c4 / contain-01 
                        :ARG1 (c3 / country 
                              :mod (m / mm) 
                              :name (n5 / name 
                                    :op1 "Tris-HCl")) 
                        :ARG2 21) 
                  :ARG1 (b2 / brain 
                        :ARG1-of (d3 / dissect-01 
                              :ARG0 50 
                              :ARG2 1) 
                        :mod (w / whole))) 
            :op2 (t / thing 
                  :mod-of (b3 / briefly) 
                  :name (n4 / name 
                        :op1 "NaCl") 
                  :quant 150) 
            :op3 (c2 / country 
                  :name (n3 / name 
                        :op1 "EDTA")) 
            :op4 (p5 / person 
                  :mod (l / littermat 
                        :mod-of (p3 / percentage-entity 
                              :value 0.1)) 
                  :mod (p6 / percentage-entity 
                        :value 1) 
                  :name (n2 / name 
                        :op1 "Triton" 
                        :op2 "X-100")) 
            :op5 (d / deoxycholate 
                  :mod (s2 / sodium 
                        :mod (p4 / percentage-entity 
                              :value 1))) 
            :op6 (s / sd) 
            :op8 (p / person 
                  :name (n / name 
                        :op1 "Roche"))))

# ::snt Homogenates were diluted appropriately , mixed with 4  reducing sample buffer , and loaded onto 4 % -- 12 % precast gradient gels ( Novex , http://www.invitrogen.com ) for SDS-PAGE and immunoblotting .
# ::tok Homogenates were diluted appropriately , mixed with 4  reducing sample buffer , and loaded onto 4 % -- 12 % precast gradient gels ( Novex , http://www.invitrogen.com ) for SDS-PAGE and immunoblotting .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:08.450
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The antibodies to Itpr1 ( 1:2,000 ) and Actb ( 1:5,000 ) were used as recommended by manufacturers .
# ::tok The antibodies to Itpr1 ( 1:2,000 ) and Actb ( 1:5,000 ) were used as recommended by manufacturers .
# ::alignments 17-18|0.0.0.0+0.0.0 15-16|0.0 13-14|0.0.1 8-9|0.2.0.0+0.2.0+0.2 7-8|0 3-4|0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:08.531
(a / and 
      :ARG1-of (r / recommend-01 
            :ARG0 (p / person 
                  :ARG0-of (m / manufacture-01)) 
            :purpose-of (u / use-01 
                  :ARG1 (a2 / antibodi))) 
      :op1 (i / Itpr1) 
      :op2 (p2 / person 
            :name (n / name 
                  :op1 "Actb")))

# ::snt Immunohistochemistry .
# ::tok Immunohistochemistry .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:08.535
(i / immunohistochemistry)

# ::snt Brains were isolated from 21-d-old mice , perfused with 4 % paraformaldehyde in PBS , and post-fixed overnight in the same fixative .
# ::tok Brains were isolated from 21-d-old mice , perfused with 4 % paraformaldehyde in PBS , and post-fixed overnight in the same fixative .
# ::alignments 21-22|0.0.1.1.0 20-21|0.0.1.1 17-18|0.0.1.0 15-16|0 13-14|0.1 10-11|0.0.0.0 9-10|0.0.0 5-6|0.0.2 2-3|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:08.679
(a / and 
      :op1 (i / isolate-01 
            :ARG0 (4 / 4 
                  :value-of (p2 / percentage-entity)) 
            :ARG1 (b / brain-01 
                  :ARG0 (o / overnight) 
                  :ARG1 (s / same-01 
                        :ARG1 (f / fixative))) 
            :ARG2 (m / mouse)) 
      :op2 (p / pb))

# ::snt Brains were embedded in gelatin , and 35-m sagittal sections were cut using a sliding microtome ( NeuroScience Associates , http://www.neuroscienceassociates.com ) .
# ::tok Brains were embedded in gelatin , and 35-m sagittal sections were cut using a sliding microtome ( NeuroScience Associates , http://www.neuroscienceassociates.com ) .
# ::alignments 18-19|0.0.0.0 15-16|0.1.0.1 14-15|0.1.0.1.0 12-13|0.1.0 11-12|0.1 9-10|0.1.0.0 8-9|0.1.0.0.0 6-7|0 4-5|0.0.1 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:08.980
(a2 / and 
      :op1 (e / embed-01 
            :ARG1 (b / brain-01 
                  :ARG1-of (a / associate-01)) 
            :location (g / gelatin)) 
      :op2 (c / cut-01 
            :ARG1 (u / use-01 
                  :ARG0 (s2 / section 
                        :mod (s3 / sagittal)) 
                  :ARG1 (m / microtome 
                        :ARG1-of (s / slide-01)))))

# ::snt Sections from wild-type , heterozygote , and homozygous brains were placed in the MultiBrain template .
# ::tok Sections from wild-type , heterozygote , and homozygous brains were placed in the MultiBrain template .
# ::alignments 14-15|0.0.0.0 13-14|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 10-11|0.0.0 8-9|0.2 7-8|0.2.0 6-7|0 4-5|0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:09.037
(a / and 
      :ARG1-of (s / section-01 
            :ARG1-of (p / place-01 
                  :ARG2 (t / template 
                        :mod (c / country 
                              :name (n / name 
                                    :op1 "MultiBrain"))))) 
      :op1 (h2 / heterozygote) 
      :op2 (b / brain 
            :mod (h / homozygou)))

# ::snt Sections were washed in 1  PBS prior to 1 h of incubation in block solution containing 1  PBS with 20 % normal goat serum and 0.3 % Triton X-100 ( pH 7.4 ) .
# ::tok Sections were washed in 1  PBS prior to 1 h of incubation in block solution containing 1  PBS with 20 % normal goat serum and 0.3 % Triton X-100 ( pH 7.4 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:09.038
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Sections were incubated overnight at 4 C in primary antibodies : affinity purified polyclonal Itpr1 antibody ( 1:2,000 , Chemicon International , http://www.chemicon.com ) and monoclonal anti-Calb1 antibody ( 1:6,000 , Sigma-Aldrich , http://www.sigmaaldrich.com ) diluted in carrier solution .
# ::tok Sections were incubated overnight at 4 C in primary antibodies : affinity purified polyclonal Itpr1 antibody ( 1:2,000 , Chemicon International , http://www.chemicon.com ) and monoclonal anti-Calb1 antibody ( 1:6,000 , Sigma-Aldrich , http://www.sigmaaldrich.com ) diluted in carrier solution .
# ::alignments 38-39|0.1.2.0 37-38|0.1.2.0.0 35-36|0.1.2 31-32|0.1.2.1.1.1.0.0+0.1.2.1.1.1.0+0.1.2.1.1.1 27-28|0.1.2.1 25-26|0.1.2.1.0 24-25|0.1.2.1.1 19-21|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 15-16|0.1.2.1.1.0 12-13|0.1.1 11-12|0.1.1.0 9-10|0.2 8-9|0.2.0 6-7|0.2.0.0 5-6|0.0 3-4|0.3 2-3|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:09.784
(i / incubate-01 
      :ARG0 4 
      :ARG1 (s2 / section-01 
            :ARG1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "Chemicon" 
                        :op2 "International")) 
            :ARG1-of (p / purify-01 
                  :mod (a4 / affinity)) 
            :ARG2-of (d / dilute-01 
                  :ARG0 (s / solution 
                        :mod (c / carrier)) 
                  :ARG1 (a / antibody 
                        :mod (m / monoclonal) 
                        :op2-of (a2 / and 
                              :op1 (a3 / antibody) 
                              :op3 (o / organization 
                                    :name (n / name 
                                          :op1 "Sigma-Aldrich")))))) 
      :location (a5 / antibodi 
            :mod (p2 / primary 
                  :mod (c2 / C))) 
      :time (o3 / overnight))

# ::snt Following extensive washes ( in 6.0 ml of PBS , three times ) , sections were incubated with appropriate secondary antibodies ( Alexa Fluor 555 goat anti-rabbit IgG and Alexa Fluor 488 goat anti-mouse IgG [ Invitrogen , http://www.invitrogen.com ] ) for 1 h at room temperature .
# ::tok Following extensive washes ( in 6.0 ml of PBS , three times ) , sections were incubated with appropriate secondary antibodies ( Alexa Fluor 555 goat anti-rabbit IgG and Alexa Fluor 488 goat anti-mouse IgG [ Invitrogen , http://www.invitrogen.com ] ) for 1 h at room temperature .
# ::alignments 46-47|0.0.1.3.0 45-46|0.0.1.3.0.0 43-44|0.0.1.3 42-43|0.0.1.0 32-33|0.2.0 29-32|0.2.1.2+0.2.1.1+0.2.1.0+0.2.1+0.2 28-29|0 27-28|0.1 25-26|0.0.1.2.1.2.0.0 22-25|0.0.1.2.1.2.0.1.2+0.0.1.2.1.2.0.1.1+0.0.1.2.1.2.0.1.0+0.0.1.2.1.2.0.1+0.0.1.2.1.2.0 20-21|0.0 19-20|0.0.1.2.1.0 18-19|0.0.0 16-17|0.0.1 14-15|0.0.1.1 10-11|0.0.0.0 8-9|0.0.1.2.1.1 6-7|0.0.1.2.1.1.0 5-6|0.0.1.2.0 2-3|0.0.1.2.1 1-2|0.0.1.2.1.2 0-1|0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.024
(a / and 
      :op1 (a2 / antibodi 
            :ARG1-of (a3 / appropriate-02 
                  :ARG0 3) 
            :ARG3-of (i2 / incubate-01 
                  :ARG0 1 
                  :ARG1 (s2 / section) 
                  :ARG1-of (f / follow-01 
                        :ARG0 6.0 
                        :ARG2 (w / wash-01 
                              :ARG0 (s / secondary) 
                              :ARG1 (p / pb 
                                    :mod-of (m / ml)) 
                              :ARG1-of (e / extensive-03 
                                    :ARG0 (t3 / thing 
                                          :mod-of (g2 / goat) 
                                          :name (n2 / name 
                                                :op1 "Alexa" 
                                                :op2 "Fluor" 
                                                :op3 "555"))))) 
                  :duration (h / h 
                        :location (t / temperature 
                              :consist-of (r / room))))) 
      :op2 (i / igg) 
      :op3 (t2 / thing 
            :mod-of (g / goat) 
            :name (n / name 
                  :op1 "Alexa" 
                  :op2 "Fluor" 
                  :op3 "488")))

# ::snt Sections were washed and mounted on glass slides in a buffered medium containing Mowiol ( Calbiochem , http://www.emdbiosciences.com ) as described earlier [ 14 ] .
# ::tok Sections were washed and mounted on glass slides in a buffered medium containing Mowiol ( Calbiochem , http://www.emdbiosciences.com ) as described earlier [ 14 ] .
# ::alignments 23-24|0.1.0.0 21-22|0.0.0.0.0.1.0 20-21|0.0.0.0.0.1 15-16|0.2.0.0+0.2.0+0.2 13-14|0.0.0.0.0.2.0+0.0.0.0.0.2+0.0.0.0.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0.0.0 10-11|0.0.0.0.0.0.0.0 7-8|0.0.0.0 6-7|0.0.0 4-5|0.1 3-4|0 2-3|0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.233
(a / and 
      :op1 (w / wash-01 
            :ARG1 (g / glass 
                  :ARG1-of (s / slide-01 
                        :mod (p2 / person 
                              :ARG1-of (c / contain-01 
                                    :ARG0 (m / medium 
                                          :ARG1-of (b / buffer-01))) 
                              :ARG1-of (d / describe-01 
                                    :time (e / early)) 
                              :name (n2 / name 
                                    :op1 "Mowiol"))))) 
      :op2 (m2 / mount-01 
            :ARG1 (s2 / section-01 
                  :ARG1 14)) 
      :op3 (p / person 
            :name (n / name 
                  :op1 "Calbiochem")))

# ::snt Sections were imaged using a laser scanning confocal microscope ( LSM 510 ; Zeiss , http://www.zeiss.com ) .
# ::tok Sections were imaged using a laser scanning confocal microscope ( LSM 510 ; Zeiss , http://www.zeiss.com ) .
# ::alignments 13-14|0.0.1.0+0.0.1+0.0 12-13|0 8-9|0.0.0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0 3-4|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.381
(a / and 
      :op1 (o / organization 
            :ARG0-of (u / use-01 
                  :ARG1 (l / laser 
                        :ARG0-of (s / scan-01 
                              :ARG1 (m / microscope))) 
                  :ARG2 (s2 / section-01)) 
            :name (n / name 
                  :op1 "Zeiss")))

# ::snt Imaging parameters ( pinhole , detector gain , laser power ) were optimized , and were kept constant for the wild-type , heterozygous , and homozygous mutant brains .
# ::tok Imaging parameters ( pinhole , detector gain , laser power ) were optimized , and were kept constant for the wild-type , heterozygous , and homozygous mutant brains .
# ::alignments 27-28|0.1 26-27|0.1.1 24-25|0 17-18|0.0.2 16-17|0.0 14-15|0.0.3 12-13|0.0.3.0 9-10|0.0.3.0.0 8-9|0.0.3.0.0.0 6-7|0.1.0 5-6|0.1.0.0.0+0.1.0.0 3-4|0.0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.597
(a / and 
      :op1 (k / keep-01 
            :ARG0 (p2 / pinhole) 
            :ARG1 (p3 / parameter 
                  :mod (i / image)) 
            :ARG2 (c / constant) 
            :op2-of (a2 / and 
                  :op1 (o / optimize-01 
                        :ARG1 (p / power 
                              :mod (l / laser))))) 
      :op2 (b / brain 
            :ARG0-of (g / gain-02 
                  :ARG1 (t / thing 
                        :ARG0-of (d / detect-01))) 
            :mod (m / mutant)))

# ::snt Specificity of the Itpr1 antibodies was verified by preabsorption control experiments .
# ::tok Specificity of the Itpr1 antibodies was verified by preabsorption control experiments .
# ::alignments 10-11|0.0 9-10|0.0.1 6-7|0 4-5|0.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.651
(v / verify-01 
      :ARG0 (e / experiment-01 
            :ARG1 (a / antibodi) 
            :ARG2 (c / control-01)) 
      :ARG1 (s / specificity))

# ::snt Antibody dilutions were incubated for 24 h at 4 C with the immunizing peptide .
# ::tok Antibody dilutions were incubated for 24 h at 4 C with the immunizing peptide .
# ::alignments 13-14|0.0.0.0.0 12-13|0.0.0.0 9-10|0.0.0.0.1.0 8-9|0.0.0.0.1 6-7|0.1 5-6|0.1.0 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.757
(i2 / incubate-01 
      :ARG1 (d / dilution 
            :mod (a / antibody 
                  :ARG0-of (i / immunize-01 
                        :ARG1 (p / peptide) 
                        :ARG2 (4 / 4 
                              :era (c / C))))) 
      :ARG2 (h / h 
            :quant 24))

# ::snt Tissue sections were incubated with the preabsorbed antibodies and processed as described above .
# ::tok Tissue sections were incubated with the preabsorbed antibodies and processed as described above .
# ::alignments 12-13|0.0.1.0 11-12|0.0.1 9-10|0.0 8-9|0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.871
(a2 / and 
      :op1 (p / process-01 
            :ARG0 (s / section 
                  :ARG1-of (i / incubate-01 
                        :ARG2 (a3 / antibodi 
                              :mod (p2 / preabsorb))) 
                  :mod (t / tissue)) 
            :ARG1 (d / describe-01 
                  :ARG1 (a / above))))

# ::snt Under these conditions , no staining above autofluorescence was detected .
# ::tok Under these conditions , no staining above autofluorescence was detected .
# ::alignments 9-10|0 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0 4-5|0.0.1 2-3|0.1.0 1-2|0.1.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.923
(d / detect-01 
      :ARG1 (s / stain-01 
            :ARG1 (a / autofluorescence 
                  :op1-of (a2 / above)) 
            :polarity -) 
      :time (u / under 
            :op1 (c / condition 
                  :mod (t / this))))

# ::snt Analysis of ITPR1 in SCA15 patients .
# ::tok Analysis of ITPR1 in SCA15 patients .
# ::alignments 5-6|0.0.1+0.0+0.0.0 4-5|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.943
(a / analysi 
      :ARG1-of (h / have-rel-role-91 
            :ARG0 (p / person 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "SCA15"))) 
            :ARG2 (p2 / patient)))

# ::snt DNA was extracted from EBV immortalized lymphocytes , derived from family members .
# ::tok DNA was extracted from EBV immortalized lymphocytes , derived from family members .
# ::alignments 11-12|0.1.0.0.0.1+0.1.0.0.0+0.1.0.0 10-11|0.1.0.0.0.0 8-9|0.1.0 6-7|0.1 5-6|0.1.1 4-5|0.1.2.0.0+0.1.2.0+0.1.2 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:11.999
(e / extract-01 
      :ARG1 (d2 / DNA) 
      :ARG2 (l / lymphocyt 
            :ARG1-of (d / derive-01 
                  :ARG2 (p / person 
                        :ARG0-of (h / have-org-role-91 
                              :ARG1 (f / family) 
                              :ARG2 (m / member)))) 
            :mod (i / immortalize) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "EBV"))))

# ::snt The coding exons and at least 50 bp of flanking introns of ITPR1 were PCR amplified and sequenced using dye-terminator sequencing ( BigDye version 3.1 ; Applied Biosystems , http://www.appliedbiosystems.com ) .
# ::tok The coding exons and at least 50 bp of flanking introns of ITPR1 were PCR amplified and sequenced using dye-terminator sequencing ( BigDye version 3.1 ; Applied Biosystems , http://www.appliedbiosystems.com ) .
# ::alignments 26-28|0.0.0.1+0.0.0.0+0.0.0+0.0 25-26|0 23-24|0.1.1.0.0 20-21|0.1.0.1.0.1 18-19|0.1.0.1.0 16-17|0.1.0.1 15-16|0.1.0 10-11|0.1.0.0 9-10|0.1.0.0.0 6-7|0.1.0.1.0.0 3-4|0.1 2-3|0.1.1 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:12.198
(a / and 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "Applied" 
                  :op2 "Biosystems")) 
      :op2-of (a4 / and 
            :ARG1-of (a3 / amplify-01 
                  :ARG0 (i / intron 
                        :ARG1-of (f / flank-01)) 
                  :op1-of (a2 / and 
                        :op2 (u / use-01 
                              :ARG0 50 
                              :ARG1 (s / sequence)))) 
            :op1 (e / exon 
                  :ARG1-of (c / code-01 
                        :ARG0 (v / version)))))

# ::snt Sequence reactions were run on an ABI3730XP automated sequencer as per the manufacturer 's instructions ( Applied Biosystems ) .
# ::tok Sequence reactions were run on an ABI3730XP automated sequencer as per the manufacturer 's instructions ( Applied Biosystems ) .
# ::alignments 16-18|0.1.0.1+0.1.0.0+0.1.0+0.1 14-15|0.2 12-13|0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 3-4|0.0.0.0 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:12.313
(m / manufacture-01 
      :ARG0 (s2 / sequence 
            :ARG1-of (r2 / react-01 
                  :ARG1-of (r / run-01 
                        :ARG0 (s / sequenc 
                              :mod (a / automate-01) 
                              :mod (t / thing 
                                    :name (n2 / name 
                                          :op1 "ABI3730XP")))))) 
      :ARG1 (o / organization 
            :name (n / name 
                  :op1 "Applied" 
                  :op2 "Biosystems")) 
      :poss-of (i / instruction))

# ::snt This analysis was performed in all three affected family members for whom genomic DNA was available ( members 6 , 7 , and 19 ) .
# ::tok This analysis was performed in all three affected family members for whom genomic DNA was available ( members 6 , 7 , and 19 ) .
# ::alignments 23-24|0.0.0.1 22-23|0 20-21|0.0.0.0.1.2.1.0 18-19|0.0.0.0.1.0 17-18|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 15-16|0.0.0.0.1 13-14|0.0.0.0.1.1 9-10|0.0.0.0.1.2.0.1+0.0.0.0.1.2.0+0.0.0.0.1.2 8-9|0.0.0.0.1.2.0.0 7-8|0.0.0.0.1.2.1 6-7|0.0.0.0.1.2.3 5-6|0.0.0.0.1.2.2 3-4|0.0 1-2|0.0.0 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:12.855
(a / and 
      :op1 (p3 / perform-02 
            :ARG1 (a5 / analyze-01 
                  :ARG0 (p / person 
                        :ARG0-of (h / have-org-role-91 
                              :ARG2 (m / member)) 
                        :ARG1-of (a2 / available-02 
                              :ARG0 6 
                              :ARG2 (d / DNA) 
                              :time (p2 / person 
                                    :ARG0-of (h2 / have-org-role-91 
                                          :ARG1 (f / family) 
                                          :ARG2 (m2 / member)) 
                                    :ARG1-of (a3 / affect-01 
                                          :ARG0 7) 
                                    :quant (a4 / all) 
                                    :quant 3))) 
                  :ARG1 19 
                  :mod (t / this))))

# ::snt Primer sequences and conditions are available upon request .
# ::tok Primer sequences and conditions are available upon request .
# ::alignments 7-8|0.0.0 5-6|0 3-4|0.0.1 2-3|0.0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:12.882
(a / available-02 
      :ARG1 (a2 / and 
            :ARG1-of (r / request-01) 
            :condition (c / condition)) 
      :ARG2 (s / sequence 
            :mod (p / primer)))

# ::snt Sequence data were analyzed using Sequencher ( Gene Codes Corporation , http://www.genecodes.com ) .
# ::tok Sequence data were analyzed using Sequencher ( Gene Codes Corporation , http://www.genecodes.com ) .
# ::alignments 7-10|0.0.0.1.0.2+0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 5-6|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 4-5|0.0.0 3-4|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:13.165
(a / analyze-01 
      :ARG1 (d / data 
            :ARG0-of (u / use-01 
                  :ARG1 (p / person 
                        :name (n2 / name 
                              :op1 "Sequencher")) 
                  :ARG2 (o / organization 
                        :name (n / name 
                              :op1 "Gene" 
                              :op2 "Codes" 
                              :op3 "Corporation"))) 
            :source (s / sequence)))

# ::snt Genome-wide SNP genotyping was performed using Infinium HumanHap550 SNP genotyping chips as per the manufacturer 's protocol ( Illumina , http://www.illumina.com ) .
# ::tok Genome-wide SNP genotyping was performed using Infinium HumanHap550 SNP genotyping chips as per the manufacturer 's protocol ( Illumina , http://www.illumina.com ) .
# ::alignments 18-19|0.0.1.0.0+0.0.1.0+0.0.1 16-17|0 14-15|0.0 10-11|0.0.0 8-9|0.0.2.1.2+0.0.2.1.0.0+0.0.2.1.0+0.0.2.1 6-8|0.0.2.1.1.0.1+0.0.2.1.1.0.0+0.0.2.1.1.0+0.0.2.1.1 5-6|0.0.2 4-5|0.0.2.2 2-3|0.0.2.0 1-2|0.0.2.0.0.1+0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:13.778
(p2 / protocol 
      :poss (m / manufacture-01 
            :ARG0 (c / chip) 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "Illumina")) 
            :ARG2-of (u / use-01 
                  :ARG0 (g / genotyp 
                        :mod (p5 / political-party 
                              :name (n4 / name 
                                    :op1 "SNP") 
                              :wiki "Scottish_National_Party")) 
                  :ARG1 (p3 / political-party 
                        :name (n2 / name 
                              :op1 "SNP") 
                        :poss (t / thing 
                              :name (n3 / name 
                                    :op1 (i / Infinium) 
                                    :op2 (h / HumanHap550))) 
                        :wiki "Scottish_National_Party") 
                  :ARG1-of (p4 / perform-02))))

# ::snt This product assays 555,352 unique SNPs .
# ::tok This product assays 555,352 unique SNPs .
# ::alignments 5-6|0 4-5|0.0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:13.795
(s / snp 
      :mod (u / unique) 
      :prep-with (p / product 
            :mod (t / this)))

# ::snt Data were collected using the Illumina BeadStation scanner and data collection software .
# ::tok Data were collected using the Illumina BeadStation scanner and data collection software .
# ::alignments 11-12|0.0.1.1 10-11|0.0.1.1.0 9-10|0.0.1.1.0.0 8-9|0.0.1 7-8|0.0.1.0 5-7|0.0.1.0.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 3-4|0.0 2-3|0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:14.122
(c2 / collect-01 
      :ARG1 (u / use-01 
            :ARG0 (d2 / data) 
            :ARG1 (a / and 
                  :op1 (s2 / scann 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Illumina" 
                                    :op2 "BeadStation"))) 
                  :op2 (s / software 
                        :ARG0-of (c / collect-01 
                              :ARG1 (d / data))))))

# ::snt Genotypes were produced using the genotyping module of BeadStudio ( version 2.3.25 ; Illumina ) , and log R ratio and B allele frequency were visualized using the genome viewer tool within this package .
# ::tok Genotypes were produced using the genotyping module of BeadStudio ( version 2.3.25 ; Illumina ) , and log R ratio and B allele frequency were visualized using the genome viewer tool within this package .
# ::alignments 33-34|0.0.0.1.0.0.1.0.1.0.0 32-33|0.0.0.1.0.0.1.0.1.0.0.0 30-31|0.0.0.1.0.0.1.0.1 29-30|0.0.0.1.0.0.1.0.1.0 28-29|0.0.0.1.0.0.1.0.1.0.1 26-27|0.0.0.1.0.0.1.0 25-26|0.0.0.1.0.0 23-24|0.0.0.1.0.0.0.1 22-23|0.0.0.1.0.0.0.1.0 21-22|0.0.0.1.0.0.0.0.0.0.1+0.0.0.1.0.0.0.0.0.0.0.0+0.0.0.1.0.0.0.0.0.0.0+0.0.0.1.0.0.0.0.0.0 20-21|0.0.0.1.0.0.0 19-20|0.0.0.1.0.0.0.0 18-19|0.0.0.1.0.0.0.0.1 17-18|0.0.0.1.0.0.0.0.0 16-17|0.0.0.1.0.0.1 13-14|0.0.1.0+0.0.1+0.0 12-13|0 10-11|0.0.0.1.0.0.1.0.0 8-9|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 6-7|0.0.0.0.1+0.0.0.0 3-4|0.0.0 2-3|0.0.0.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:15.976
(a4 / and 
      :op1 (p2 / person 
            :ARG0-of (u2 / use-01 
                  :ARG1 (m / module 
                        :poss (p3 / person 
                              :name (n3 / name 
                                    :op1 "BeadStudio")) 
                        :wiki -) 
                  :ARG2 (p4 / produce-01 
                        :ARG1 (g2 / genotyp 
                              :ARG0-of (v2 / visualize-01 
                                    :ARG1 (a2 / and 
                                          :op1 (r / ratio 
                                                :ARG1-of (l2 / log-01 
                                                      :ARG0 (l / location 
                                                            :name (n / name 
                                                                  :op1 "B") 
                                                            :wiki -)) 
                                                :op1 (r2 / r)) 
                                          :op2 (f / frequency 
                                                :mod (a / allele))) 
                                    :op1-of (a3 / and 
                                          :op2 (u / use-01 
                                                :ARG0 (v3 / version) 
                                                :ARG1 (t2 / tool 
                                                      :purpose (v / view-01 
                                                            :ARG0 (p / package 
                                                                  :mod (t / this)) 
                                                            :ARG1 (g / genome))))))))) 
            :name (n2 / name 
                  :op1 "Illumina")))

# ::snt In order to rule out the possibility that the observed deletion within ITPR1 was a benign copy number variant we examined log R ratio and B allele frequency metrics of HumanHap550 genotyping data at this locus from 577 individuals of Northern European descent from North America and Europe , produced by us as a part of an ongoing study .
# ::tok In order to rule out the possibility that the observed deletion within ITPR1 was a benign copy number variant we examined log R ratio and B allele frequency metrics of HumanHap550 genotyping data at this locus from 577 individuals of Northern European descent from North America and Europe , produced by us as a part of an ongoing study .
# ::alignments 58-59|0.0.0.0.0.0.0.0.0.0.0.2 57-58|0.0.0.0.0.0.0.0.0.0.0.2.0 49-50|0.0.0.0.0.0.0.0.0.0.0.1.0 47-48|0.0.0.0.0.0.0.0.0.0.0.1.1.1+0.0.0.0.0.0.0.0.0.0.0.1.1.0.0+0.0.0.0.0.0.0.0.0.0.0.1.1.0+0.0.0.0.0.0.0.0.0.0.0.1.1 46-47|0.0.0.0.0.0.0.0.0.0.0.1 44-46|0.0.0.0.0.0.0.0.0.0.0.5.1+0.0.0.0.0.0.0.0.0.0.0.5.0.1+0.0.0.0.0.0.0.0.0.0.0.5.0.0+0.0.0.0.0.0.0.0.0.0.0.5.0+0.0.0.0.0.0.0.0.0.0.0.5 42-43|0.0.0.0.0.0.0.0.0.0.0 41-42|0.0.0.0.0.0.0.0.0.0.0.3.1+0.0.0.0.0.0.0.0.0.0.0.3.0.0+0.0.0.0.0.0.0.0.0.0.0.3.0+0.0.0.0.0.0.0.0.0.0.0.3 40-41|0.0.0.0.0.0.0.0.0.0.0.4 38-39|0.0.0.0.0.0.0.0.0.0 35-36|0.0.0.0.0.0.0.0.0.0.0.0 34-35|0.0.0.0.0.0.0.0.0.0.0.0.0 32-33|0.0.0.0.0.0.0.0.1.0.0 31-32|0.0.0.0.0.0.0.0.1.0.0.0 28-29|0.0.0.0.0.0.0.0.1.0 27-28|0.0.0.0.0.0.0.0.1.0.1 26-27|0.0.0.0.0.0.0.0.1.0.1.0 25-26|0.0.0.0.0.0.0.0.0.1.0.0.1+0.0.0.0.0.0.0.0.0.1.0.0.0.0+0.0.0.0.0.0.0.0.0.1.0.0.0+0.0.0.0.0.0.0.0.0.1.0.0 24-25|0.0.0.0.0.0.0.0.1 23-24|0.0.0.0.0.0.0.0.0.1 22-23|0.0.0.0.0.0.0.0.0.1.1 21-22|0.0.0.0.0.0.0.0.0.1.0 20-21|0.0.0.0.0.0.0.0 19-20|0.0.0.0.0.0.0.0.0 18-19|0.0.0.0.0 17-18|0.0.0.0.1 16-17|0.0.0+0.0.0.0 15-16|0.0.0.0.0.0.1 10-11|0 9-10|0.0 6-7|0.0.0.0.0.0 3-4|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:18.763
(d3 / deletion 
      :ARG1-of (o2 / observe-01 
            :ARG1-of (c4 / copy-01 
                  :ARG2 (t2 / thing 
                        :mod-of (v / variant 
                              :ARG1-of (p2 / possible-01 
                                    :ARG1-of (r3 / rule-03 
                                          :condition-of (e / examine-01 
                                                :ARG0 (w / we 
                                                      :poss-of (i / individual 
                                                            :consist-of (d / descend-01 
                                                                  :ARG0 (l / locu 
                                                                        :mod (t / this)) 
                                                                  :ARG1 (a / and 
                                                                        :ARG1-of (p / produce-01) 
                                                                        :op1 (c / continent 
                                                                              :name (n / name 
                                                                                    :op1 "Europe") 
                                                                              :wiki "Europe")) 
                                                                  :ARG1-of (s / study-01 
                                                                        :location (o / ongo)) 
                                                                  :mod (c3 / continent 
                                                                        :name (n3 / name 
                                                                              :op1 "Europe") 
                                                                        :wiki "Europe") 
                                                                  :mod "Northern_Ireland" 
                                                                  :source (c2 / continent 
                                                                        :name (n2 / name 
                                                                              :op1 "North" 
                                                                              :op2 "America") 
                                                                        :wiki "North_America"))) 
                                                      :poss-of (r / ratio 
                                                            :ARG1-of (l3 / log-01 
                                                                  :ARG0 (l2 / location 
                                                                        :name (n4 / name 
                                                                              :op1 "B") 
                                                                        :wiki -)) 
                                                            :op1 (r2 / r))) 
                                                :ARG1 (a3 / and 
                                                      :op1 (m / metric 
                                                            :mod (d2 / data 
                                                                  :source (g / genotyp)) 
                                                            :mod (f / frequency 
                                                                  :mod (a2 / allele)))))) 
                                    :domain-of (b / benign))) 
                        :mod-of (n5 / number)))))

# ::snt In an attempt to narrow the unknown intervals flanking the deletion observed in family AUS1 , we designed primers for 30 PCR amplifications that would generate overlapping fragments across the two bordering regions ( primer sequence and conditions available upon request ) .
# ::tok In an attempt to narrow the unknown intervals flanking the deletion observed in family AUS1 , we designed primers for 30 PCR amplifications that would generate overlapping fragments across the two bordering regions ( primer sequence and conditions available upon request ) .
# ::alignments 40-41|0 38-39|0.1 37-38|0.1.0 36-37|0.1.0.0 35-36|0.1.0.0.1 34-35|0.1.0.0.1.0 32-33|0.1.0.0.0.0.1.1.0 31-32|0.1.0.0.0.0.1.1.0.0 30-31|0.1.0.0.0.0.1.1.0.1 28-29|0.1.0.0.0.0.1.1 27-28|0.1.0.0.0.0 26-27|0.1.0.0.0.0.0 25-26|0.1.0.0.0.0.1 22-23|0.1.0.0.0.0.1.0 20-21|0.0 18-19|0.1.0.0.0.1.1.0.0.0.0 17-18|0.1.0.0.0.1.1.0.0.0 16-17|0.1.0.0.0.1.1.0.0 14-15|0.1.0.0.0.1.0.0.0.0.1.0+0.1.0.0.0.1.0.0.0.0.1+0.1.0.0.0.1.0.0.0.0 13-14|0.1.0.0.0.1.0.0.0.0.0 11-12|0.1.0.0.0.1.0.0.0 10-11|0.1.0.0.0.1.0.0 8-9|0.1.0.0.0.1.0 7-8|0.1.0.0.0.1 6-7|0.1.0.0.0.2+0.1.0.0.0 4-5|0.1.0.0.0.1.1 2-3|0.1.0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:19.960
(r / request-01 
      :ARG1 30 
      :ARG1-of (a / available-02 
            :ARG2 (c / condition 
                  :condition-of (a2 / and 
                        :ARG1-of (k / know-01 
                              :ARG1-of (f / fragment-01 
                                    :ARG1-of (o / overlap-01) 
                                    :ARG1-of (g / generate-01 
                                          :ARG0 (a4 / amplification) 
                                          :path (a3 / across 
                                                :op1 (r2 / region 
                                                      :ARG1-of (b / border-01) 
                                                      :quant 2)))) 
                              :mod-of (i / interval 
                                    :ARG0-of (f3 / flank-01 
                                          :ARG1 (d2 / deletion 
                                                :ARG1-of (o3 / observe-01 
                                                      :ARG0 (o2 / organization 
                                                            :mod (f2 / family) 
                                                            :name (n / name 
                                                                  :op1 "AUS1"))))) 
                                    :ARG1-of (n2 / narrow-01 
                                          :ARG1-of (a5 / attempt-01 
                                                :ARG0 (w / we 
                                                      :ARG0-of (d / design-01 
                                                            :ARG1 (p2 / primer)))))) 
                              :polarity -) 
                        :op1 (s / sequence 
                              :mod (p / primer))))))

# ::snt There were ten primer pairs in the telomeric flanking region and 20 pairs in the centromeric flanking region ( Figure S3 ) .
# ::tok There were ten primer pairs in the telomeric flanking region and 20 pairs in the centromeric flanking region ( Figure S3 ) .
# ::alignments 19-21|0.0.1+0+0.0+0.0.0 17-18|0.0.0.0.1.0 16-17|0.0.0.0.1.0.0 15-16|0.0.0.0.1.0.1 12-13|0.0.0.0.1 11-12|0.0.0.0.1.1 10-11|0.0.0.0 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0 4-5|0.0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:20.195
(f / Figure 
      :op1-of (n / name 
            :name-of (t / thing 
                  :op3-of (a / and 
                        :op1 (f3 / flank-01 
                              :ARG1 (r2 / region 
                                    :ARG0-of (p2 / pair-01 
                                          :ARG1 (p3 / primer)))) 
                        :op2 (p / pair-01 
                              :ARG1 (r / region 
                                    :ARG1-of (f2 / flank-01) 
                                    :mod (c / centromeric)) 
                              :quant 20))) 
            :op2 (s / S3)))

# ::snt On average each product was ~ 750 bp in size , and amplifications were performed using genomic DNA from each of the three affected individuals ( family members 6 , 7 , and 19 ) .
# ::tok On average each product was ~ 750 bp in size , and amplifications were performed using genomic DNA from each of the three affected individuals ( family members 6 , 7 , and 19 ) .
# ::alignments 33-34|0.0.0.2 32-33|0.0.0.1.1.3 30-31|0.0.0.1.1.0.2 28-29|0.0.0.1.1.0.1 27-28|0.0.0.1.1.2.0.1+0.0.0.1.1.2.0+0.0.0.1.1.2 26-27|0.0.0.1.1.2.0.0 24-25|0.1 23-24|0 22-23|0.1.0 19-20|0.0.0.1.1.0.0 17-18|0.0.0.0 15-16|0.0.0 14-15|0.0.0.1 12-13|0.0 11-12|0.0.0.1.1 9-10|0.0.0.1.1.1 6-7|0.2 3-4|0.0.0.1.0 2-3|0.0.0.1.0.0 1-2|0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:20.853
(a2 / affect-01 
      :ARG0 (a3 / amplification 
            :ARG0-of (u / use-01 
                  :ARG1 (d / DNA) 
                  :ARG1-of (p2 / perform-02 
                        :ARG0 (p3 / product 
                              :mod (e2 / each)) 
                        :op3-of (a4 / and 
                              :op1 (a5 / average-01 
                                    :ARG1 (e / each) 
                                    :op1-of 6 
                                    :op1-of 7) 
                              :op2 (s / size) 
                              :op4 (p / person 
                                    :ARG0-of (h / have-org-role-91 
                                          :ARG1 (f / family) 
                                          :ARG2 (m / member))) 
                              :op5 (a / and))) 
                  :ARG2 19)) 
      :ARG1 (i / individual 
            :quant 3) 
      :ARG2 750)

# ::snt Dye-terminator sequencing of each product was performed using the forward and reverse primers designed for amplification ; running and analysis of each fragment was performed as described above .
# ::tok Dye-terminator sequencing of each product was performed using the forward and reverse primers designed for amplification ; running and analysis of each fragment was performed as described above .
# ::alignments 27-28|0.0.0.0 26-27|0.0.0 24-25|0.0.0.1 22-23|0.0 21-22|0.0.1 19-20|0.2 18-19|0 17-18|0.1 16-17|0.0.0.1.0 15-16|0.1.0 13-14|0.0.0.1.0.0.0.0.0 12-13|0.0.0.1.0.0.0.0 11-12|0.0.0.1.0.0.0.0.1 10-11|0.0.0.1.0.0.0.0.1.0 9-10|0.0.0.1.0.0.0.0.1.0.0 7-8|0.0.0.1.0.0.0 6-7|0.0.0.1.0.0 4-5|0.2.0.0 3-4|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:21.541
(a3 / and 
      :ARG1-of (f / fragment-01 
            :ARG0-of (d / describe-01 
                  :ARG1 (a / above) 
                  :ARG1-of (p / perform-02 
                        :ARG0 (a4 / and 
                              :op1 (p3 / perform-02 
                                    :ARG1 (u / use-01 
                                          :ARG1 (p2 / primer 
                                                :ARG1-of (d2 / design-01) 
                                                :ARG1-of (r2 / reverse-01 
                                                      :op2-of (a6 / and 
                                                            :op1 (f2 / forward))))))))) 
            :mod (e / each)) 
      :op1 (r / run-01 
            :ARG1 (a5 / amplification)) 
      :op2 (a2 / analyze-01 
            :ARG1 (e2 / each 
                  :mod-of (p4 / product))))

# ::snt Amplification of a fragment from a normal diploid genome was denoted by the presence of a heterozygous polymorphism ; amplification of a fragment from a region of the genome harboring a heterozygous genomic deletion was inferred when homozygosity for the major allele and the minor allele were noted among the three affected family members ( i.e. , this is inconsistent with Mendelian inheritance in related individuals known to share a common haplotype ) .
# ::tok Amplification of a fragment from a normal diploid genome was denoted by the presence of a heterozygous polymorphism ; amplification of a fragment from a region of the genome harboring a heterozygous genomic deletion was inferred when homozygosity for the major allele and the minor allele were noted among the three affected family members ( i.e. , this is inconsistent with Mendelian inheritance in related individuals known to share a common haplotype ) .
# ::alignments 71-72|0.2.1.0.0.1.0.0 70-71|0.2.1.0.0.1.0.0.0 68-69|0.2.1.0.0.1.0 66-67|0.2.1.0.0.1.0.1 65-66|0.2.1.0.0.1 64-65|0.2.1.0.0 62-63|0.2.1.0.0.1.0.2 61-62|0.2.1.0.0.1.0.2.0.0.0+0.2.1.0.0.1.0.2.0.0+0.2.1.0.0.1.0.2.0 59-60|0.2.1.0.0.1.0.2.1.1+0.2.1.0.0.1.0.2.1 57-58|0.2.1.0.0.0 55-56|0.2.1.0.0.1.0.2.1.0 53-54|0.2.0.0.1+0.2.0.0+0.2.0 52-53|0.2.0.0.0 51-52|0.2.0.1 50-51|0.2.0.2 47-48|0.2 45-46|0.2.1.0.2 44-45|0.2.1.0.2.0 42-43|0.2.1.0 41-42|0.2.1.0.1 40-41|0.2.1.0.1.0 37-38|0.2.1 35-36|0 33-34|0.0.0.0.1 29-30|0.0.0.0 28-29|0.0.0.0.0 25-26|0.0.0.0.0.0 22-23|0.0.0 19-20|0.0 18-19|0.1 17-18|0.0.0.0.0.0.0 16-17|0.0.0.0.0.0.0.0 13-14|0.0.0.0.0.0.0.1 10-11|0.0.0.0.0.0.0.1.0 8-9|0.0.0.0.0.0.0.1.0.1.0 7-8|0.0.0.0.0.0.0.1.0.1.0.1 6-7|0.0.0.0.0.0.0.1.0.1.0.0 3-4|0.0.0.0.0.0.0.1.0.1 0-1|0.0.0.0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:25.370
(i4 / infer-01 
      :ARG1 (a5 / amplification 
            :topic (f2 / fragment-01 
                  :ARG1 (h4 / harbor-01 
                        :ARG0 (g / genome 
                              :mod-of (r2 / region 
                                    :op1 (p2 / polymorphism 
                                          :mod (h5 / heterozygou) 
                                          :poss-of (p3 / presence 
                                                :ARG0-of (d2 / denote-01 
                                                      :ARG1 (a7 / amplification) 
                                                      :ARG2 (f3 / fragment-01 
                                                            :ARG1 (g2 / genome 
                                                                  :ARG1-of (n3 / normal-02) 
                                                                  :mod (d3 / diploid)))))))) 
                        :ARG1 (d / deletion)))) 
      :op1-of (a6 / and) 
      :purpose (n2 / note-01 
            :ARG0 (p / person 
                  :ARG0-of (h2 / have-org-role-91 
                        :ARG1 (f / family) 
                        :ARG2 (m / member)) 
                  :ARG1-of (a / affect-01) 
                  :quant 3) 
            :ARG1 (h3 / homozygosity 
                  :poss (a3 / and 
                        :ARG2-of (r / relate-01 
                              :ARG0 (t2 / this) 
                              :ARG1 (i / individual 
                                    :ARG0-of (s / share-01 
                                          :ARG1 (h / haplotype 
                                                :mod (c / common)) 
                                          :ARG1-of (k / know-02) 
                                          :ARG2-of (i2 / inherit-01 
                                                :ARG1 (t / thing 
                                                      :name (n / name 
                                                            :op1 "Mendelian")) 
                                                :ARG2-of (c2 / consistent-01 
                                                      :ARG1 (i3 / i.e.) 
                                                      :polarity -))))) 
                        :op1 (a4 / allele 
                              :ARG1-of (m3 / major-02)) 
                        :op2 (a2 / allele 
                              :mod (m2 / minor))))))

# ::snt Using the data from the experiments described above we were able to limit the size of unknown regions flanking the deletion to ~ 4 kb on the telomeric side and 7 kb on the centromeric side .
# ::tok Using the data from the experiments described above we were able to limit the size of unknown regions flanking the deletion to ~ 4 kb on the telomeric side and 7 kb on the centromeric side .
# ::alignments 35-36|0.0.0.0.0 34-35|0.0.0.0 30-31|0.0.1.2.0 29-30|0 28-29|0.0.0.1.1.1.0 24-25|0.0.0.1.1.1 23-24|0.0.1.0 20-21|0.0.0.1.1.0 18-19|0.0.0.1.1 17-18|0.0.0.1.0 16-17|0.0.0.1.0.0.0+0.0.0.1.0.0 14-15|0.0.0.1 12-13|0.0.0 10-11|0.0 8-9|0.0.1.2.1.0.0 7-8|0.0.1.2.1.0 6-7|0.0.1.2.1 5-6|0.0.1.2 2-3|0.0.1.1 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:26.043
(a / and 
      :op1 (p / possible-01 
            :ARG1 (l / limit-01 
                  :ARG0 (c / centromeric 
                        :mod-of (s / side)) 
                  :ARG1 (s3 / size 
                        :poss (r / region 
                              :ARG1-of (k2 / know-01 
                                    :polarity -)) 
                        :quant-of (f / flank-01 
                              :ARG1 (d / deletion) 
                              :ARG2 (k / kb 
                                    :location (s2 / side))))) 
            :domain (u / use-01 
                  :ARG0 4 
                  :ARG1 (d3 / data) 
                  :ARG2 (e / experiment-01 
                        :ARG1 7 
                        :ARG1-of (d2 / describe-01 
                              :ARG2 (a2 / above 
                                    :op1 (w / we)))))))

# ::snt All combinations of forward primers from the newly defined region flanking the deletion on the telomeric side with reverse primers from the newly defined region flanking the deletion on the centromeric side were used in PCR amplification reactions performed with DNA from the three affected family members and single unaffected family members .
# ::tok All combinations of forward primers from the newly defined region flanking the deletion on the telomeric side with reverse primers from the newly defined region flanking the deletion on the centromeric side were used in PCR amplification reactions performed with DNA from the three affected family members and single unaffected family members .
# ::alignments 51-52|0.0.0.1+0.0.0+0.0 50-51|0.0.0.0 49-50|0.1+0 48-49|0.0.1 47-48|0.0.2 46-47|0.0.2.1.0.1+0.0.2.1.0+0.0.2.1 45-46|0.0.2.1.0.0 44-45|0.0.2.1.1 43-44|0.0.2.1.2 40-41|0.0.2.0.1 38-39|0.0.2.0 37-38|0.0.2.0.0 36-37|0.0.2.0.0.0 33-34|0.0.2.0.0.1.0.0 31-32|0.0.2.0.0.2.0 30-31|0.0.2.0.0.2.0.0 27-28|0.0.2.0.0.1.0 25-26|0.0.2.0.0.1 24-25|0.0.2.0.0.1.0.0.0 23-24|0.0.2.0.0.1.0.0.0.0 19-20|0.0.2.0.0.2.2.0.0.0 18-19|0.0.2.0.0.2.2.0.0 16-17|0.0.2.0.0.2.1.0 12-13|0.0.2.0.0.2.1 10-11|0.0.2.0.0.2 9-10|0.0.2.0.0.2.2 8-9|0.0.2.0.0.2.2.0 7-8|0.0.2.0.0.2.2.0.1 4-5|0.0.2.0.0.1.0.0.1 3-4|0.0.2.0.0.1.0.0.1.0 1-2|0.0.2.0.0.1.0.0.1.1 0-1|0.0.2.0.0.1.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:28.585
(a / affect-01 
      :ARG1 (p / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f / family) 
                  :ARG2 (m / member)) 
            :ARG1-of (s / single-02) 
            :op2-of (a2 / and 
                  :ARG0-of (p3 / perform-02 
                        :ARG1 (r / react-01 
                              :ARG1 (a4 / amplification) 
                              :ARG2-of (f3 / flank-01 
                                    :ARG1 (d2 / deletion 
                                          :ARG2-of (u / use-01 
                                                :ARG0 (r2 / region 
                                                      :ARG1-of (d3 / define-01)) 
                                                :ARG1 (p5 / primer 
                                                      :mod (f5 / forward) 
                                                      :mod-of (c2 / combination 
                                                            :quant (a5 / all)))))) 
                              :purpose-of (f4 / flank-01 
                                    :ARG0 (s2 / side 
                                          :mod (c / centromeric)) 
                                    :ARG1 (d4 / deletion 
                                          :location (s3 / side)) 
                                    :ARG2 (r4 / region 
                                          :ARG1-of (d5 / define-01 
                                                :ARG2 (r3 / reverse-01 
                                                      :ARG1 (p4 / primer)) 
                                                :degree (n / newly))))) 
                        :ARG2 (d / DNA)) 
                  :op1 (p2 / person 
                        :ARG0-of (h2 / have-org-role-91 
                              :ARG1 (f2 / family) 
                              :ARG2 (m2 / member)) 
                        :ARG1-of (a3 / affect-01) 
                        :quant 3))) 
      :polarity -)

# ::snt This experiment was performed in an attempt to amplify across the deleted fragment and define the exact breakpoint .
# ::tok This experiment was performed in an attempt to amplify across the deleted fragment and define the exact breakpoint .
# ::alignments 17-18|0.0.0.2.0.0 16-17|0.0.0.2.0.0.0 14-15|0.0.0.2.0 13-14|0.0.0.2 12-13|0.0 11-12|0 9-10|0.0.0.1 8-9|0.0.0 6-7|0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0.0.0.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:28.775
(d2 / delete-01 
      :ARG1 (f / fragment-01 
            :ARG1-of (a3 / amplify-01 
                  :ARG1-of (a4 / attempt-01 
                        :ARG2-of (p / perform-02 
                              :ARG1 (e2 / experiment-01 
                                    :mod (t / this)))) 
                  :direction (a2 / across) 
                  :op1-of (a / and 
                        :op2 (d / define-01 
                              :ARG1 (b / breakpoint 
                                    :mod (e / exact)))))))

# ::snt A single fragment was obtained from the third forward primer from the telomeric side ( T3f 5  - TGAATGCTCAATTTTCCAGC-3  ) with the 11th reverse primer from the centromeric side ( C11r 5  - GGGAAAATGGATAGAGGGTG-3  ) .
# ::tok A single fragment was obtained from the third forward primer from the telomeric side ( T3f 5  - TGAATGCTCAATTTTCCAGC-3  ) with the 11th reverse primer from the centromeric side ( C11r 5  - GGGAAAATGGATAGAGGGTG-3  ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:28.777
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The fragment , which is 953 bp in size , was sequenced as described above and compared to the current build of the human genome .
# ::tok The fragment , which is 953 bp in size , was sequenced as described above and compared to the current build of the human genome .
# ::alignments 24-25|0.2.1 23-24|0.2.1.0 20-21|0.2 19-20|0.2.0 16-17|0.1 15-16|0 14-15|0.0.2 13-14|0.0 8-9|0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:28.873
(a / and 
      :op1 (d / describe-01 
            :ARG0 (s / size) 
            :ARG1 (f / fragment-01) 
            :ARG2 (a2 / above)) 
      :op2 (c2 / compare-01) 
      :op3 (b / build-01 
            :ARG0 (c / current) 
            :ARG1 (g / genome 
                  :mod (h / human))))

# ::snt A similar series of experiments was performed to identify the deletion breakpoints in families H27 and H33 ; we were able to amplify a 369-bp PCR product across the breakpoint found in affected members of family H27 using primer pair H27-11F 5  - GACCTCAAGAAGGCATGAATAC-3  and H27-3R 5  - ATGGTGGCCAGGTACACAAG-3  ( Figure S4 ) , but to date we have been unable to identify the breakpoint in family H33 .
# ::tok A similar series of experiments was performed to identify the deletion breakpoints in families H27 and H33 ; we were able to amplify a 369-bp PCR product across the breakpoint found in affected members of family H27 using primer pair H27-11F 5  - GACCTCAAGAAGGCATGAATAC-3  and H27-3R 5  - ATGGTGGCCAGGTACACAAG-3  ( Figure S4 ) , but to date we have been unable to identify the breakpoint in family H33 .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:28.878
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Western blot analysis in SCA15 patients .
# ::tok Western blot analysis in SCA15 patients .
# ::alignments 5-6|0.0.0.0+0.0.0+0.0 4-5|0.0.1.0.0+0.0.1.0+0.0.1 2-3|0 1-2|0.2 0-1|0.1.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:28.936
(a / analyze-01 
      :ARG0 (p / person 
            :ARG0-of (h / have-rel-role-91 
                  :ARG2 (p2 / patient)) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "SCA15"))) 
      :ARG1 (w / world-region 
            :name (n2 / name 
                  :op1 "West") 
            :wiki "Western_world") 
      :ARG1-of (b / blot-01))

# ::snt EBV immortalized lymphoblasts from three affected family members who carry the deletion and one family member without the mutation were used as a readily accessible source of protein ; all samples came from members of family AUS1 .
# ::tok EBV immortalized lymphoblasts from three affected family members who carry the deletion and one family member without the mutation were used as a readily accessible source of protein ; all samples came from members of family AUS1 .
# ::alignments 36-37|0.1.0.0.0.1.0+0.1.0.0.0.1+0.1.0.0.0 35-36|0.1.0.0.0.0 33-34|0.1.0.0.1+0.1.0.0+0.1.0 31-32|0.1.0.1 30-31|0.1.0.1.1.0+0.1.0.1.1 29-30|0.1.0.1.1.1 28-29|0.1.0.1.2 27-28|0.0.0.0.2.0 25-26|0.0.0.0.1.0 24-25|0.0.0.0.1 23-24|0.0.0.0.1.1 20-21|0.0.0.0.1.0.0 18-19|0.0.0.1 15-16|0.1.2+0.1 14-15|0.1.1 12-13|0 11-12|0.0 9-10|0.0.0 7-8|0.0.0.0.0.1+0.0.0.0.0+0.0.0.0 6-7|0.0.0.0.0.0 5-6|0.0.0.0.2 4-5|0.1.0.1.0 2-3|0.0.0.0.1.0.0.0 1-2|0.0.0.0.1.0.0.0.0 0-1|0.0.0.0.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:32.644
(a4 / and 
      :op1 (d / deletion 
            :ARG1-of (c2 / carry-01 
                  :ARG0 (p3 / person 
                        :ARG0-of (h3 / have-org-role-91 
                              :ARG1 (f3 / family) 
                              :ARG2 (m4 / member)) 
                        :ARG0-of (a3 / access-01 
                              :ARG1 (s2 / source 
                                    :ARG2-of (u / use-01 
                                          :ARG1 (l / lymphoblast 
                                                :mod (i / immortalize) 
                                                :mod (e / ebv)))) 
                              :ARG1-of (r / ready-02)) 
                        :ARG1-of (a5 / affect-01 
                              :ARG0 (p2 / protein))) 
                  :prep-without (m2 / mutation))) 
      :op2 (h2 / have-org-role-91 
            :ARG0 (p / person 
                  :ARG0-of (h / have-org-role-91 
                        :ARG1 (o / organization 
                              :mod (f / family) 
                              :name (n / name 
                                    :op1 "AUS1")) 
                        :ARG2 (m / member)) 
                  :ARG3-of (c / come-01 
                        :ARG0 3 
                        :ARG1 (t / thing 
                              :ARG1-of (s / sample-01) 
                              :quant (a / all)) 
                        :mode (a2 / and))) 
            :ARG1 (f2 / family) 
            :ARG2 (m3 / member)))

# ::snt Protein extraction was performed using lysis buffer containing 1  TBS , 1 % Triton X-100 , and a cocktail of protease inhibitors ( Roche ) with overnight lysis at  80 C .
# ::tok Protein extraction was performed using lysis buffer containing 1  TBS , 1 % Triton X-100 , and a cocktail of protease inhibitors ( Roche ) with overnight lysis at  80 C .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:32.646
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Homogenates were diluted appropriately , mixed with 4  reducing sample buffer , and loaded onto 4 % -- 12 % precast gradient gels ( NuPAGE , Invitrogen ) for SDS-PAGE and immunoblotting .
# ::tok Homogenates were diluted appropriately , mixed with 4  reducing sample buffer , and loaded onto 4 % -- 12 % precast gradient gels ( NuPAGE , Invitrogen ) for SDS-PAGE and immunoblotting .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:32.649
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The antibodies to ITPR1 ( 1:1,000 ) and ACTB ( 1:5,000 ) were used as recommended by manufacturers .
# ::tok The antibodies to ITPR1 ( 1:1,000 ) and ACTB ( 1:5,000 ) were used as recommended by manufacturers .
# ::alignments 17-18|0.0.0.0+0.0.0 15-16|0.0 13-14|0.0.1 8-9|0.1.0.0+0.1.0+0.1 7-8|0 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:32.719
(a / and 
      :ARG1-of (r / recommend-01 
            :ARG0 (p / person 
                  :ARG0-of (m / manufacture-01)) 
            :purpose-of (u / use-01 
                  :ARG1 (a2 / antibodi))) 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "ACTB")))

# ::snt Schematic of Genotyping Results across Mouse Chromosome 6 in Affected Mice .
# ::tok Schematic of Genotyping Results across Mouse Chromosome 6 in Affected Mice .
# ::alignments 10-11|0.0.0.0 9-10|0.0.0.0.0 7-8|0.0.0.0.0.0 5-7|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 4-5|0.0.1 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:32.790
(s / schematic 
      :ARG2-of (r / result-01 
            :ARG1 (g / genotyp 
                  :name-of (m / mouse 
                        :ARG1-of (a / affect-01 
                              :ARG0 6))) 
            :location (a2 / across 
                  :op1 (o / organization 
                        :name (n / name 
                              :op1 "Mouse" 
                              :op2 "Chromosome")))))

# ::snt Black squares are indicative of a C57BL/6J homozygous genotype ; light grey squares , a 129x1/SvJ homozygous genotype ; grey squares , a C57BL/6J 129x1/SvJ heterozygous genotype ; white squares , undetermined genotype .
# ::tok Black squares are indicative of a C57BL/6J homozygous genotype ; light grey squares , a 129x1/SvJ homozygous genotype ; grey squares , a C57BL/6J 129x1/SvJ heterozygous genotype ; white squares , undetermined genotype .
# ::alignments 32-33|0.0.1.1.0.0 31-32|0.0.1.1.0 29-30|0.0.0.0 28-29|0.0.0.0.0 26-27|0.1.0.0 25-26|0.1.0 20-21|0.1 19-20|0.1.1 17-18|0.0.0.1 16-17|0.0.0 12-13|0.0 11-12|0.0.2 10-11|0.0.1 9-10|0 8-9|0.0.1.0 7-8|0.0.1.0.0 6-7|0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 3-4|0.0.1.1.2 1-2|0.0.1.1 0-1|0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:33.278
(a / and 
      :op1 (s3 / square-01 
            :ARG1 (h2 / homozygou 
                  :ARG1-of (s / square-01 
                        :mod (w / white)) 
                  :mod-of (g4 / genotype)) 
            :ARG1-of (l / light-06 
                  :ARG0 (g6 / genotype 
                        :mod (h3 / homozygou) 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "C57BL/6J"))) 
                  :ARG1-of (s4 / square-01 
                        :ARG0 (u / undetermin 
                              :mod-of (g / genotype)) 
                        :ARG1-of (b / black-05) 
                        :domain-of (i / indicative))) 
            :mod (g5 / grey)) 
      :op2 (s2 / square-01 
            :ARG1 (h / heterozygou 
                  :mod-of (g2 / genotype)) 
            :mod (g3 / grey)))

# ::snt The black box bounds a region of homozygous 129x1/SvJ genotypes that segregate with disease ; thus , the critical region was determined to be between markers D6Mit37 and 44 .
# ::tok The black box bounds a region of homozygous 129x1/SvJ genotypes that segregate with disease ; thus , the critical region was determined to be between markers D6Mit37 and 44 .
# ::alignments 28-29|0.0.0.0.1.0.0.0.0 27-28|0 25-26|0.0.1.1 21-22|0.0.1 19-20|0.0.1.0 18-19|0.0.1.0.0 15-16|0.0.0.0.2 14-15|0.0 13-14|0.0.0 11-12|0.0.0.0 9-10|0.0.0.0.0 7-8|0.0.1.0.0.0 5-6|0.0.0.0.1 3-4|0.0.0.0.1.0 2-3|0.0.0.0.1.0.0 1-2|0.0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:33.785
(a / and 
      :op2-of (a2 / and 
            :example-of (d2 / disease 
                  :ARG2-of (s / segregate-01 
                        :ARG0 (g / genotyp) 
                        :ARG1 (r2 / region 
                              :ARG1-of (b / bound-09 
                                    :ARG0 (b2 / box 
                                          :ARG1-of (b3 / black-04 
                                                :ARG0 44)))) 
                        :mod (t / thus-far))) 
            :op1 (d / determined-02 
                  :ARG0 (r / region 
                        :ARG1-of (c / critical-02 
                              :ARG0 (h / homozygou))) 
                  :ARG1 (m / marker))))

# ::snt MMHAP85FLG5 .
# ::tok MMHAP85FLG5 .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:33.790
(m / MMHAP85FLG5)

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:33.809
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Sequence of Exon 36 of Itpr1 from Four Mice .
# ::tok Sequence of Exon 36 of Itpr1 from Four Mice .
# ::alignments 8-9|0.0.1.0 7-8|0.0.1.0.0 5-6|0.0.1.1.0+0.0.1.1+0.0.1 3-4|0.0.1.2 2-3|0.0.0.0+0.0.0+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:33.846
(s / sequence 
      :poss (t2 / thing 
            :name (n2 / name 
                  :op1 "Exon") 
            :poss (t / thing 
                  :location (m / mouse 
                        :quant 4) 
                  :name (n / name 
                        :op1 "Itpr1") 
                  :quant 36)))

# ::snt A wild-type homozygous C57BL/6J mouse ( A ) , a wild-type homozygous 129x1/SvJ mouse ( B ) , an affected 129x1B6 mice homozygous for the 18-bp deletion mutation ( C ) , and an unaffected mouse heterozygous for the 18-bp deletion mutation ( D ) .
# ::tok A wild-type homozygous C57BL/6J mouse ( A ) , a wild-type homozygous 129x1/SvJ mouse ( B ) , an affected 129x1B6 mice homozygous for the 18-bp deletion mutation ( C ) , and an unaffected mouse heterozygous for the 18-bp deletion mutation ( D ) .
# ::alignments 43-44|0.1.3.0.0 41-42|0.1.0 40-41|0.1.0.0 35-36|0.1.4 34-35|0.1.4.0.1+0.1.4.0 32-33|0.1 29-30|0.1.4.0.0 27-28|0.1.3.1 26-27|0.1.3.1.0 22-23|0.1.3 21-22|0.1.3.2 19-20|0.1.3.0 15-16|0.2+0.0.0+0.0+0 13-14|0.1.2 4-5|0.1.1 3-4|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 2-3|0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:34.204
(l / location 
      :name (n / name 
            :op1 "B") 
      :op3-of (a2 / and 
            :beneficiary (m / mutation 
                  :mod (d2 / deletion)) 
            :op1 (m6 / mouse 
                  :mod (t / thing 
                        :name (n2 / name 
                              :op1 "C57BL/6J")) 
                  :mod (h2 / homozygou)) 
            :op2 (m5 / mouse) 
            :op4 (h / homozygou 
                  :ARG1-of (a3 / affect-01 
                        :ARG0 (d / D)) 
                  :beneficiary (m3 / mutation 
                        :mod (d3 / deletion)) 
                  :mod (m4 / mouse)) 
            :op5 (m2 / mouse 
                  :ARG1-of (a / affect-01 
                        :ARG0 (c / C) 
                        :polarity -))) 
      :wiki -)

# ::snt The deleted nucleotides are bounded by a green box .
# ::tok The deleted nucleotides are bounded by a green box .
# ::alignments 8-9|0.0 7-8|0.0.0 4-5|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:34.226
(b2 / bound-01 
      :ARG0 (b / box 
            :ARG1-of (g / green-02)) 
      :ARG1 (n / nucleotid 
            :ARG1-of (d / delete-01)))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:34.250
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Additional Families Harboring Deletion at the SCA15 Locus .
# ::tok Additional Families Harboring Deletion at the SCA15 Locus .
# ::alignments 6-8|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 2-4|0+0.0.1+0.0+0.0.0 1-2|0.0.0.1 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:34.300
(d / Deletion 
      :op2-of (n2 / name 
            :name-of (t2 / thing 
                  :location (t / thing 
                        :name (n / name 
                              :op1 "SCA15" 
                              :op2 "Locus")) 
                  :mod (f / famili 
                        :mod (a / additional))) 
            :op1 (h / Harboring)))

# ::snt ( A ) Family H33 ; ( B ) family H27 .
# ::tok ( A ) Family H33 ; ( B ) family H27 .
# ::alignments 10-11|0.2.1.0+0.2.1+0.2 9-10|0.2.0 7-8|0.1.1+0.1.0.0+0.1.0+0.1 5-6|0 3-5|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:34.363
(a / and 
      :op1 (t / thing 
            :name (n3 / name 
                  :op1 (f2 / Family) 
                  :op2 (h / H33))) 
      :op2 (l / location 
            :name (n2 / name 
                  :op1 "B") 
            :wiki -) 
      :op3 (o / organization 
            :mod (f / family) 
            :name (n / name 
                  :op1 "H27")))

# ::snt Upper panel shows log R ratio and B allele frequency metrics generated from Infinium HumanHap550 arrays for an affected family member from each family .
# ::tok Upper panel shows log R ratio and B allele frequency metrics generated from Infinium HumanHap550 arrays for an affected family member from each family .
# ::alignments 23-24|0.0.2.0.1.0 22-23|0.0.2.0.1.0.0 20-21|0.0.2.0.1.3+0.0.2.0.1 19-20|0.0.2.0.1.1 18-19|0.0.2.0.1.2 15-16|0.0.2.0 13-15|0.0.2.0.0.0.1+0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 11-12|0.0.2 10-11|0.1.2 9-10|0.1.2.0 8-9|0.0.2.0.2 7-8|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 6-7|0.1 5-6|0.1.0 4-5|0.1.0.0 3-4|0 2-3|0.0 1-2|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:36.007
(l2 / log-01 
      :ARG0 (s / show-01 
            :ARG0 (u / upper) 
            :ARG1 (p / panel) 
            :ARG1-of (g / generate-01 
                  :ARG2 (a2 / array-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 (i / Infinium) 
                                    :op2 (h2 / HumanHap550))) 
                        :purpose (h / have-org-role-91 
                              :ARG0 (f / family 
                                    :mod (e / each)) 
                              :ARG1 (f2 / family) 
                              :ARG1-of (a / affect-01) 
                              :ARG2 (m / member)) 
                        :topic-of (a3 / allele)))) 
      :ARG1 (a4 / and 
            :op1 (r / ratio 
                  :op1 (r2 / r)) 
            :op2 (l / location 
                  :name (n2 / name 
                        :op1 "B") 
                  :wiki -) 
            :op3 (m2 / metric 
                  :mod (f3 / frequency))))

# ::snt Log R ratio is the ratio of normalized , observed R to expected R for each SNP ( each SNP is a blue dot ) and thus serves as a surrogate of copy number at each locus .
# ::tok Log R ratio is the ratio of normalized , observed R to expected R for each SNP ( each SNP is a blue dot ) and thus serves as a surrogate of copy number at each locus .
# ::alignments 36-37|0.0.0 35-36|0.0 33-34|0.1.1.0.0 32-33|0.1.1.0.0.0.0+0.1.1.0.0.0 30-31|0.1.1.0 27-28|0.1.1 26-27|0.1.1.2 25-26|0.1 23-24|0.1.0.0.0.0.0 22-23|0.1.0.0.0.0 19-20|0.1.0.0.0.0.0.0.2+0.1.0.0.0.0.0.0.1.0+0.1.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0 18-19|0.1.0.0.0.0.0.0.0 16-17|0.1.1.1.2+0.1.1.1.1.0+0.1.1.1.1+0.1.1.1 15-16|0.1.1.1.0 12-13|0 9-10|0.1.0 7-8|0.2 5-6|0.1.0.0.1 2-3|0.1.0.0 1-2|0.1.0.0.2 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:36.975
(e4 / expect-01 
      :ARG0 (e / each 
            :mod-of (l / locu)) 
      :ARG1 (a / and 
            :op1 (o / observe-01 
                  :ARG1 (r2 / ratio 
                        :ARG1-of (l2 / log-01 
                              :ARG0 (b / blue 
                                    :mod-of (d / dot-01 
                                          :ARG0 (p / political-party 
                                                :mod (e2 / each) 
                                                :name (n2 / name 
                                                      :op1 "SNP") 
                                                :wiki "Scottish_National_Party")))) 
                        :domain-of (r / ratio) 
                        :op1 (r3 / r))) 
            :op2 (s2 / serve-01 
                  :ARG1 (s / surrogate 
                        :mod (n / number 
                              :mod (t / thing 
                                    :ARG2-of (c / copy-01)))) 
                  :ARG2 (p2 / political-party 
                        :mod (e3 / each) 
                        :name (n3 / name 
                              :op1 "SNP") 
                        :wiki "Scottish_National_Party") 
                  :time (t2 / thus-far))) 
      :ARG1-of (n4 / normalize-01))

# ::snt B allele frequency is a measure of the number of times the A or B alleles are detected at each locus ( each SNP is denoted by a blue dot ) .
# ::tok B allele frequency is a measure of the number of times the A or B alleles are detected at each locus ( each SNP is denoted by a blue dot ) .
# ::alignments 29-30|0.0.1 28-29|0.0.1.1 25-26|0.0.1.0 23-24|0.0.1.0.0.2+0.0.1.0.0.1.0+0.0.1.0.0.1+0.0.1.0.0 22-23|0.0.1.0.0.0 20-21|0.1.1 19-20|0.1.1.0 17-18|0.1 15-16|0.1.0 14-15|0.2.1+0.2.0.0+0.2.0+0.2 13-14|0 8-9|0.0.0 5-6|0.0 2-3|0.0.2 1-2|0.0.2.0 0-1|0.0.2.0.0.1+0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:37.904
(o / or 
      :ARG1-of (m / measure-01 
            :ARG0 (n3 / number) 
            :ARG1-of (d / dot-01 
                  :ARG0-of (d2 / denote-01 
                        :ARG1 (p / political-party 
                              :mod (e / each) 
                              :name (n / name 
                                    :op1 "SNP") 
                              :wiki "Scottish_National_Party")) 
                  :mod (b / blue)) 
            :ARG2 (f / frequency 
                  :mod (a2 / allele 
                        :mod (l3 / location 
                              :name (n4 / name 
                                    :op1 "B") 
                              :wiki -)))) 
      :ARG2-of (d3 / detect-01 
            :ARG1 (a / allel) 
            :location (l / locu 
                  :mod (e2 / each))) 
      :op1 (l2 / location 
            :name (n2 / name 
                  :op1 "B") 
            :wiki -))

# ::snt Thus , SNPs with a B allele frequency of one are apparent B/B homozygotes , SNPs with a B allele frequency of 0.5 are apparent A/B heterozygotes , and those with a B allele frequency of zero are apparent A/A homozygotes .
# ::tok Thus , SNPs with a B allele frequency of one are apparent B/B homozygotes , SNPs with a B allele frequency of 0.5 are apparent A/B heterozygotes , and those with a B allele frequency of zero are apparent A/A homozygotes .
# ::alignments 40-41|0.3.0 39-40|0.3.1.0+0.3.1+0.3 38-39|0.3.0.0 36-37|0.3.2 34-35|0.2.1.0.1 33-34|0.2.1.0 32-33|0.2.1.0.0.1+0.2.1.0.0.0.0+0.2.1.0.0.0+0.2.1.0.0 28-29|0 26-27|0.1.0 25-26|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 24-25|0.1.0.0 22-23|0.1.0.1.1 20-21|0.2.2.0.0 19-20|0.2.2.0 18-19|0.2.2.2+0.2.2.1.0+0.2.2.1+0.2.2 13-14|0.2 12-13|0.2.1.1.0+0.2.1.1+0.2.1 11-12|0.2.0 7-8|0.1.1.0 6-7|0.1.1 5-6|0.1.3+0.1.2.0+0.1.2+0.1 2-3|0.0 0-1|0.1.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:38.270
(a3 / and 
      :op1 (s / snp) 
      :op2 (l3 / location 
            :mod-of (h2 / heterozygot 
                  :mod (a4 / apparent) 
                  :mod (t2 / thing 
                        :name (n3 / name 
                              :op1 "A/B") 
                        :quant (0 / 0.5 
                              :mod (t4 / thu)))) 
            :mod-of (a7 / allele 
                  :mod-of (f3 / frequency)) 
            :name (n6 / name 
                  :op1 "B") 
            :wiki -) 
      :op3 (h3 / homozygot 
            :mod (a6 / apparent) 
            :mod (t3 / thing 
                  :mod-of (a2 / allele 
                        :mod (l / location 
                              :name (n2 / name 
                                    :op1 "B") 
                              :wiki -) 
                        :mod-of (f / frequency)) 
                  :name (n5 / name 
                        :op1 "B/B")) 
            :part (l2 / location 
                  :mod-of (a5 / allele 
                        :mod-of (f2 / frequency)) 
                  :name (n4 / name 
                        :op1 "B") 
                  :wiki -)) 
      :op4 (t / thing 
            :mod-of (h / homozygot 
                  :mod (a / apparent)) 
            :name (n / name 
                  :op1 "A/A") 
            :quant (z / zero)))

# ::snt These plots show a contiguous region ~ 310 kb long ( family H33 ) and ~ 350 kb long ( family H27 ) with decreased copy number and apparent homozygosity indicative of a genomic deletion ( shaded grey ) .
# ::tok These plots show a contiguous region ~ 310 kb long ( family H33 ) and ~ 350 kb long ( family H27 ) with decreased copy number and apparent homozygosity indicative of a genomic deletion ( shaded grey ) .
# ::alignments 37-38|0.2.0.0.0.0.1 36-37|0.2.0.0.0.0 34-35|0.3.1.2 30-31|0.3.1 29-30|0.3.1.1 28-29|0.3.1.0 27-28|0.3 26-27|0.3.0.0 25-26|0.3.0.0.0.0+0.3.0.0.0 24-25|0.3.0 20-21|0.2.1 18-19|0.2.0.0.0 16-17|0.2.0.0.0.0.0 14-15|0.2 11-12|0.2.0.0 9-10|0.2.0 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:39.582
(s2 / show-01 
      :ARG0 (p / plot 
            :mod (t2 / this)) 
      :ARG1 (r / region 
            :mod (c2 / contiguou)) 
      :manner (a3 / and 
            :op1 (l2 / long-03 
                  :ARG1 (f2 / family 
                        :ARG1-of (l / long-03 
                              :purpose-of (s / shade-01 
                                    :ARG0 350 
                                    :ARG1 (g / grey))))) 
            :op2 (f / family)) 
      :op1-of (a2 / and 
            :op2 (d2 / decrease-01 
                  :ARG1 (n / number 
                        :mod (t / thing 
                              :ARG2-of (c / copy-01)))) 
            :op3 (i / indicative 
                  :mod (a / apparent) 
                  :mod (h / homozygosity) 
                  :poss (d / deletion))))

# ::snt The pedigrees below show the available family members assayed for these deletions , all of whom were affected and all of whom carried a deletion at this locus .
# ::tok The pedigrees below show the available family members assayed for these deletions , all of whom were affected and all of whom carried a deletion at this locus .
# ::alignments 27-28|0.1.2.1.2 26-27|0.1.2.1.2.0 24-25|0.1.2.1.1 22-23|0.1.2.1 19-20|0.1.1.0 18-19|0.1.2 17-18|0.1.2.0 13-14|0.1.2.0.0 11-12|0.1.2.1.0 10-11|0.1.2.1.0.0 7-8|0.1.0.1+0.1.0+0.1 6-7|0.1.0.0 5-6|0.1.1 3-4|0 2-3|0.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:40.047
(s / show-01 
      :ARG0 (p2 / pedigre) 
      :ARG1 (p / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f / family) 
                  :ARG2 (m / member)) 
            :ARG2-of (a5 / available-02 
                  :ARG1 (a / all)) 
            :op1-of (a2 / and 
                  :op2 (a3 / affect-01 
                        :ARG1 (a4 / all)) 
                  :op3 (c / carry-01 
                        :ARG0 (d2 / deletion 
                              :mod (t2 / this)) 
                        :ARG1 (d / deletion) 
                        :ARG2 (l / locu 
                              :mod (t / this))))) 
      :mod (b / below))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:40.062
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Deleted Regions Identified in Families AUS1 and H27 .
# ::tok Deleted Regions Identified in Families AUS1 and H27 .
# ::alignments 7-8|0.1.1.0.0+0.1.1.0+0.1.1 6-7|0.1 4-6|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 2-3|0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:40.147
(i / identify-01 
      :ARG1 (t2 / thing 
            :name (n3 / name 
                  :op1 (d / Deleted) 
                  :op2 (r / Regions))) 
      :ARG2 (a / and 
            :op1 (t / thing 
                  :name (n2 / name 
                        :op1 (f / Families) 
                        :op2 (a2 / AUS1))) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "H27"))))

# ::snt ( Top ) Family AUS1 ; sequence from the PCR product generated using primers T3f and C11r from genomic DNA from an affected family member .
# ::tok ( Top ) Family AUS1 ; sequence from the PCR product generated using primers T3f and C11r from genomic DNA from an affected family member .
# ::alignments 24-25|0.1.2+0.1 23-24|0.1.1 22-23|0 19-20|0.1.0 16-17|0.2.2.1.0.1.0.0+0.2.2.1.0.1.0+0.2.2.1.0.1 15-16|0.2.2.1.0 14-15|0.2.2.1.0.0.1.0+0.2.2.1.0.0.1+0.2.2.1.0.0 13-14|0.2.2.1.0.0.0 12-13|0.2.2.1 11-12|0.2.2 10-11|0.2.2.0 6-7|0.2.1 5-6|0.2 3-5|0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:41.572
(a / affect-01 
      :ARG0 (t2 / top) 
      :ARG1 (h / have-org-role-91 
            :ARG0 (d / DNA) 
            :ARG1 (f / family) 
            :ARG2 (m / member)) 
      :op4-of (a3 / and 
            :op1 (t / thing 
                  :name (n3 / name 
                        :op1 (f2 / Family) 
                        :op2 (a4 / AUS1))) 
            :op2 (s / sequence) 
            :op3 (g / generate-01 
                  :ARG0 (p2 / product) 
                  :ARG1 (u / use-01 
                        :ARG1 (a2 / and 
                              :op1 (o2 / organization 
                                    :mod (p / primer) 
                                    :name (n2 / name 
                                          :op1 "T3f")) 
                              :op2 (o / organization 
                                    :name (n / name 
                                          :op1 "C11r")))))))

# ::snt Red arrowhead denotes the deletion breakpoint ; the deletion is 201,510 bp in length .
# ::tok Red arrowhead denotes the deletion breakpoint ; the deletion is 201,510 bp in length .
# ::alignments 13-14|0.0.0.0.0 8-9|0.0.1.0.0 6-7|0 5-6|0.0.1 4-5|0.0.1.0 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:41.750
(a / and 
      :op1 (d3 / denote-01 
            :ARG0 (a2 / arrowhead 
                  :mod (r / red 
                        :poss (l / length))) 
            :ARG1 (b / breakpoint 
                  :mod (d2 / deletion 
                        :purpose-of (d / deletion)))))

# ::snt ( Bottom ) Family H27 ; sequence flanking deleted region .
# ::tok ( Bottom ) Family H27 ; sequence flanking deleted region .
# ::alignments 9-10|0.1.0.0 8-9|0.1.0.0.0 7-8|0.1.0 6-7|0.1 5-6|0 3-5|0.0.1.1+0.0.1.0+0.0.1+0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:41.928
(a / and 
      :op1 (t / thing 
            :ARG1-of (b / bottom-01) 
            :name (n / name 
                  :op1 (f2 / Family) 
                  :op2 (h / H27))) 
      :op2 (s / sequence 
            :ARG0-of (f / flank-01 
                  :ARG1 (r / region 
                        :ARG1-of (d / delete-01)))))

# ::snt Green font indicates nucleotides telomeric to the deletion ; blue font indicates nucleotides centromeric to the deletion .
# ::tok Green font indicates nucleotides telomeric to the deletion ; blue font indicates nucleotides centromeric to the deletion .
# ::alignments 16-17|0.3.0.1.0.0 13-14|0.3.0.1.0 12-13|0.3.0.1 11-12|0.3.0 10-11|0.3.0.0 9-10|0.3.0.0.0 8-9|0.3 7-8|0.2 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.097
(i2 / indicate-01 
      :ARG0 (f2 / font 
            :mod (p / political-party 
                  :name (n3 / name 
                        :op1 "Green"))) 
      :ARG1 (n2 / nucleotid) 
      :ARG2 (d2 / deletion) 
      :op1-of (a / and 
            :op2 (i / indicate-01 
                  :ARG0 (f / font 
                        :mod (b / blue)) 
                  :ARG1 (n / nucleotid 
                        :domain-of (c / centromeric 
                              :op1 (d / deletion))))))

# ::snt The deletion is 344,408 bp in length .
# ::tok The deletion is 344,408 bp in length .
# ::alignments 6-7|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.105
(d / deletion 
      :domain (l / length))

# ::snt Basepair positions are based on NCBI genome build 36 reference assembly .
# ::tok Basepair positions are based on NCBI genome build 36 reference assembly .
# ::alignments 10-11|0.1.0 9-10|0.1.0.0 8-9|0.1.0.0.0 7-8|0.1 6-7|0.2 5-6|0.2.0 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.377
(b2 / base-02 
      :ARG0 (p / position) 
      :ARG1 (b / build-01 
            :ARG1 (a / assembly 
                  :ARG1-of (r / reference-04 
                        :quant 36))) 
      :ARG2 (g / genome 
            :mod (n / NCBI)))

# ::snt ( 876 KB MB TIF ) .
# ::tok ( 876 KB MB TIF ) .
# ::alignments 3-5|0.0.1+0+0.0+0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.390
(m / MB 
      :op1-of (n / name 
            :name-of (t / thing 
                  :domain 876) 
            :op2 (t2 / TIF)))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.405
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt The OMIM ( http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM ) accession number for SUMF1 is 607939 .
# ::tok The OMIM ( http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM ) accession number for SUMF1 is 607939 .
# ::alignments 10-11|0.3+0.2+0.0+0 6-7|0.1.0 5-6|0.1 1-2|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.441
(d / date-entity 
      :day 39 
      :domain-of (a / accession 
            :mod-of (n / number 
                  :consist-of (p / person 
                        :name (n2 / name 
                              :op1 "OMIM")))) 
      :month 79 
      :year 60)

# ::snt We thank the SCA15 family members for participating in this study .
# ::tok We thank the SCA15 family members for participating in this study .
# ::alignments 10-11|0.2.1 9-10|0.2.1.0 7-8|0.2 5-6|0.1.0.1+0.1.0+0.1 4-5|0.1.0.0 3-4|0.2.0.0.0+0.2.0.0+0.2.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.680
(t3 / thank-01 
      :ARG0 (w / we) 
      :ARG1 (p2 / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f / family) 
                  :ARG2 (m / member))) 
      :ARG2 (p / participate-01 
            :ARG0 (t2 / thing 
                  :name (n / name 
                        :op1 "SCA15")) 
            :ARG1 (s / study-01 
                  :mod (t / this))))

# ::snt EBV - Epstein-Barr virus .
# ::tok EBV - Epstein-Barr virus .
# ::alignments 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.686
(e / ebv 
      :poss-of (v / virus))

# ::snt SCA [ number ] - spinocerebellar ataxia [ number ] .
# ::tok SCA [ number ] - spinocerebellar ataxia [ number ] .
# ::alignments 8-9|0.0.0 6-7|0.0 5-6|0 2-3|0.0.0.0 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.712
(s / spinocerebellar 
      :mod-of (a / ataxia 
            :mod-of (n / number 
                  :poss (n2 / number 
                        :quant (o / organization 
                              :name (n3 / name 
                                    :op1 "SCA"))))))

# ::snt SNP - single nucleotide polymorphism .
# ::tok SNP - single nucleotide polymorphism .
# ::alignments 4-5|0 3-4|0.1 2-3|0.0 0-1|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.752
(p / polymorphism 
      :ARG1-of (s / single-02 
            :ARG0 (p2 / political-party 
                  :name (n2 / name 
                        :op1 "SNP") 
                  :wiki "Scottish_National_Party")) 
      :mod (n / nucleotide))

# ::snt Immunohistochemistry and Western Blot Analysis of ITPR1 Protein Levels in Mouse Cerebellum .
# ::tok Immunohistochemistry and Western Blot Analysis of ITPR1 Protein Levels in Mouse Cerebellum .
# ::alignments 10-12|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 2-9|0.1.1.6+0.1.1.5+0.1.1.4+0.1.1.3+0.1.1.2+0.1.1.1+0.1.1.0+0.1.1+0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:42.785
(a / and 
      :op1 (i / immunohistochemistry) 
      :op2 (o / organization 
            :location (c / country 
                  :name (n / name 
                        :op1 "Mouse" 
                        :op2 "Cerebellum")) 
            :name (n2 / name 
                  :op1 "Western" 
                  :op2 "Blot" 
                  :op3 "Analysis" 
                  :op4 "of" 
                  :op5 "ITPR1" 
                  :op6 "Protein" 
                  :op7 "Levels")))

# ::snt ( A -- F ) Immunohistochemistry of cerebellum from a wild-type mouse ( A and D ) , a mouse heterozygous for the Itpr1 18-bp deletion ( B and E ) , and a mouse homozygous for the 18-bp Itpr1 deletion ( C and F ) .
# ::tok ( A -- F ) Immunohistochemistry of cerebellum from a wild-type mouse ( A and D ) , a mouse heterozygous for the Itpr1 18-bp deletion ( B and E ) , and a mouse homozygous for the 18-bp Itpr1 deletion ( C and F ) .
# ::alignments 44-45|0.3.1+0.3.0.0+0.3.0+0.3 43-44|0 42-43|0.2 40-41|0.1 34-35|0.1.0.4 32-33|0.1.0 29-30|0.1.0.1.0.3 28-29|0.1.0.1.0 27-28|0.1.0.1.0.2.1+0.1.0.1.0.2.0.0+0.1.0.1.0.2.0+0.1.0.1.0.2 25-26|0.1.0.1.0.1 23-24|0.0.0.0+0.0.0+0.0 20-21|0.1.0.3 19-20|0.1.0.3.0 15-16|0.1.0.2 14-15|0.1.0.1 11-12|0.1.0.0.0.0 7-8|0.1.0.0.0 5-6|0.1.0.0 3-4|0.1.0.1.0.0.1+0.1.0.1.0.0.0.0+0.1.0.1.0.0.0+0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:43.092
(a2 / and 
      :op1 (t / thing 
            :name (n3 / name 
                  :op1 "Itpr1")) 
      :op2 (d / deletion 
            :beneficiary-of (a3 / and 
                  :op1 (i / immunohistochemistry 
                        :mod (c2 / cerebellum 
                              :source (m3 / mouse))) 
                  :op2 (a5 / and 
                        :op1 (a4 / and 
                              :op1 (a6 / aircraft-type 
                                    :name (n4 / name 
                                          :op1 "F22") 
                                    :wiki "Lockheed_Martin_F-22_Raptor") 
                              :op2 (d2 / deletion) 
                              :op3 (l / location 
                                    :name (n2 / name 
                                          :op1 "B") 
                                    :wiki -) 
                              :op4 (e / E))) 
                  :op3 (d3 / D) 
                  :op4 (h / heterozygou 
                        :mod (m2 / mouse)) 
                  :op5 (m / mouse))) 
      :op3 (c / C) 
      :op4 (a / aircraft-type 
            :name (n / name 
                  :op1 "F22") 
            :wiki "Lockheed_Martin_F-22_Raptor"))

# ::snt ( A -- C ) Immunohistochemistry using polyclonal Itpr1 anti-rabbit antibody ( 1:2,000 ; Alexa Fluor 555 ) ; ( D -- F ) immunohistochemistry using monoclonal Calb1 anti-mouse antibody ( 1:6,000 ; Alexa Fluor 488 ) .
# ::tok ( A -- C ) Immunohistochemistry using polyclonal Itpr1 anti-rabbit antibody ( 1:2,000 ; Alexa Fluor 555 ) ; ( D -- F ) immunohistochemistry using monoclonal Calb1 anti-mouse antibody ( 1:6,000 ; Alexa Fluor 488 ) .
# ::alignments 34-36|0.1.0.1+0.1.0.0+0.1.0+0.1 29-30|0.1.1.2.0.1 26-27|0.1.1.2.0.1.0 25-26|0.1.1.2.0 24-25|0.1.1.2.0.2 22-23|0.1.1.3.1+0.1.1.3.0.0+0.1.1.3.0+0.1.1.3 20-21|0.1.1.2.0.0 15-17|0.0.0.1+0.0.0.0+0.0.0+0.0 13-14|0 10-11|0.1.1.4 8-9|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 6-7|0.1.1 5-6|0.1.1.0 3-4|0.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:44.341
(a3 / and 
      :op1 (t2 / thing 
            :name (n3 / name 
                  :op1 (f2 / Fluor) 
                  :op2 555)) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 (f / Fluor) 
                  :op2 488) 
            :op1 (u2 / use-01 
                  :ARG0 (i2 / immunohistochemistry) 
                  :ARG1 (t3 / thing 
                        :name (n4 / name 
                              :op1 "Itpr1")) 
                  :ARG2 (c / C 
                        :op1 (u / use-01 
                              :ARG0 (d / D) 
                              :ARG1 (a / antibody 
                                    :mod (m / monoclonal)) 
                              :ARG2 (i / immunohistochemistry))) 
                  :op1-of (a2 / aircraft-type 
                        :name (n2 / name 
                              :op1 "F22") 
                        :wiki "Lockheed_Martin_F-22_Raptor") 
                  :time (a4 / antibody))))

# ::snt Scale bars denote 100 m .
# ::tok Scale bars denote 100 m .
# ::alignments 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:44.367
(d / denote-01 
      :ARG0 (b / bar 
            :mod (s / scale)) 
      :ARG1 (m / m 
            :quant 100))

# ::snt As previously described , Iptr1 is highly expressed in the Purkinje cells .
# ::tok As previously described , Iptr1 is highly expressed in the Purkinje cells .
# ::alignments 11-12|0.2 10-11|0.2.0 7-8|0 6-7|0.1 4-5|0.0.0.0+0.0.0+0.0 2-3|0.3 1-2|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:44.421
(e / express-01 
      :ARG1 (p2 / person 
            :name (n / name 
                  :op1 "Iptr1")) 
      :degree (h / high) 
      :manner (c / cell 
            :mod (p / purkinje)) 
      :time (d / describe-01 
            :time (p3 / previous)))

# ::snt Notably , there appears to be decreased immunoreactivity to Itpr1 in the heterozygous and homozygous mutant mice .
# ::tok Notably , there appears to be decreased immunoreactivity to Itpr1 in the heterozygous and homozygous mutant mice .
# ::alignments 16-17|0.0.1 15-16|0.0.1.0 13-14|0.0 12-13|0.0.0.1 9-10|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 6-7|0.0.0 3-4|0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:44.469
(a2 / appear-02 
      :ARG1 (a / and 
            :op1 (d / decrease-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "Itpr1")) 
                  :ARG2 (h / heterozygou)) 
            :op2 (m / mouse 
                  :mod (m2 / mutant)) 
            :time (n2 / notably)))

# ::snt ( G ) Western blot performed to examine Itpr1 levels in whole brain from wild-type , Itpr1wt/18 , and Itpr118/18 mice ; this clearly shows a reduction of Itpr1 in brain tissue from Itpr1wt/18 mice and a greater reduction of Itpr1 in Itpr118/18 mice .
# ::tok ( G ) Western blot performed to examine Itpr1 levels in whole brain from wild-type , Itpr1wt/18 , and Itpr118/18 mice ; this clearly shows a reduction of Itpr1 in brain tissue from Itpr1wt/18 mice and a greater reduction of Itpr1 in Itpr118/18 mice .
# ::alignments 43-44|0.3.0 38-39|0.3 37-38|0.3.1 35-36|0 34-35|0.2 31-32|0.0.1.1 30-31|0.1 26-27|0.0.1 24-25|0.0 23-24|0.0.2 22-23|0.0.0 21-22|0.0.1.0 20-21|0.0.1.0.0.1 18-19|0.0.1.0.0 12-13|0.0.1.0.0.0.2.1.0 11-12|0.0.1.0.0.0.2.1 9-10|0.0.1.0.0.0.1 8-9|0.0.1.0.0.0.2.0.1.0.0+0.0.1.0.0.0.2.0.1.0+0.0.1.0.0.0.2.0.1 7-8|0.0.1.0.0.0 5-6|0.0.1.0.0.0.2 4-5|0.0.1.0.0.0.2.0 3-4|0.0.1.0.0.0.2.0.0.1+0.0.1.0.0.0.2.0.0.0.0+0.0.1.0.0.0.2.0.0.0+0.0.1.0.0.0.2.0.0 1-2|0.0.1.0.0.0.0.1+0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:46.104
(a / and 
      :op1 (s / show-01 
            :ARG0 (t2 / this) 
            :ARG1 (r2 / reduce-01 
                  :ARG1 (a2 / and 
                        :op3-of (a3 / and 
                              :op1 (e / examine-01 
                                    :ARG0 (o / organization 
                                          :name (n3 / name 
                                                :op1 "G-8") 
                                          :wiki "G8") 
                                    :ARG1 (l / level) 
                                    :ARG1-of (p / perform-02 
                                          :ARG0 (b3 / blot-01 
                                                :ARG1 (w2 / world-region 
                                                      :name (n2 / name 
                                                            :op1 "West") 
                                                      :wiki "Western_world") 
                                                :compared-to (t3 / thing 
                                                      :name (n / name 
                                                            :op1 "Itpr1"))) 
                                          :manner (w / whole 
                                                :mod-of (b2 / brain)))) 
                              :op2 (m3 / mouse))) 
                  :location (t / tissue)) 
            :ARG1-of (c / clear-06)) 
      :op2 (b / brain) 
      :op3 (m2 / mouse) 
      :op4 (r / reduce-01 
            :ARG1 (m / mouse) 
            :mod (g / great)))

# ::snt Metrics Derived from Analysis of DNA from Affected Family Member 7 Using Illumina Infinium HumanHap550 Genotyping Chips .
# ::tok Metrics Derived from Analysis of DNA from Affected Family Member 7 Using Illumina Infinium HumanHap550 Genotyping Chips .
# ::alignments 16-17|0.1.0.3.0 15-16|0.1.0.3.0.1 14-15|0.1.0.3.0.2.0 12-14|0.1.0.3.0.2.1.1+0.1.0.3.0.2.1.0+0.1.0.3.0.2.1+0.1.0.3.0.2 11-12|0.1.0.3 10-11|0.1.0.3.0.0 9-10|0.1.0.1+0.1.0 8-9|0.1.0.0 7-8|0.1.0.2.0 5-6|0.1.0.2 3-4|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:46.652
(d2 / derive-01 
      :ARG0 (m2 / metric) 
      :ARG2 (a2 / analysi 
            :ARG0-of (h2 / have-org-role-91 
                  :ARG1 (f / family) 
                  :ARG2 (m / member) 
                  :domain-of (d / DNA 
                        :ARG1-of (a / affect-01)) 
                  :purpose (u / use-01 
                        :ARG1 (c / chip-01 
                              :ARG0 7 
                              :ARG1 (g / genotyp) 
                              :ARG2 (t / thing 
                                    :mod-of (h / HumanHap550) 
                                    :name (n / name 
                                          :op1 (i / Illumina) 
                                          :op2 (i2 / Infinium))))))))

# ::snt The upper and lower plots are log R ratio and B allele frequency , respectively , at an ~ 800-kb segment on the p arm of Chromosome 3 .
# ::tok The upper and lower plots are log R ratio and B allele frequency , respectively , at an ~ 800-kb segment on the p arm of Chromosome 3 .
# ::alignments 27-28|0.1.0.0 26-27|0.2.0.2.0.0+0.2.0.2.0+0.2.0.2 24-25|0.2.0.1 23-24|0.2.0.1.1 20-21|0.2.0.1.0 14-15|0.0 12-13|0.4 11-12|0.4.0 10-11|0.3.1+0.3.0.0+0.3.0+0.3 9-10|0 8-9|0.2 7-8|0.2.1 6-7|0.1.1 4-5|0.1 3-4|0.1.0 2-3|0.2.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:47.013
(a3 / and 
      :mod (r / respective) 
      :op1 (p3 / plot 
            :ARG1-of (l3 / low-04 
                  :ARG0 3) 
            :ARG1-of (l2 / log-01)) 
      :op2 (r2 / ratio 
            :domain (a4 / and 
                  :op1 (u / upper) 
                  :op2 (a / arm 
                        :location-of (s / segment) 
                        :mod (p2 / p)) 
                  :op3 (p / person 
                        :name (n / name 
                              :op1 "Chromosome"))) 
            :op1 (r3 / r)) 
      :op3 (l / location 
            :name (n2 / name 
                  :op1 "B") 
            :wiki -) 
      :op4 (f / frequency 
            :mod (a2 / allele)))

# ::snt Log R ratio is the ratio of normalized , observed R to expected R for each SNP ( each SNP is a blue dot ) and thus serves as a surrogate of copy number at each locus .
# ::tok Log R ratio is the ratio of normalized , observed R to expected R for each SNP ( each SNP is a blue dot ) and thus serves as a surrogate of copy number at each locus .
# ::alignments 36-37|0.0.0 35-36|0.0 33-34|0.1.1.0.0 32-33|0.1.1.0.0.0.0+0.1.1.0.0.0 30-31|0.1.1.0 27-28|0.1.1 26-27|0.1.1.2 25-26|0.1 23-24|0.1.0.0.0.0.0 22-23|0.1.0.0.0.0 19-20|0.1.0.0.0.0.0.0.2+0.1.0.0.0.0.0.0.1.0+0.1.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0 18-19|0.1.0.0.0.0.0.0.0 16-17|0.1.1.1.2+0.1.1.1.1.0+0.1.1.1.1+0.1.1.1 15-16|0.1.1.1.0 12-13|0 9-10|0.1.0 7-8|0.2 5-6|0.1.0.0.1 2-3|0.1.0.0 1-2|0.1.0.0.2 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:47.950
(e4 / expect-01 
      :ARG0 (e / each 
            :mod-of (l / locu)) 
      :ARG1 (a / and 
            :op1 (o / observe-01 
                  :ARG1 (r2 / ratio 
                        :ARG1-of (l2 / log-01 
                              :ARG0 (b / blue 
                                    :mod-of (d / dot-01 
                                          :ARG0 (p / political-party 
                                                :mod (e2 / each) 
                                                :name (n2 / name 
                                                      :op1 "SNP") 
                                                :wiki "Scottish_National_Party")))) 
                        :domain-of (r / ratio) 
                        :op1 (r3 / r))) 
            :op2 (s2 / serve-01 
                  :ARG1 (s / surrogate 
                        :mod (n / number 
                              :mod (t / thing 
                                    :ARG2-of (c / copy-01)))) 
                  :ARG2 (p2 / political-party 
                        :mod (e3 / each) 
                        :name (n3 / name 
                              :op1 "SNP") 
                        :wiki "Scottish_National_Party") 
                  :time (t2 / thus-far))) 
      :ARG1-of (n4 / normalize-01))

# ::snt B allele frequency is a measure of the number of times the A or B alleles are detected at each locus ( each SNP is denoted by a blue dot ) .
# ::tok B allele frequency is a measure of the number of times the A or B alleles are detected at each locus ( each SNP is denoted by a blue dot ) .
# ::alignments 29-30|0.0.1 28-29|0.0.1.1 25-26|0.0.1.0 23-24|0.0.1.0.0.2+0.0.1.0.0.1.0+0.0.1.0.0.1+0.0.1.0.0 22-23|0.0.1.0.0.0 20-21|0.1.1 19-20|0.1.1.0 17-18|0.1 15-16|0.1.0 14-15|0.2.1+0.2.0.0+0.2.0+0.2 13-14|0 8-9|0.0.0 5-6|0.0 2-3|0.0.2 1-2|0.0.2.0 0-1|0.0.2.0.0.1+0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:48.885
(o / or 
      :ARG1-of (m / measure-01 
            :ARG0 (n3 / number) 
            :ARG1-of (d / dot-01 
                  :ARG0-of (d2 / denote-01 
                        :ARG1 (p / political-party 
                              :mod (e / each) 
                              :name (n / name 
                                    :op1 "SNP") 
                              :wiki "Scottish_National_Party")) 
                  :mod (b / blue)) 
            :ARG2 (f / frequency 
                  :mod (a2 / allele 
                        :mod (l3 / location 
                              :name (n4 / name 
                                    :op1 "B") 
                              :wiki -)))) 
      :ARG2-of (d3 / detect-01 
            :ARG1 (a / allel) 
            :location (l / locu 
                  :mod (e2 / each))) 
      :op1 (l2 / location 
            :name (n2 / name 
                  :op1 "B") 
            :wiki -))

# ::snt Thus , SNPs with a B allele frequency of one are apparent B/B homozygotes , SNPs with a B allele frequency of 0.5 are apparent A/B heterozygotes , and those with a B allele frequency of zero are apparent A/A homozygotes .
# ::tok Thus , SNPs with a B allele frequency of one are apparent B/B homozygotes , SNPs with a B allele frequency of 0.5 are apparent A/B heterozygotes , and those with a B allele frequency of zero are apparent A/A homozygotes .
# ::alignments 40-41|0.3.0 39-40|0.3.1.0+0.3.1+0.3 38-39|0.3.0.0 36-37|0.3.2 34-35|0.2.1.0.1 33-34|0.2.1.0 32-33|0.2.1.0.0.1+0.2.1.0.0.0.0+0.2.1.0.0.0+0.2.1.0.0 28-29|0 26-27|0.1.0 25-26|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 24-25|0.1.0.0 22-23|0.1.0.1.1 20-21|0.2.2.0.0 19-20|0.2.2.0 18-19|0.2.2.2+0.2.2.1.0+0.2.2.1+0.2.2 13-14|0.2 12-13|0.2.1.1.0+0.2.1.1+0.2.1 11-12|0.2.0 7-8|0.1.1.0 6-7|0.1.1 5-6|0.1.3+0.1.2.0+0.1.2+0.1 2-3|0.0 0-1|0.1.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:49.260
(a3 / and 
      :op1 (s / snp) 
      :op2 (l3 / location 
            :mod-of (h2 / heterozygot 
                  :mod (a4 / apparent) 
                  :mod (t2 / thing 
                        :name (n3 / name 
                              :op1 "A/B") 
                        :quant (0 / 0.5 
                              :mod (t4 / thu)))) 
            :mod-of (a7 / allele 
                  :mod-of (f3 / frequency)) 
            :name (n6 / name 
                  :op1 "B") 
            :wiki -) 
      :op3 (h3 / homozygot 
            :mod (a6 / apparent) 
            :mod (t3 / thing 
                  :mod-of (a2 / allele 
                        :mod (l / location 
                              :name (n2 / name 
                                    :op1 "B") 
                              :wiki -) 
                        :mod-of (f / frequency)) 
                  :name (n5 / name 
                        :op1 "B/B")) 
            :part (l2 / location 
                  :mod-of (a5 / allele 
                        :mod-of (f2 / frequency)) 
                  :name (n4 / name 
                        :op1 "B") 
                  :wiki -)) 
      :op4 (t / thing 
            :mod-of (h / homozygot 
                  :mod (a / apparent)) 
            :name (n / name 
                  :op1 "A/A") 
            :quant (z / zero)))

# ::snt Clearly , these plots show a contiguous region ~ 200 kb long with decreased copy number and apparent homozygosity ( bounded by a red box ) .
# ::tok Clearly , these plots show a contiguous region ~ 200 kb long with decreased copy number and apparent homozygosity ( bounded by a red box ) .
# ::alignments 24-25|0.1.1.0.0 23-24|0.1.1.0.0.0 20-21|0.1.1.0 18-19|0.1.0.1.1.0 17-18|0.1.0.1.1.0.0 16-17|0.1.0.1.1 15-16|0.1.0.1.0 14-15|0.1.0.1.0.0.0+0.1.0.1.0.0 13-14|0.1.0.1 11-12|0.1.0 10-11|0.1.0.0 9-10|0.2.0 7-8|0.1 6-7|0.1.1 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:49.624
(s / show-01 
      :ARG0 (p / plot 
            :mod (t2 / this)) 
      :ARG1 (r2 / region 
            :ARG1-of (l / long-03 
                  :ARG0 (k / kb) 
                  :ARG2 (d / decrease-01 
                        :ARG1 (n / number 
                              :mod (t / thing 
                                    :ARG2-of (c / copy-01))) 
                        :op1-of (a2 / and 
                              :op2 (h / homozygosity 
                                    :mod (a / apparent))))) 
            :mod (c2 / contiguou 
                  :ARG1-of (b2 / bound-01 
                        :ARG0 (b / box 
                              :mod (r / red))))) 
      :ARG1-of (c3 / clear-06 
            :ARG0 200))

# ::snt As we have demonstrated previously , this is indicative of a heterozygous genomic deletion [ 15 ] .
# ::tok As we have demonstrated previously , this is indicative of a heterozygous genomic deletion [ 15 ] .
# ::alignments 15-16|0.0.0.1 13-14|0.0.1 11-12|0.0.1.0 8-9|0 6-7|0.0 4-5|0.0.0.2 3-4|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:49.717
(i / indicative 
      :domain (t / this 
            :ARG1-of (d2 / demonstrate-01 
                  :ARG0 (w / we) 
                  :ARG2 15 
                  :time (p / previous)) 
            :domain-of (d / deletion 
                  :mod (h / heterozygou))))

# ::snt Below these plots is a schematic of the two known genes affected by this deletion , ITPR1 and SUMF1 .
# ::tok Below these plots is a schematic of the two known genes affected by this deletion , ITPR1 and SUMF1 .
# ::alignments 18-19|0.2 17-18|0 16-17|0.1 14-15|0.0 13-14|0.0.1 11-12|0.0.0 10-11|0.0.0.0 9-10|0.0.0.0.0 8-9|0.0.0.0.1 5-6|0.0.0.1.0.0 2-3|0.0.0.1.0 1-2|0.0.0.1 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:50.321
(a / and 
      :op1 (d / deletion 
            :manner-of (a2 / affect-01 
                  :ARG1 (g / gene 
                        :ARG1-of (k / know-02 
                              :ARG0 (b / below)) 
                        :quant 2) 
                  :ARG2 (t2 / this 
                        :mod-of (p / plot 
                              :domain-of (s2 / schematic)))) 
            :mod (t / this)) 
      :op2 (i / ITPR1) 
      :op3 (s / SUMF1))

# ::snt Mutation Analysis in the Australian SCA15 Family .
# ::tok Mutation Analysis in the Australian SCA15 Family .
# ::alignments 6-7|0.0 5-6|0.0.0 4-5|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 0-2|0.1.1+0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:50.344
(o / organization 
      :location (f / family 
            :mod (s / SCA15) 
            :mod (c / country 
                  :name (n / name 
                        :op1 "Australia") 
                  :wiki "Australia")) 
      :name (n2 / name 
            :op1 "Mutation" 
            :op2 "Analysis"))

# ::snt ( Top ) Pedigree of kindred .
# ::tok ( Top ) Pedigree of kindred .
# ::alignments 5-6|0.0 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:50.355
(p / pedigree 
      :mod (k / kindr) 
      :mod-of (t / top))

# ::snt Filled symbols denote affected individuals ; open symbols , unaffected individuals ; grey symbol denotes unknown disease status ; bulls-eye symbol denotes obligate carrier .
# ::tok Filled symbols denote affected individuals ; open symbols , unaffected individuals ; grey symbol denotes unknown disease status ; bulls-eye symbol denotes obligate carrier .
# ::alignments 23-24|0.0 22-23|0 21-22|0.0.0 20-21|0.0.0.0.0+0.0.0.0 17-18|0.0.0.1.0.1 16-17|0.0.0.1.0.1.0 15-16|0.0.0.1.0.1.0.0.0+0.0.0.1.0.1.0.0 14-15|0.0.0.1.0 13-14|0.0.0.1.0.0.0+0.0.0.1.0.0 12-13|0.0.0.1.0.0.0.0 10-11|0.0.0.1.2 9-10|0.0.0.1.2.0.0+0.0.0.1.2.0 7-8|0.0.0.1.1.1.0.0+0.0.0.1.1.1.0 6-7|0.0.0.1.1.1.0.1 5-6|0.0.0.1 4-5|0.0.0.1.1.1.1 3-4|0.0.0.1.1.1 2-3|0.0.0.1.1 1-2|0.0.0.1.1.0.1+0.0.0.1.1.0 0-1|0.0.0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:51.777
(o / obligate-01 
      :ARG1 (c / carrier 
            :ARG1-of (d / denote-01 
                  :ARG0 (t / thing 
                        :ARG1-of (s / symbolize-01)) 
                  :op3-of (a2 / and 
                        :mode-of (d3 / denote-01 
                              :ARG0 (t2 / thing 
                                    :ARG1-of (s3 / symbolize-01 
                                          :duration (g / grey))) 
                              :ARG1 (s2 / status 
                                    :mod (d2 / disease 
                                          :ARG1-of (k / know-01 
                                                :polarity -)))) 
                        :op1 (d4 / denote-01 
                              :ARG0 (t4 / thing 
                                    :ARG1-of (f / fill-01) 
                                    :ARG1-of (s5 / symbolize-01)) 
                              :ARG1 (a3 / affect-01 
                                    :ARG1 (t3 / thing 
                                          :ARG1-of (s4 / symbolize-01) 
                                          :ARG1-of (o2 / open-04)) 
                                    :ARG2 (i2 / individual))) 
                        :op2 (i / individual 
                              :ARG1-of (a / affect-01 
                                    :polarity -))))))

# ::snt w/w , wild-type at ITPR1 ; w/m , heterozygous carrier of the ITPR1 deletion .
# ::tok w/w , wild-type at ITPR1 ; w/m , heterozygous carrier of the ITPR1 deletion .
# ::alignments 13-14|0.0 9-10|0.0.0 5-6|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:51.792
(a / and 
      :mod-of (d / deletion 
            :poss-of (c / carrier)))

# ::snt ( Middle ) Schematic of primer pairs used to narrow the unknown regions between known deleted sequence and known diploid sequence at the SCA15 locus .
# ::tok ( Middle ) Schematic of primer pairs used to narrow the unknown regions between known deleted sequence and known diploid sequence at the SCA15 locus .
# ::alignments 24-25|0.0.0 20-21|0.2.1 19-20|0.2.1.1 18-19|0.2.1.0 17-18|0.2 16-17|0.2.0 15-16|0.2.0.0 14-15|0.2.0.1 12-13|0.1.1 11-12|0.1.1.0.0+0.1.1.0 9-10|0.1 7-8|0 6-7|0.0 5-6|0.0.1 3-4|0.1.0 1-2|0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:52.067
(u / use-01 
      :ARG0 (p / pair-01 
            :ARG0 (l / locu) 
            :ARG1 (p2 / primer)) 
      :ARG2 (n / narrow-01 
            :ARG0 (s3 / schematic) 
            :ARG1 (r / region 
                  :ARG1-of (k3 / know-01 
                        :polarity -))) 
      :op1-of (a / and 
            :op2 (s2 / sequence 
                  :ARG1-of (d2 / delete-01 
                        :ARG0 "Middle_East") 
                  :ARG1-of (k2 / know-02)) 
            :op3 (s / sequence 
                  :ARG1-of (k / know-02) 
                  :mod (d / diploid))))

# ::snt Nine primer pairs ( T1 -- T9 ) were used to amplify across the unknown region telomeric to the known deleted region ; 19 primer pairs ( C1 -- C19 ) were used to amplify across the unknown region centromeric to the known deleted region .
# ::tok Nine primer pairs ( T1 -- T9 ) were used to amplify across the unknown region telomeric to the known deleted region ; 19 primer pairs ( C1 -- C19 ) were used to amplify across the unknown region centromeric to the known deleted region .
# ::alignments 44-45|0.0.0.0.2.0.0 43-44|0.0.0.0.2.0.0.0 42-43|0.0.0.0.2.0 39-40|0.0.0 38-39|0.0 37-38|0.1+0 35-36|0.0.0.0.1 34-35|0.0.0.0 32-33|0.0.0.0.2 25-26|0.0.0.0.0 24-25|0.0.0.0.0.0 23-24|0.0.0.0.0.1 22-23|0.0.0.0.2.1 21-22|0.0.0.0.2.1.0.1.0.0.1.0.0 20-21|0.0.0.0.2.1.0.1.0.0.1.0.0.0 19-20|0.0.0.0.2.1.0.1.0.0.1.0 15-16|0.0.0.0.2.1.0.1 14-15|0.0.0.0.2.1.0.2+0.0.0.0.2.1.0 12-13|0.0.0.0.2.1.0.1.0 11-12|0.0.0.0.2.1.0.1.0.0 9-10|0.0.0.0.2.1.0.1.0.0.1 2-3|0.0.0.0.2.1.0.1.0.0.0 1-2|0.0.0.0.2.1.0.1.0.0.0.0 0-1|0.0.0.0.2.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:52.517
(k2 / know-01 
      :ARG1 (r2 / region 
            :mod-of (c / centromeric 
                  :ARG2-of (a2 / amplify-01 
                        :ARG0 (p / pair-01 
                              :ARG1 (p2 / primer) 
                              :quant 19) 
                        :ARG1 (a / across) 
                        :ARG2-of (u / use-01 
                              :ARG1 (k / know-02 
                                    :ARG1 (r / region 
                                          :ARG1-of (d / delete-01))) 
                              :op1-of (a3 / and 
                                    :ARG1-of (k4 / know-01 
                                          :ARG0 (n / nine) 
                                          :mod-of (r4 / region 
                                                :op1-of (a4 / across 
                                                      :ARG1-of (a5 / amplify-01 
                                                            :ARG0 (p3 / pair-01 
                                                                  :ARG1 (p4 / primer)) 
                                                            :ARG2-of (u2 / use-01 
                                                                  :ARG1 (k3 / know-02 
                                                                        :ARG1 (r3 / region 
                                                                              :ARG1-of (d2 / delete-01))))))) 
                                          :polarity -)))))) 
      :polarity -)

# ::snt All PCRs were carried out in the three affected family members .
# ::tok All PCRs were carried out in the three affected family members .
# ::alignments 10-11|0.0.0.1+0.0.0+0.0 9-10|0.0.0.0 8-9|0.0.1 7-8|0.0.2 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:52.556
(c / carry-out-03 
      :ARG0 (p / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f / family) 
                  :ARG2 (m / member)) 
            :ARG1-of (a / affect-01) 
            :quant 3) 
      :ARG1 (p2 / pcr 
            :quant (a2 / all)))

# ::snt Analysis of these data narrowed the unknown region , and ultimately we were able to use primer T3f and C11r to amplify across the deletion breakpoint in the three affected family members , producing a fragment of 953 bp in affected individuals .
# ::tok Analysis of these data narrowed the unknown region , and ultimately we were able to use primer T3f and C11r to amplify across the deletion breakpoint in the three affected family members , producing a fragment of 953 bp in affected individuals .
# ::alignments 41-42|0.0.0.0.2.0 40-41|0.0.0.0.2 35-36|0.0.0.0.0.2.1.0 33-34|0.0.0.0.0.2.1 31-32|0.0.1.1+0.0.1+0.0 30-31|0.0.1.0 29-30|0 28-29|0.0.2 25-26|0.0.0.0.0.2.2.0 24-25|0.0.0.0.0.2.2.0.0 22-23|0.0.0.0.0.2.2 21-22|0.0.0.0.0.2 19-20|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 18-19|0.0.0.0 17-18|0.0.0.0.0.2.0.1.0+0.0.0.0.0.2.0.1+0.0.0.0.0.2.0 16-17|0.0.0.0.0.2.0.0 15-16|0.0.0.0.0 13-14|0.0.0.0.0.1 11-12|0.0.0.0.0.0 10-11|0.0.0.0.0.1.0 9-10|0.0.0.0.0.1.1 7-8|0.0.0.0.0.1.1.1.1 6-7|0.0.0.1+0.0.0 4-5|0.0.0.0.0.1.1.1 3-4|0.0.0.0.0.1.1.0 2-3|0.0.0.0.0.1.1.0.0 0-1|0.0.0.0.0.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:55.407
(a2 / affect-01 
      :ARG1 (p2 / person 
            :ARG0-of (k / know-01 
                  :ARG1 (a5 / and 
                        :ARG1-of (u / use-01 
                              :ARG0 (w / we) 
                              :ARG1-of (p4 / possible-01 
                                    :mod (u2 / ultimate) 
                                    :op3-of (a6 / and 
                                          :op1 (d2 / data 
                                                :mod (t / this)) 
                                          :op2 (n3 / narrow-01 
                                                :ARG0 (a7 / analysi) 
                                                :ARG1 (r / region)))) 
                              :ARG2 (a4 / amplify-01 
                                    :ARG0 (o2 / organization 
                                          :mod (p3 / primer) 
                                          :name (n2 / name 
                                                :op1 "T3f")) 
                                    :ARG1 (p / produce-01 
                                          :ARG1 (f / fragment-01)) 
                                    :location (a3 / across 
                                          :op1 (b / breakpoint 
                                                :mod (d / deletion))))) 
                        :op1 (o / organization 
                              :name (n / name 
                                    :op1 "C11r")) 
                        :op2 (a / affect-01 
                              :ARG1 (i / individual))) 
                  :polarity -) 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (f2 / family) 
                  :ARG2 (m / member)) 
            :quant 3))

# ::snt ( Bottom ) Gel showing amplification product using primer pair T3f and C11r from affected pedigree members 6 , 7 , and 19 ; in pedigree member 23 , with unknown disease affection status ; in a neurologically normal control ( C ) ; and in a no template control ( NC ) .
# ::tok ( Bottom ) Gel showing amplification product using primer pair T3f and C11r from affected pedigree members 6 , 7 , and 19 ; in pedigree member 23 , with unknown disease affection status ; in a neurologically normal control ( C ) ; and in a no template control ( NC ) .
# ::alignments 51-52|0.2.2.0.0.2.0.0.0.1+0.2.2.0.0.2.0.0.0.0.0+0.2.2.0.0.2.0.0.0.0+0.2.2.0.0.2.0.0.0 49-50|0.2.2.0.0.2.0.1 48-49|0.2.2.0.0.2.0.1.0 47-48|0.2.2.0.0.0.2 44-45|0.2.2.0.0.2.0 41-42|0.0 39-40|0.2.2.0.0.2.0.0 38-39|0.2.2.0.0.2.0.0.2 33-34|0.2.2.0.0.0.0 32-33|0.2.2.0.0.0.0.1 31-32|0.2.2.0.0.0.0.0 30-31|0.2.2.0.0.0.1+0.2.2.0.0.0 27-28|0.2.2.0.0.2.0.1.1 26-27|0.2.2.0.0.1.1+0.2.2.0.0.1 25-26|0.2.2.0.0.1.0 23-24|0.2.2.0.0.2.0.1.2 22-23|0.2.0.0.0.0.0.0 21-22|0.2.2.0.0.2 19-20|0.2.2.0.0.2.0.0.1 17-18|0.2.2.0.0.2.0.0.2.0 16-17|0.2.2.0.1+0.2.2.0+0.2.2.0.0 15-16|0.1 14-15|0 12-13|0.2.2.1.0+0.2.2.1+0.2.2 11-12|0.2 10-11|0.2.1.1.0+0.2.1.1+0.2.1 9-10|0.2.1.0 8-9|0.2.1.0.0 7-8|0.2.0 6-7|0.2.0.0 5-6|0.2.2.0.0.1.2 4-5|0.2.0.0.0 3-4|0.2.0.0.0.0 1-2|0.2.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:58.863
(a5 / affect-01 
      :ARG0 (c2 / C) 
      :ARG1 (p3 / pedigree) 
      :op3-of (a6 / and 
            :ARG1-of (u / use-01 
                  :ARG0 (p6 / product 
                        :ARG1-of (s3 / show-01 
                              :ARG0 (g / gel 
                                    :ARG1-of (b / bottom-01 
                                          :ARG2 19))))) 
            :op1 (o2 / organization 
                  :ARG0-of (p4 / pair-01 
                        :ARG1 (p5 / primer)) 
                  :name (n4 / name 
                        :op1 "T3f")) 
            :op2 (o / organization 
                  :ARG1-of (h2 / have-org-role-91 
                        :ARG0 (p2 / person 
                              :ARG0-of (k / know-01 
                                    :ARG1 (s2 / status 
                                          :mod (d / disease) 
                                          :mod (a2 / affection)) 
                                    :polarity - 
                                    :polarity -) 
                              :ARG0-of (h / have-org-role-91 
                                    :ARG1 (p / pedigree) 
                                    :ARG2 (m / member) 
                                    :ARG3 (a7 / amplification)) 
                              :op1-of (a4 / and 
                                    :op1-of (a / and 
                                          :op2 (c3 / control-01 
                                                :ARG0 (s / state 
                                                      :name (n / name 
                                                            :op1 "NC") 
                                                      :wiki "North_Carolina") 
                                                :ARG1 7 
                                                :ARG1-of (n2 / normal-02 
                                                      :ARG2 6)) 
                                          :op3 (c / control-01 
                                                :ARG0 (t / template) 
                                                :ARG2 23 
                                                :op1-of (a3 / and))))) 
                        :ARG2 (m2 / member)) 
                  :name (n3 / name 
                        :op1 "C11r"))))

# ::snt Western Blot Analysis of ITPR1 Protein Levels in EBV Immortalized Lymphoblasts from AUS1 Family Members .
# ::tok Western Blot Analysis of ITPR1 Protein Levels in EBV Immortalized Lymphoblasts from AUS1 Family Members .
# ::alignments 14-15|0.0.0.0 13-14|0.0.0.0.0 9-11|0+0.0.1+0.0+0.0.0 8-9|0.0.0.2 0-7|0.0.0.1.0.6+0.0.0.1.0.5+0.0.0.1.0.4+0.0.0.1.0.3+0.0.0.1.0.2+0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:08:58.911
(l / Lymphoblasts 
      :op2-of (n / name 
            :name-of (t / thing 
                  :beneficiary (m / member 
                        :mod (f / family)) 
                  :medium-of (o / organization 
                        :name (n2 / name 
                              :op1 "Western" 
                              :op2 "Blot" 
                              :op3 "Analysis" 
                              :op4 "of" 
                              :op5 "ITPR1" 
                              :op6 "Protein" 
                              :op7 "Levels")) 
                  :mod (e / ebv)) 
            :op1 (i / Immortalized)))

# ::snt Western blot performed to examine ITPR1 levels in EBV immortalized lymphocytes from AUS1 affected family members carrying the ITPR1 deletion and from an AUS1 family member of unknown disease status who does not carry the deletion .
# ::tok Western blot performed to examine ITPR1 levels in EBV immortalized lymphocytes from AUS1 affected family members carrying the ITPR1 deletion and from an AUS1 family member of unknown disease status who does not carry the deletion .
# ::alignments 35-36|0.0.0.0.0 33-34|0.0.0.0 32-33|0.0.0.0.1 29-30|0.0.0 28-29|0.0 27-28|0.1+0 25-26|0.0.0.1.0+0.0.0.1 24-25|0.0.0.2 20-21|0.0.0.1.1 19-20|0.0.0.1.1.1.1.0 16-17|0.0.0.1.1.1.1 15-16|0.0.0.1.1.1.0.1+0.0.0.1.1.1.0+0.0.0.1.1.1 14-15|0.0.0.1.1.1.0.0 13-14|0.0.0.1.1.1.2 10-11|0.0.0.1.1.0.0.0.1 9-10|0.0.0.1.1.0.0.0.1.0 8-9|0.0.0.1.1.0.0.0.1.1 6-7|0.0.0.1.1.0.0.1 5-6|0.0.0.1.1.0.0.1.0 4-5|0.0.0.1.1.0.0 2-3|0.0.0.1.1.0 1-2|0.0.0.1.1.0.0.0 0-1|0.0.0.1.1.0.0.0.0.1+0.0.0.1.1.0.0.0.0.0.0+0.0.0.1.1.0.0.0.0.0+0.0.0.1.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:00.811
(k / know-01 
      :ARG1 (d2 / disease 
            :mod-of (s / status 
                  :ARG0-of (c / carry-out-03 
                        :ARG1 (d / deletion) 
                        :polarity -) 
                  :ARG1-of (h / have-org-role-91 
                        :ARG2 (m / member) 
                        :op2-of (a / and 
                              :ARG0-of (p2 / perform-02 
                                    :ARG1 (e2 / examine-01 
                                          :ARG0 (b / blot-01 
                                                :mod (w / world-region 
                                                      :name (n / name 
                                                            :op1 "West") 
                                                      :wiki "Western_world") 
                                                :op1-of (l / lymphocyt 
                                                      :mod (i / immortalize) 
                                                      :mod (e / ebv))) 
                                          :ARG1 (l2 / level 
                                                :mod (i2 / ITPR1)))) 
                              :op1 (p / person 
                                    :ARG0-of (h2 / have-org-role-91 
                                          :ARG1 (f2 / family) 
                                          :ARG2 (m2 / member)) 
                                    :ARG0-of (c2 / carry-01 
                                          :ARG1 (d3 / deletion)) 
                                    :ARG1-of (a2 / affect-01)))) 
                  :mod (f / family))) 
      :polarity -)

# ::snt Notably the samples from patients with ITPR1 deletion show a dramatic decrease in ITPR1 levels .
# ::tok Notably the samples from patients with ITPR1 deletion show a dramatic decrease in ITPR1 levels .
# ::alignments 14-15|0.2 11-12|0.1 10-11|0.1.1 8-9|0 7-8|0.0 6-7|0.0.0 4-5|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 2-3|0.1.0.0+0.1.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:00.953
(s / show-01 
      :ARG0 (d3 / deletion 
            :mod (i / ITPR1 
                  :mod (n / notably))) 
      :ARG1 (d / decrease-01 
            :ARG1 (t / thing 
                  :ARG1-of (s2 / sample-01 
                        :ARG0 (p / person 
                              :ARG0-of (h / have-rel-role-91 
                                    :ARG2 (p2 / patient))))) 
            :mod (d2 / dramatic)) 
      :time (l / level))

# ::snt To demonstrate equal loading , these samples were diluted one in five , and the Western blot was repeated using an antibody against ACTB .
# ::tok To demonstrate equal loading , these samples were diluted one in five , and the Western blot was repeated using an antibody against ACTB .
# ::alignments 23-24|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 21-22|0.2.0.0 19-20|0.2.0 18-19|0.2 16-17|0.2.0.1 15-16|0.2.0.1.0.1+0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 13-14|0 11-12|0.0.0.0 8-9|0.1 6-7|0.1.0.0+0.1.0 5-6|0.1.0.1 3-4|0.0.0 2-3|0.0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:01.954
(a2 / and 
      :op1 (d2 / demonstrate-01 
            :ARG1 (l / load-01 
                  :ARG1 5 
                  :ARG1-of (e / equal-01 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "ACTB"))))) 
      :op2 (d / dilute-01 
            :ARG1 (t / thing 
                  :ARG1-of (s / sample-01) 
                  :mod (t2 / this))) 
      :op3 (r / repeat-01 
            :ARG1 (u / use-01 
                  :ARG1 (a / antibody) 
                  :ARG2 (b / blot-01 
                        :mod (w / world-region 
                              :name (n2 / name 
                                    :op1 "West") 
                              :wiki "Western_world")))))

# ::snt A previous version of this article appeared as an Early Online Release on May 16 , 2007 ( doi : 10.1371 / journal.pgen .0030108 .
# ::tok A previous version of this article appeared as an Early Online Release on May 16 , 2007 ( doi : 10.1371 / journal.pgen .0030108 .
# ::alignments 21-22|0.0.2 20-21|0.0.3+0.0.1+0.0.0+0.0 18-19|0.1.0.0.0.0 13-17|0.1.0.0.0.2.2+0.1.0.0.0.2.1+0.1.0.0.0.2.0+0.1.0.0.0.2 11-12|0.1.0.0.0 10-11|0.1.0.0.0.1 9-10|0.1.0.0 6-7|0 5-6|0.1 4-5|0.1.0 2-3|0.1.1 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:02.399
(a / appear-01 
      :ARG0 (d / date-entity 
            :day 71 
            :month 13 
            :op1-of (s / slash) 
            :year 10) 
      :ARG1 (a2 / article 
            :mod (t / this 
                  :mod-of (e / early 
                        :ARG1-of (r / release-01 
                              :ARG0 (d2 / doi) 
                              :mod (o / online) 
                              :time (d3 / date-entity 
                                    :day 16 
                                    :month 5 
                                    :year 2007)))) 
            :mod (v / version 
                  :time (p / previous))))

# ::snt eor ) .
# ::tok eor ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:02.401
(a / amr-empty)

# ::snt Author contributions .
# ::tok Author contributions .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:02.410
(c / contribute-01 
      :ARG1-of (a / author-01))

# ::snt EMCF , JTR , and ABS conceived and designed the experiments .
# ::tok EMCF , JTR , and ABS conceived and designed the experiments .
# ::alignments 10-11|0.1.0 8-9|0.1 7-8|0 6-7|0.1.1.0 5-6|0.0.0.0+0.0.0+0.0 4-5|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:02.460
(a / and 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "ABS")) 
      :op2 (d / design-01 
            :ARG1 (e / experiment-01) 
            :op1-of (a2 / and 
                  :ARG0-of (c / conceive-01))))

# ::snt JvdL , JC , MAK , LAH , SS , MRC , HCF , XL , DH , JSS , IR , and HC performed the experiments .
# ::tok JvdL , JC , MAK , LAH , SS , MRC , HCF , XL , DH , JSS , IR , and HC performed the experiments .
# ::alignments 26-27|0.0.0 24-25|0.0 23-24|0.9.0.0+0.9.0+0.9 22-23|0 18-19|0.8.0.0+0.8.0+0.8 16-17|0.7.0.0+0.7.0+0.7 14-15|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 12-13|0.6.0.0+0.6.0+0.6 10-11|0.5.0.0+0.5.0+0.5 8-9|0.4.1+0.4.0.0+0.4.0+0.4 6-7|0.3.0.0+0.3.0+0.3 4-5|0.2.0.0+0.2.0+0.2 2-3|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:04.143
(a / and 
      :ARG0-of (p / perform-02 
            :ARG1 (e / experiment-01 
                  :ARG0 (o3 / organization 
                        :name (n3 / name 
                              :op1 "XL")) 
                  :ARG1 (p3 / person 
                        :name (n9 / name 
                              :op1 "JC")))) 
      :op1 (p4 / person 
            :name (n10 / name 
                  :op1 "JvdL")) 
      :op2 (o7 / organization 
            :name (n8 / name 
                  :op1 "MAK")) 
      :op3 (o6 / organization 
            :name (n7 / name 
                  :op1 "LAH")) 
      :op4 (m / military 
            :name (n6 / name 
                  :op1 "SS") 
            :wiki "SS_(Nazi_Germany)") 
      :op5 (o5 / organization 
            :name (n5 / name 
                  :op1 "MRC")) 
      :op6 (o4 / organization 
            :name (n4 / name 
                  :op1 "HCF")) 
      :op7 (p2 / person 
            :ARG0-of (h / have-rel-role-91 
                  :ARG2 (d / DH))) 
      :op8 (o2 / organization 
            :name (n2 / name 
                  :op1 "JSS")) 
      :op9 (o / organization 
            :name (n / name 
                  :op1 "HC")))

# ::snt JvdL , JC , MAK , SS , MRC , KGH , HCF , JSS , JTR , and ABS analyzed the data .
# ::tok JvdL , JC , MAK , SS , MRC , KGH , HCF , JSS , JTR , and ABS analyzed the data .
# ::alignments 22-23|0.1 20-21|0 19-20|0.0.8.0.0+0.0.8.0+0.0.8 18-19|0.0 14-15|0.0.7.0.0+0.0.7.0+0.0.7 12-13|0.0.6.0.0+0.0.6.0+0.0.6 10-11|0.0.5.0.0+0.0.5.0+0.0.5 8-9|0.0.4.0.0+0.0.4.0+0.0.4 6-7|0.0.3.1+0.0.3.0.0+0.0.3.0+0.0.3 4-5|0.0.2.0.0+0.0.2.0+0.0.2 2-3|0.0.1.0.0+0.0.1.0+0.0.1 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:05.288
(a / analyze-01 
      :ARG0 (a2 / and 
            :op1 (p2 / person 
                  :name (n9 / name 
                        :op1 "JvdL")) 
            :op2 (p / person 
                  :name (n8 / name 
                        :op1 "JC")) 
            :op3 (o6 / organization 
                  :name (n7 / name 
                        :op1 "MAK")) 
            :op4 (m / military 
                  :name (n6 / name 
                        :op1 "SS") 
                  :wiki "SS_(Nazi_Germany)") 
            :op5 (o5 / organization 
                  :name (n5 / name 
                        :op1 "MRC")) 
            :op6 (o4 / organization 
                  :name (n4 / name 
                        :op1 "KGH")) 
            :op7 (o3 / organization 
                  :name (n3 / name 
                        :op1 "HCF")) 
            :op8 (o2 / organization 
                  :name (n2 / name 
                        :op1 "JSS")) 
            :op9 (o / organization 
                  :name (n / name 
                        :op1 "ABS"))) 
      :ARG1 (d / data))

# ::snt HH , NWW , PG , JH , ES , RJMG , SMF , HC , and ABS contributed reagents/materials/analysis tools .
# ::tok HH , NWW , PG , JH , ES , RJMG , SMF , HC , and ABS contributed reagents/materials/analysis tools .
# ::alignments 20-21|0.1 19-20|0.1.0 18-19|0 17-18|0.0.3.0.0+0.0.3.0+0.0.3 16-17|0.0 14-15|0.0.2.0.0+0.0.2.0+0.0.2 8-9|0.0.1 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:05.353
(c / contribute-01 
      :ARG0 (a / and 
            :op1 (p / person 
                  :name (n3 / name 
                        :op1 "HH")) 
            :op2 (e / e) 
            :op3 (o2 / organization 
                  :name (n2 / name 
                        :op1 "HC")) 
            :op4 (o / organization 
                  :name (n / name 
                        :op1 "ABS"))) 
      :ARG1 (t / tool 
            :mod (r / reagents/materials/analysi)))

# ::snt RJMG , EMCF , and ABS wrote the paper .
# ::tok RJMG , EMCF , and ABS wrote the paper .
# ::alignments 8-9|0.1 6-7|0 5-6|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:05.470
(w / write-01 
      :ARG0 (a / and 
            :op1 (o / organization 
                  :name (n / name 
                        :op1 "ABS"))) 
      :ARG1 (p / paper))

# ::snt Funding .
# ::tok Funding .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:05.473
(f / fund-01)

# ::snt This research was funded in part by the intramural programs of the National Institute on Aging and the National Institute on Neurological Disorders and Stroke ( NINDS ) , both of the National Institutes of Health , Department of Health and Human Services , United States of America .
# ::tok This research was funded in part by the intramural programs of the National Institute on Aging and the National Institute on Neurological Disorders and Stroke ( NINDS ) , both of the National Institutes of Health , Department of Health and Human Services , United States of America .
# ::alignments 44-48|0.0.3.1.0.0.3+0.0.3.1.0.0.2+0.0.3.1.0.0.1+0.0.3.1.0.0.0+0.0.3.1.0.0+0.0.3.1.0 32-43|0.0.3.0.2+0.0.3.0.1+0.0.3.0.10+0.0.3.0.9+0.0.3.0.8+0.0.3.0.7+0.0.3.0.6+0.0.3.0.5+0.0.3.0.4+0.0.3.0.3+0.0.3.0.0+0.0.3.0+0.0.3 29-30|0.0.3.1 26-27|0.1.0.0+0.1.0+0.1 19-25|0.0.2.1.0.5+0.0.2.1.0.4+0.0.2.1.0.3+0.0.2.1.0.2+0.0.2.1.0.1+0.0.2.1.0.0+0.0.2.1.0+0.0.2.1 16-17|0.0.2 15-16|0 12-14|0.0.2.0.0.1+0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 9-10|0.0 8-9|0.0.1 3-4|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:05.987
(a3 / age-01 
      :ARG0 (p / program 
            :ARG0-of (f / fund-01 
                  :ARG1 (r / research-01 
                        :mod (t2 / this))) 
            :mod (i2 / intramural) 
            :poss (a2 / and 
                  :op1 (o4 / organization 
                        :name (n6 / name 
                              :op1 "National" 
                              :op2 "Institute")) 
                  :op2 (t / thing 
                        :name (n4 / name 
                              :op1 (i / Institute) 
                              :op2 (o3 / on) 
                              :op3 (n5 / Neurological) 
                              :op4 (d / Disorders) 
                              :op5 (a / and) 
                              :op6 (s / Stroke)))) 
            :poss (o / organization 
                  :name (n2 / name 
                        :op1 "National" 
                        :op10 "Human" 
                        :op11 "Services" 
                        :op2 "Institutes" 
                        :op3 "of" 
                        :op4 "Health" 
                        :op5 "," 
                        :op6 "Department" 
                        :op7 "of" 
                        :op8 "Health" 
                        :op9 "and") 
                  :quant (b / both 
                        :op1 (c / country 
                              :name (n / name 
                                    :op1 "United" 
                                    :op2 "States" 
                                    :op3 "of" 
                                    :op4 "America"))))) 
      :ARG1 (o2 / organization 
            :name (n3 / name 
                  :op1 "NINDS")))

# ::snt MAK was supported by a NINDS Competitive Postdoctoral Fellowship .
# ::tok MAK was supported by a NINDS Competitive Postdoctoral Fellowship .
# ::alignments 5-9|0.0.0.3+0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 2-3|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:06.009
(s / support-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "NINDS" 
                  :op2 "Competitive" 
                  :op3 "Postdoctoral" 
                  :op4 "Fellowship")) 
      :ARG1 (o2 / organization 
            :name (n2 / name 
                  :op1 "MAK")))

# ::snt HH is supported by the Medical Research Council , United Kingdom .
# ::tok HH is supported by the Medical Research Council , United Kingdom .
# ::alignments 9-11|0.2.1+0.2.0.1+0.2.0.0+0.2.0+0.2 5-8|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 2-3|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:06.389
(s / support-01 
      :ARG0 (o / organization 
            :name (n2 / name 
                  :op1 "Medical" 
                  :op2 "Research" 
                  :op3 "Council")) 
      :ARG1 (p / person 
            :name (n3 / name 
                  :op1 "HH")) 
      :time (c / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "Kingdom") 
            :wiki "United_Kingdom"))

# ::snt Competing interests .
# ::tok Competing interests .
# ::alignments 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:06.395
(c / compete-01 
      :topic-of (i / interest))

# ::snt The authors have declared that no competing interests exist .
# ::tok The authors have declared that no competing interests exist .
# ::alignments 8-9|0.1 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T06:09:06.454
(d / declare-01 
      :ARG0 (a / author-01) 
      :ARG1 (e / exist-01 
            :ARG1 (i / interest 
                  :ARG1-of (c / compete-02)) 
            :polarity -))

